sanuyah commited on
Commit
3d1bae9
·
verified ·
1 Parent(s): e2061e6

Add files using upload-large-folder tool

Browse files
Files changed (38) hide show
  1. .gitattributes +7 -0
  2. CITATION.md +9 -0
  3. LICENSE_DATA.md +9 -0
  4. README.md +73 -0
  5. annotation_and_boundary_rules.md +21 -0
  6. data/README.md +7 -0
  7. data/extraction/pubmed_gold.csv +0 -0
  8. data/extraction/reddit_gold.csv +0 -0
  9. data/probes/pubmed_probes.csv +0 -0
  10. data/probes/reddit_probes.csv +3 -0
  11. data/probes/synthetic_probes.csv +3 -0
  12. data/splits/extraction/domain_exp3_1_extraction_splits/pubmed/pubmed_exp3_1_extraction_test.csv +0 -0
  13. data/splits/extraction/domain_exp3_1_extraction_splits/pubmed/pubmed_exp3_1_extraction_train.csv +0 -0
  14. data/splits/extraction/domain_exp3_1_extraction_splits/pubmed/pubmed_exp3_1_extraction_validation.csv +69 -0
  15. data/splits/extraction/domain_exp3_1_extraction_splits/reddit/reddit_exp3_1_extraction_test.csv +0 -0
  16. data/splits/extraction/domain_exp3_1_extraction_splits/reddit/reddit_exp3_1_extraction_train.csv +0 -0
  17. data/splits/extraction/domain_exp3_1_extraction_splits/reddit/reddit_exp3_1_extraction_validation.csv +0 -0
  18. data/splits/extraction/domain_exp3_1_extraction_splits/synthetic/synthetic_exp3_1_extraction_test.csv +0 -0
  19. data/splits/extraction/domain_exp3_1_extraction_splits/synthetic/synthetic_exp3_1_extraction_train.csv +0 -0
  20. data/splits/extraction/domain_exp3_1_extraction_splits/synthetic/synthetic_exp3_1_extraction_validation.csv +0 -0
  21. data/splits/probes/pubmed/pubmed_exp3_2_probe_test.csv +0 -0
  22. data/splits/probes/pubmed/pubmed_exp3_2_probe_train.csv +3 -0
  23. data/splits/probes/pubmed/pubmed_exp3_2_probe_validation.csv +0 -0
  24. data/splits/probes/pubmed/split_assignments.csv +679 -0
  25. data/splits/probes/reddit/reddit_exp3_2_probe_test.csv +3 -0
  26. data/splits/probes/reddit/reddit_exp3_2_probe_train.csv +3 -0
  27. data/splits/probes/reddit/reddit_exp3_2_probe_validation.csv +0 -0
  28. data/splits/probes/reddit/split_assignments.csv +682 -0
  29. data/splits/probes/synthetic/README_exp3_2_probe_splits.txt +16 -0
  30. data/splits/probes/synthetic/exp3_2_probe_split_assignments.csv +3001 -0
  31. data/splits/probes/synthetic/exp3_2_probe_split_ids_wide.csv +1801 -0
  32. data/splits/probes/synthetic/exp3_2_probe_split_summary.csv +4 -0
  33. data/splits/probes/synthetic/exp3_2_probe_test.csv +3 -0
  34. data/splits/probes/synthetic/exp3_2_probe_train.csv +3 -0
  35. data/splits/probes/synthetic/exp3_2_probe_validation.csv +0 -0
  36. data_dictionary.md +27 -0
  37. probe_construction.md +24 -0
  38. split_protocol.md +26 -0
.gitattributes CHANGED
@@ -58,3 +58,10 @@ saved_model/**/* filter=lfs diff=lfs merge=lfs -text
58
  # Video files - compressed
59
  *.mp4 filter=lfs diff=lfs merge=lfs -text
60
  *.webm filter=lfs diff=lfs merge=lfs -text
 
 
 
 
 
 
 
 
58
  # Video files - compressed
59
  *.mp4 filter=lfs diff=lfs merge=lfs -text
60
  *.webm filter=lfs diff=lfs merge=lfs -text
61
+ data/splits/probes/pubmed/pubmed_exp3_2_probe_train.csv filter=lfs diff=lfs merge=lfs -text
62
+ data/probes/reddit_probes.csv filter=lfs diff=lfs merge=lfs -text
63
+ data/probes/synthetic_probes.csv filter=lfs diff=lfs merge=lfs -text
64
+ data/splits/probes/reddit/reddit_exp3_2_probe_test.csv filter=lfs diff=lfs merge=lfs -text
65
+ data/splits/probes/synthetic/exp3_2_probe_test.csv filter=lfs diff=lfs merge=lfs -text
66
+ data/splits/probes/reddit/reddit_exp3_2_probe_train.csv filter=lfs diff=lfs merge=lfs -text
67
+ data/splits/probes/synthetic/exp3_2_probe_train.csv filter=lfs diff=lfs merge=lfs -text
CITATION.md ADDED
@@ -0,0 +1,9 @@
 
 
 
 
 
 
 
 
 
 
1
+ # Citation
2
+
3
+ Please cite **CondRelBench: A Mixed-Domain Benchmark for Condition-Scoped Relation
4
+ Understanding** and the dataset DOI:
5
+
6
+ https://doi.org/10.6084/m9.figshare.32948507
7
+
8
+ Add the final paper author list, venue, and year here when those metadata are public.
9
+
LICENSE_DATA.md ADDED
@@ -0,0 +1,9 @@
 
 
 
 
 
 
 
 
 
 
1
+ # Data license
2
+
3
+ The CondRelBench Figshare dataset is distributed under Creative Commons Attribution
4
+ 4.0 International (CC BY 4.0): https://creativecommons.org/licenses/by/4.0/
5
+
6
+ The original project archive did not record a license choice for source code. The
7
+ repository owner must add a code license before public release; this file does not
8
+ grant permissions beyond the stated dataset license.
9
+
README.md ADDED
@@ -0,0 +1,73 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ ---
2
+ license: cc-by-4.0
3
+ language:
4
+ - en
5
+ task_categories:
6
+ - text-classification
7
+ - information-extraction
8
+ pretty_name: CondRelBench
9
+ size_categories:
10
+ - 10K<n<100K
11
+ tags:
12
+ - conditional-relations
13
+ - relation-extraction
14
+ - natural-language-inference
15
+ ---
16
+
17
+ # CondRelBench
18
+
19
+ CondRelBench is a mixed-domain benchmark for condition-scoped relation
20
+ understanding. It contains extraction data and handcrafted P1–P5 probe families
21
+ from Synthetic, PubMed, and Reddit domains.
22
+
23
+ Dataset record: [https://doi.org/10.6084/m9.figshare.32948507](https://doi.org/10.6084/m9.figshare.32948507)
24
+
25
+ Code and evaluation repository:
26
+ [sydneyanuyah/ConditionalCausality](https://github.com/sydneyanuyah/ConditionalCausality)
27
+
28
+ ## Dataset contents
29
+
30
+ | Path | Contents |
31
+ |---|---|
32
+ | `data/extraction/` | Gold condition-scoped extraction data |
33
+ | `data/probes/` | Canonical P1–P5 probe tables and gold labels |
34
+ | `data/splits/extraction/` | Extraction train, validation, and test splits |
35
+ | `data/splits/probes/` | Probe train, validation, and test splits |
36
+
37
+ The canonical probe files contain 52,112 rows grouped into 10,449 tuple families.
38
+
39
+ ## Probe structure
40
+
41
+ Each condition-scoped tuple has five intended probe claims:
42
+
43
+ | Probe | Transformation | Gold label |
44
+ |---|---|---|
45
+ | P1 | Contradict the relation | Not Supported |
46
+ | P2 | Replace the condition | Not Enough Evidence |
47
+ | P3 | Remove the condition | Not Enough Evidence |
48
+ | P4 | Preserve the original condition-scoped relation | Supported |
49
+ | P5 | Contradict the condition | Not Supported |
50
+
51
+ `Tuple_ID` identifies the probe family, and `ProbeID` identifies an individual
52
+ claim. Labels describe whether the complete claim is licensed by the supplied
53
+ paragraph.
54
+
55
+ ## Included documentation
56
+
57
+ - `data_dictionary.md`
58
+ - `split_protocol.md`
59
+ - `probe_construction.md`
60
+ - `annotation_and_boundary_rules.md`
61
+ - `CITATION.md`
62
+ - `LICENSE_DATA.md`
63
+
64
+ ## Citation
65
+
66
+ Please cite **CondRelBench: A Mixed-Domain Benchmark for Condition-Scoped Relation
67
+ Understanding** and the dataset DOI. See `CITATION.md` for the current citation
68
+ record.
69
+
70
+ ## License
71
+
72
+ The dataset is distributed under Creative Commons Attribution 4.0 International
73
+ (CC BY 4.0). See `LICENSE_DATA.md`.
annotation_and_boundary_rules.md ADDED
@@ -0,0 +1,21 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ # Annotation and boundary rules
2
+
3
+ An extraction annotation is a condition-scoped tuple with fields `e1`, `relation`,
4
+ `e2`, and `condition`. The condition must remain attached to the relation rather
5
+ than being treated as optional background. Multiple tuples may be annotated for a
6
+ paragraph.
7
+
8
+ Probe labels use three classes:
9
+
10
+ - `Supported`: the paragraph supports the complete probe claim under its stated
11
+ condition.
12
+ - `Not Supported`: the paragraph contradicts the relation or condition asserted by
13
+ the probe.
14
+ - `Not Enough Evidence`: the paragraph does not license the altered or unconditioned
15
+ claim, even if it could be plausible elsewhere.
16
+
17
+ All P1–P5 rows for the same `Tuple_ID` must stay in the same split. When a source
18
+ document identifier is available, all paragraphs from that document must also stay
19
+ together. Blank evidence must not be converted to support, and external knowledge
20
+ must not override the paragraph.
21
+
data/README.md ADDED
@@ -0,0 +1,7 @@
 
 
 
 
 
 
 
 
1
+ # Data
2
+
3
+ `extraction/` contains gold condition-scoped tuples, `probes/` contains the full
4
+ handcrafted probe benchmark with gold labels and grouping IDs, and `splits/` contains
5
+ the exact released partitions and assignment metadata. See `../docs/data_dictionary.md`
6
+ and `../docs/split_protocol.md` before transforming these files.
7
+
data/extraction/pubmed_gold.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/extraction/reddit_gold.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/probes/pubmed_probes.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/probes/reddit_probes.csv ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:ca3bff1f4aff00a0e31ff3294d360abddc07857a4f04a26d31b010db52afeef5
3
+ size 22119780
data/probes/synthetic_probes.csv ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:4fc0dee30a379c07b2636655f260b5ffd3028651b874333383343a6e63ad956c
3
+ size 27162620
data/splits/extraction/domain_exp3_1_extraction_splits/pubmed/pubmed_exp3_1_extraction_test.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/splits/extraction/domain_exp3_1_extraction_splits/pubmed/pubmed_exp3_1_extraction_train.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/splits/extraction/domain_exp3_1_extraction_splits/pubmed/pubmed_exp3_1_extraction_validation.csv ADDED
@@ -0,0 +1,69 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ Paragraph_ID,Paragraph,Gold Annotation
2
+ P71P8,"The unique properties of mtDNA including its small size, high copy number, susceptibility to mutations and heteroplasmic populations has spearheaded investigations into the clinical significance of somatic mtDNA variation. A recent study suggested that, it is more likely the accumulation of mitochondrial mutations across the entire genome rather than specific mutations that contribute to prostate cancer progression. The latter study showed an association between the mutational load, which is the total number and frequency of mtDNA somatic mutations, and higher Gleason score at diagnosis. We concur that the number and cumulative frequency of SNVs in the mitochondrial genome appears to be an independent predictor for prostate cancer presentation, with significant diagnostic potential for aggressive disease. While we confirm a diagnostic value to the number and frequency of somatic mtDNA SNVs based on a single core interrogation, we do not provide support for the previously reported 3.4 kb mtDNA deletion variant. It should be noted, however, that Mitomics proposes a minimum five-specimen requirement to achieve adequate sensitivity for early prostate cancer detection.","[{'e1': 'the mutational load', 'e2': 'higher Gleason score ', 'relation': 'showed an association with ', 'condition': 'at diagnosis'}]"
3
+ P57P3,"CXCL12 methylation was determined by means of a methylation specific quantitative PCR analysis in a radical prostatectomy patient cohort (n = 247, training cohort). Data published by The Cancer Genome Atlas served as a testing cohort (n = 498). CXCL12 methylation results were correlated to clinicopathological parameters including biochemical recurrence (BCR)-free survival.","[{'e1': 'CXCL12 methylation ', 'e2': 'means of a methylation specific quantitative PCR analysis ', 'relation': 'was determined by ', 'condition': 'in a radical prostatectomy patient cohort'}]"
4
+ P195P6,"In this study, we show that ANO7, a gene specifically expressed in the prostate, is a promising biomarker to predict PrCa aggressiveness. We identified two pathogenic variants that could possibly be utilized in genetic testing of PrCa patients. The stop-gain variant rs148609049 in exon 1 contributes to decreased survival time. The splice site/missense variant rs77559646 in exon 4 increases the risk of PrCa and is also associated with aggressive PrCa. The same variant is an eQTL for ANO7, and high mRNA levels of ANO7 strongly correlate with poor survival. ANO7 gene expression is highly elevated in PrCa tumors versus normal prostate tissue, and high expression strongly increases the PrCa patient mortality rate. These findings should spur further research to elucidate the regulatory networks of ANO7.","[{'e1': 'The stop-gain variant rs148609049 ', 'e2': 'decreased survival time', 'relation': 'contributes to ', 'condition': ' in exon 1 '}, {'e1': 'The splice site/missense variant rs77559646', 'e2': 'the risk of PrCa ', 'relation': ' increases ', 'condition': ' in exon 4'}, {'e1': 'The splice site/missense variant rs77559646', 'e2': 'aggressive PrCa', 'relation': 'is also associated with ', 'condition': ' in exon 4'}]"
5
+ P133P3,"Genomic profiling studies have highlighted disease heterogeneity, suggesting alternative molecular pathways driving prostate cancer development. Lapointe and colleagues have reported high frequency of DNA copy number alterations in prostate cancer lymph node metastases including a gain of 16p13, 8q24 and deletion of 10q23 and 16q23. These copy number alterations represent potential prognostic biomarkers that can be assessed in routine formalin-fixed paraffin-embedded tissue sections using specific DNA probes by FISH. We recently mapped the previously uncharacterized focal 16p13.3 genomic gain in primary prostate tumors and identified PDPK1 encoding 3-phosphoinositide-dependent protein kinase-1 as a likely driver of the gain with functional impact on prostate cancer cell migration. The current study, for the first time, demonstrates that 16p13.3 genomic gain is a predictor of poor clinical outcome in patients treated by radical prostatectomy that can aid to better risk stratify these patients when combined with standard clinicopathologic prognostic markers.","[{'e1': '16p13.3 genomic gain ', 'e2': 'poor clinical outcome ', 'relation': 'is a predictor of ', 'condition': 'in patients treated by radical prostatectomy '}]"
6
+ P35P6,"It is well known that sperm-associated antigen 5 (SPAG5) can bind to microtubules as a regulator of the timing of spindle organization and separation of sister chromatids. Previous studies indicated that SPAG5 was an important variable in mitosis and cell cycle checkpoint regulation. A previous study indicated that SPAG5 may act as a promoter in tumorigenesis and progression. Previous studies showed that SPAG5 overexpression can predict poor prognosis in lung cancer and cervical cancer and alter sensitivity to taxol treatment via the mTOR signaling pathway in cervical cancer. These results indicated that SPAG5 may act as an important oncogene that is involved in the formation and progression of malignancies and might influence the biological behaviors of malignancies. However, the molecular mechanism and role of SPAG5 in PCa development and progression have not yet been investigated.","[{'e1': 'SPAG5 overexpression ', 'e2': 'poor prognosis ', 'relation': 'can predict ', 'condition': 'in lung cancer '}, {'e1': 'SPAG5 overexpression ', 'e2': 'poor prognosis ', 'relation': 'can predict ', 'condition': 'in cervical cance'}, {'e1': 'SPAG5 overexpression ', 'e2': 'taxol treatment via the mTOR signaling pathway ', 'relation': ' alters sensitivity to ', 'condition': 'in cervical cancer'}, {'e1': 'SPAG5 ', 'e2': 'important oncogene that is involved ', 'relation': 'may act as an ', 'condition': 'in the formation and progression of malignancies'}]"
7
+ P105P5,"In the present study, we developed an mRNA expression signature of Gleason score using The Cancer Genome Atlas data, which predicted risk of recurrence and metastatic-lethal progression when tested in an independent patient cohort under long-term follow-up. This transcript signature may improve disease prognostication after radical prostatectomy.","[{'e1': 'This transcript signature ', 'e2': 'disease prognostication', 'relation': 'may improve ', 'condition': ' after radical prostatectomy.'}]"
8
+ P83P10,"A majority of the studies on the role of HH signaling using PCa cell lines have suggested that HH pathway blockade via cyclopamine treatment suppresses tumor growth. Using an in vivo genetic mouse model that reflects the changes in stromal content of human PCa, however, we found that aberrant activation of HH signaling in the Gli1-expressing subset of stromal cells in PB-MYC tumors results in decreased tumor progression, revealing that tumor stroma can restrain PCa progression. We propose that the partially restored smooth muscle layers act as a barrier to prevent epithelial cells from invading into the stroma. It is also possible that SMCs secrete factors, such as pro-differentiation proteins, that restrain tumor progression. Together with several recent studies showing that inhibition of HH signaling in the stroma of pancreas and bladder cancers decreases survival, our findings offer an explanation for the unsuccessful clinical trials using small-molecule HH antagonists for PCa. Further research into genetic models that represent later stages of human PCa will provide additional evidence for the value of altering HH function for PCa patients.","[{'e1': 'HH pathway blockade treatment ', 'e2': 'tumor growth', 'relation': 'suppresses ', 'condition': 'via cyclopamine'}, {'e1': 'inhibition of HH signaling ', 'e2': 'survival', 'relation': 'decreases ', 'condition': 'in the stroma of pancreas and bladder cancers'}]"
9
+ P116P4,"The mTOR signaling pathway is hyperactivated in prostate cancer tumors compared with benign tissues. Alterations leading to hyperactivation of mTOR and its upstream regulators are among the most frequent genomic alterations in metastatic castration-resistant prostate cancer. However, whether nuclear mTOR is directly implicated in prostate cancer progression or transcriptional cross-talk with the androgen receptor remains unknown. In this study, we demonstrate that activated androgen receptor enhances and reprograms mTOR chromatin binding and that nuclear mTOR activity is essential for androgen-mediated transcriptional reprogramming of metabolism in prostate cancer cells. We also observed a strong correlation between mTOR nuclear content and prostate cancer aggressiveness. Finally, we identified an mTOR-dependent transcriptional signature that discriminates between normal tissues, primary cancer, and metastatic disease and predicts recurrence, underscoring the biological and clinical importance of nuclear mTOR activity.","[{'e1': ' Alterations leading to hyperactivation of mTOR and its upstream regulators ', 'e2': 'the most frequent genomic alterations ', 'relation': 'are among ', 'condition': 'in metastatic castration-resistant prostate cancer'}, {'e1': 'nuclear mTOR activity ', 'e2': ' androgen-mediated transcriptional reprogramming of metabolism ', 'relation': 'is essential for', 'condition': 'in prostate cancer cells'}]"
10
+ P140P3,"The micro-RNAs are small noncoding RNAs regulating protein expression and numerous cellular processes. These are involved in the normal functioning of cells, while dysregulations of miRs are associated with disease. Various dysregulations of certain miRs associated with specific cancers have been identified, and they may have either tumor suppressor or oncogenic functions able to modulate nearly all stages of cancer progression including proliferation, apoptosis, cell migration, angiogenesis and stem cell maintenance. miR-205 acts either as an oncogene or as a tumor suppressor by facilitating or repressing tumor initiation and proliferation depending on type of cancer and stage. Recently, there has been a major effort to target these non-coding RNAs therapeutically, and a few miRs have entered preclinical and clinical trials. While studies have demonstrated that miR-205 in general is involved in both normal development and cancer, the prognostic role of miR-205 in prostate cancer is not unambiguously clarified in prostate cancer. miR-205 is found to be downregulated in prostate cancer tissue compared to benign tissues, and loss of miR-205 seems to be associated with an invasive phenotype and poor clinical outcome. miR-205 has a tumor suppressive function by inhibiting the transition from epithelial to mesenchymal tissue, cell migration and invasion in the prostate. In a recent study carried out in prostate cancer clinical samples, miR-205 was demonstrated to act against tumor initiation and progression by basement membrane maintenance or repressing the mitogen-activated protein kinase and androgen receptor-signaling pathway. However, high miR-205 expression has also been associated with adverse outcome in prostate cancer patients. Since miR-205 was consistently downregulated for a selected group of 14 prostate cancer patients with rapid biochemical failure in our previous screening array of 1435 miRs in tumor tissue, we set out to investigate the prognostic role of miR-205 in our large and well-described cohort of 535 Norwegian prostatectomy patients with extensive follow-up.","[{'e1': 'miR-205 ', 'e2': 'an oncogene or as a tumor suppressor ', 'relation': 'acts as ', 'condition': 'by facilitating or repressing tumor initiation and proliferation depending on type of cancer and stage'}, {'e1': 'high miR-205 expression ', 'e2': 'adverse outcome', 'relation': 'has also been associated with ', 'condition': ' in prostate cancer patients'}]"
11
+ P90P3,"Radical prostatectomy is a treatment option for organ-confined tumors and demonstrates good results in large surgical series; however, up to a quarter of patients experience recurrence after surgery. Prior identification of patients with poor prognosis and higher chances of recurrence is important to determine cases requiring adjuvant treatments. The well-established classic prognostic parameters, such as Gleason score, stage and PSA, can estimate aggressiveness and recurrence in prostate cancer. However, these parameters are often deficient, even when used in combination, which may be due to the biological variability of prostate cancer.","[{'e1': 'Radical prostatectomy', 'e2': 'good results ', 'relation': ' demonstrates ', 'condition': 'in large surgical series'}, {'e1': 'a quarter of patients ', 'e2': 'recurrence', 'relation': 'experience ', 'condition': ' after surgery.'}, {'e1': 'prognostic parameters, such as Gleason score, stage and PSA', 'e2': 'aggressiveness and recurrence ', 'relation': 'can estimate ', 'condition': 'in prostate cancer'}]"
12
+ P27P2,"Prostate cancer is the most frequent male cancer in the developed world. Whereas most prostate cancers are relatively slow growing and tumors localized to the prostate can be cured by radical prostatectomy (RP) or radiation therapy, metastatic prostate cancer is incurable. Thus, early detection and treatment is essential. Many prostate cancers, however, may not cause clinical symptoms within the patient’s lifetime and as treatment is associated with severe side-effects, only men with aggressive prostate cancer should be treated. Prostate cancer is definitively diagnosed by histopathological evaluation of prostate biopsies, but the initial indicator is often increased serum prostate specific antigen (PSA). Serum PSA has relatively high sensitivity, but rather low specificity for prostate cancer. Its use has therefore led to a large increase in prostate cancer diagnoses and treatments. Due to the high prevalence of indolent prostate cancers and lack of accurate prognostic tools to guide treatment decisions, a significant number of men may be over-treated. Novel molecular markers may aid in early detection and in determining the aggressiveness of prostate cancer, but are generally not used in current clinical practice.","[{'e1': 'Serum PSA use ', 'e2': 'a large increase ', 'relation': 'has therefore led to ', 'condition': 'in prostate cancer diagnoses and treatments'}]"
13
+ P83P7,"In three mouse models of PCa, including one with highly recurrent mutations in human PCa (ERG/PTEN), we found distinct contributions of smooth-muscle-like and fibroblast-like cells to the stroma, yet HH signaling (Gli1nlacZ expression) was restricted to stromal cells, especially near the tumor epithelium. Whereas TRAMP tumors had an increase in SMCs and little change in interductal fibroblasts, PB-MYC, and to a lesser extent ERG/PTEN, had a decrease in SMCs and an accompanying increase in fibroblast-like stromal cells between the ducts. RNA-seq analysis of Gli1GFP-labeled cells of PB-MYC and normal prostate similarly revealed a major decrease in smooth muscle genes, and the fibroblast gene Vim was not altered. Based on the Human Protein Atlas and RNA data analysis, we confirmed that human PCa tumors have a dramatic disruption of the smooth muscle layers and a clear decrease in the mature smooth muscle marker calponin (CNN1) in advanced tumors, consistent with a previous report. ACTA2 staining revealed the smooth muscle layers were disrupted and the proportion of cells was decreased in most advanced tumor samples, whereas VIM was maintained in the remaining stromal cells. Analysis of TCGA, the largest RNA-seq dataset of primary PCa samples, revealed a decrease in ACTA2 and CNN1 but not VIM expression in more advanced tumors (higher Gleason score), suggesting the proportion of SMCs in human tumors, or at least the expression levels of the cell type-specific genes, are decreased. In a separate RNA expression dataset, ACTA2 and CNN1 but not VIM expression were found to be significantly lower in metastatic samples compared with primary tumors. In addition, we found correlations between higher luminal or lower basal cell gene expression and lower smooth muscle gene expression. Our study thus demonstrates that PCa in PB-MYC mice nicely models the decrease in smooth muscle layers seen in more advanced human PCa.","[{'e1': 'RNA-seq analysis of Gli1GFP-labeled cells of PB-MYC ', 'e2': 'a major decrease ', 'relation': 'similarly revealed ', 'condition': 'in smooth muscle genes'}, {'e1': 'normal prostate ', 'e2': 'a major decrease ', 'relation': 'similarly revealed ', 'condition': 'in smooth muscle genes'}, {'e1': ' human PCa tumors ', 'e2': 'the mature smooth muscle marker calponin (CNN1) ', 'relation': 'decrease in ', 'condition': 'in advanced tumors'}, {'e1': ' ACTA2 and CNN1', 'e2': 'metastatic samples compared with primary tumors', 'relation': 'were found to be significantly lower in ', 'condition': 'In a separate RNA expression dataset'}]"
14
+ P41P3,"These uncertainties in treating PCa are mainly derived by our inability to accurately identify the natural history and aggressiveness of the tumor at an individualized level. To address this issue, many PCa classification systems have been proposed, such as TNM staging, Gleason score grading, D’Amico risk stratification, the University of California, San Francisco-Cancer of the Prostate Risk Assessment (CAPRA) score, and many others. Although these models have improved our ability to evaluate and predict the aggressiveness of PCa, their performance in many cases is still suboptimal. This may stem from the fact that these models rely heavily on the macro- and microscopic features of the tumor, which can be misleading. Further, current risk prediction methods are limited because they are unable to distinguish individual risk for patients who present with similar pathology. To overcome this limitation, genomic markers have been proposed as a complementary tool to these models. These markers offer the advantage of capturing information that is beyond the reach of the routinely available clinical and pathologic characteristics of the disease, such as tumor stage, grade, and prostate-specific antigen (PSA) value. This will likely revolutionize the way we approach PCa, and allow us to conquer new territories in our continuous fight against this disease. The objective of this review is to assess the role of one of the most promising genomic biomarkers, Decipher (GenomeDx Biosciences, San Diego, CA), in staging/grading and managing PCa.","[{'e1': ' uncertainties in treating PCa ', 'e2': 'natural history and aggressiveness of the tumor ', 'relation': 'are mainly derived by our inability to accurately identify the ', 'condition': 'at an individualized level.'}]"
15
+ P74P1,"Although the enumeration of circulating tumor cells (CTC) defined as expressing both epithelial cell adhesion molecule and cytokeratins (EpCAM+/CK+) can predict prognosis and response to therapy in metastatic breast, colon and prostate cancer, its clinical utility (i.e., the ability to improve patient outcome by guiding therapy) has not yet been proven in clinical trials. Therefore, scientists are now focusing on the molecular characterization of CTC as a way to explore its possible use as a “surrogate” of tumor tissues to non-invasively assess the genomic landscape of the cancer and its evolution during treatment. Additionally, evidences confirm the existence of CTC in epithelial-to-mesenchymal transition (EMT) characterized by a variable loss of epithelial markers. Since the EMT process can originate cells with enhanced invasiveness, stemness and drug-resistance, the enumeration and characterization of this population, perhaps the one truly responsible of tumor recurrence and progression, could be more clinically useful. For these reasons, several devices able to capture CTC independently from the expression of epithelial markers have been developed. In this review, we will describe the types of heterogeneity so far identified and the key role played by the epithelial-to-mesenchymal transition in driving CTC heterogeneity. The clinical relevance of detecting CTC-heterogeneity will be discussed as well.","[{'e1': 'circulating tumor cells (CTC) ', 'e2': 'prognosis and response to therapy ', 'relation': 'can predict ', 'condition': 'in metastatic breast'}, {'e1': 'circulating tumor cells (CTC) ', 'e2': 'prognosis and response to therapy ', 'relation': 'can predict ', 'condition': 'in prostate cancer'}, {'e1': 'circulating tumor cells (CTC) ', 'e2': 'prognosis and response to therapy ', 'relation': 'can predict ', 'condition': 'in colon cancer'}]"
16
+ P94P3,"In 2007, the first in vivo proof-of-concept for AR NTD as a novel therapeutic target was provided using copies (decoys) of the AR NTD residues 1–558 (AR1-558). In non-castrated hosts, these decoys reduced tumor incidence, decreased tumor growth and serum PSA levels. Here we provide evidence that lentiviral delivery of decoys to mice bearing established prostate cancer xenografts inhibited hormonal progression to castration-recurrence as well as investigated possible mechanisms through which decoys exert their activity.","[{'e1': 'these decoys ', 'e2': 'tumor incidence', 'relation': 'reduced ', 'condition': ' In non-castrated hosts'}, {'e1': 'these decoys ', 'e2': 'tumor growth and serum PSA levels', 'relation': 'decreased ', 'condition': ' In non-castrated hosts'}]"
17
+ P173P6,"This study has identified a new miRNA involved in prostate cancer radiotherapy resistance. miR-106a is significantly upregulated in human prostate tumors, with increased expression in high-grade tumors compared to low- and intermediate-grade tumors. We also show for the first time a novel role for LITAF in regulating radioresistance, where knockdown of LITAF induces increased survival and proliferation after radiation. LITAF expression shows the opposite trend as miR-106a in the TCGA dataset, and in addition, the combination of high miR-106a and low LITAF expression predicts for biochemical recurrence at 5 years after radical prostatectomy. We propose a model whereby miR-106a targets LITAF, resulting in ATM upregulation and radioresistance. This may be independent of ATM’s role in DNA damage repair. In addition, we have identified KU-55933 as a potential therapeutic intervention in combination with radiation, to radiosensitize miR-106a-induced radiation-resistant prostate cancer. Our findings identify miR-106a and LITAF as novel modulators of radioresistance through ATM upregulation and suggest that miR-106a may be a promising biomarker for high-grade disease and radioresistant prostate cancer.","[{'e1': ' the combination of high miR-106a and low LITAF expression ', 'e2': 'biochemical recurrence ', 'relation': 'predicts for ', 'condition': 'at 5 years after radical prostatectomy'}, {'e1': 'knockdown of LITAF', 'e2': 'increased survival and proliferation ', 'relation': ' induces ', 'condition': 'after radiation'}]"
18
+ P102P3,"Our work is motivated by a recent study of genomic biomarkers in relation to risk for prostate cancer recurrence after prostatectomy. One of the important challenges in current prostate cancer research is to develop effective methods such as biomarker assays to determine whether a patient is likely to progress to aggressive, metastatic disease or have cancer recurrence following a treatment such as surgery in order to aid clinicians in deciding on the appropriate course of treatment, for example whether immediate adjuvant therapy is warranted after prostatectomy. In particular, biomarker assays that could predict progression, metastasis and recurrence for prostate cancer patients would be of great utility in aiding clinical management of this large patient population. This study includes a training set of 73 patients and an independent testing set of 40 patients with each patient undergoing radical prostatectomy after a diagnosis of prostate cancer. RNA samples were isolated from formalin-fixed paraffin-embedded radical prostatectomy specimens that were obtained from these patients. Using these RNA samples, a customized cDNA-mediated Annealing, Selection, Extension and Ligation assay was conducted to measure expression profiles of 522 prostate cancer related genes that were selected from literature and the miRNA Expression Profiling Panel designed for the DASL assay was used to determine expression of 403 human miRNAs that were present on the miRNA microarrays used for both the training data and the testing data. Four clinical variables, prostate-specific antigen levels, histological grade, tumor stage and age, as well as the long-term clinical outcome on cancer recurrence were collected for all patients. The primary goal of this study is to identify mRNA and miRNA biomarkers that are predictive of prostate cancer recurrence after prostatectomy. Earlier analyses of the data used the l1-regularized Cox proportional hazards model and identified two prediction models, one using only mRNA biomarkers and the other using both mRNA and miRNA biomarkers, for prostate cancer recurrence, which did not incorporate biological information or conduct hierarchical feature selection.","[{'e1': 'mRNA and miRNA biomarkers ', 'e2': 'prostate cancer recurrence ', 'relation': 'are predictive of ', 'condition': 'after prostatectomy'}, {'e1': 'each patient ', 'e2': 'radical prostatectomy ', 'relation': 'undergoing ', 'condition': 'after a diagnosis of prostate cancer'}]"
19
+ P17P4,"Our recent analysis of the pioneer transcription factor FoxA1 revealed its collaborative relationship with the cAMP response element binding protein (CREB1) in determining the expression of G1/S phase cell cycle progression genes. Additionally, these factors support the androgen-independent AR-mediated expression of G2/M phase cell cycle enhancers in CRPC cells. These results suggest that comprehensive analysis of genome-wide CREB1/FoxA1 cooperativity may define disease-relevant gene expression profiles during the evolution and progression of human prostate cancer.","[{'e1': 'androgen-independent AR-mediated', 'e2': ' G2/M phase cell cycle enhancers ', 'relation': ' expression of', 'condition': 'in CRPC cells.'}]"
20
+ P87P23,"In the main cohort the five-year biochemical recurrence free rates were 100%, 75% and 46% for the patients in the low, intermediate and high NCWP-EMT score groups, respectively, and the Kaplan-Meier plot showed a significant separation between the groups. Validation of recurrence was possible in the GSE21034 cohort and showed a similar pattern with 10-year biochemical recurrence free rates of 81%, 73% and 57% in patients with low, intermediate and high NCWP-EMT score, respectively. However, there was no significant separation in the Kaplan-Meier curves for this cohort. For this validation dataset there was only one sample per patient, not necessarily extracted from the most aggressive cancer foci, which may reduce the precision of the NCWP-EMT grouping for biochemical recurrence analysis. In addition, many of the patients in the validation dataset were lost to follow-up early, and therefore censored in the analysis, causing reduced reliability of the curves. In the GSE46691 cohort, samples with high NCWP-EMT scores were significantly associated with metastases. With the significant separation in our data, and the similar trend in the validation datasets, we therefore suggest that increased NCWP-EMT signature score is associated with an increased risk of biochemical recurrence and metastases. This strengthens the NCWP-EMT signature, and the activation of the Wnt5/Fzd2 pathway, as markers of aggressive prostate cancer.","[{'e1': ' samples with high NCWP-EMT scores ', 'e2': 'metastases', 'relation': 'were significantly associated with ', 'condition': 'In the GSE46691 cohort'}]"
21
+ P81P10,"The effect of UCA1 on radiation response appears to be partly related to its role in cell cycle regulation. In bladder carcinoma cells, UCA1 regulates cell cycle progression through CREB and via PI3K-AKT-dependent signalling pathways. Our findings similarly suggest that UCA1 can modulate radiosensitivity of PCa cells by impairing cell cycle progression, potentially through downregulation of the PI3K/Akt pathway. Future experiments employing RNAseq to capture the transcriptomic landscape regulated by UCA1 may contribute to additional mechanistic findings.","[{'e1': 'The effect of UCA1 on radiation response ', 'e2': 'its role ', 'relation': 'appears to be partly related to ', 'condition': 'in cell cycle regulation'}, {'e1': ' UCA1', 'e2': 'cell cycle progression ', 'relation': ' regulates ', 'condition': 'through CREB '}, {'e1': ' UCA1', 'e2': 'cell cycle progression ', 'relation': ' regulates ', 'condition': 'via PI3K-AKT-dependent signalling pathways'}, {'e1': 'UCA1', 'e2': 'radiosensitivity of PCa cells ', 'relation': ' can modulate ', 'condition': 'by impairing cell cycle progression, potentially through downregulation of the PI3K/Akt pathway'}]"
22
+ P46P6,"In summary, we report an oncogenic role for TRIM24 as a transcriptional activator and mediator of hormone-refractory PC cell growth in SPOP mutant and CRPC. We hypothesize that our new insights will provide the rationale for targeting TRIM24 in these settings.","[{'e1': 'oncogenic role for TRIM24 ', 'e2': 'hormone-refractory PC cell growth ', 'relation': 'as a transcriptional activator and mediator of ', 'condition': 'in SPOP mutant and CRPC'}]"
23
+ P173P3,"MicroRNA are small noncoding RNA that negatively regulate gene expression. miRNA are transcribed into long stem loop structures that ultimately form a double-stranded RNA. The dominant RNA strand is incorporated into the RNA silencing complex to facilitate target mRNA binding, and the complementary strand is degraded. miRNA decrease protein expression of their target mRNA by binding imperfectly to nucleotides in the seed sequence in the mRNA 3′ untranslated region. Transcript degradation is the major outcome of miRNA-mRNA binding, occurring through the 5′-to-3′ mRNA decay pathway.","[{'e1': 'miRNA ', 'e2': 'protein expression of their target mRNA', 'relation': 'decrease ', 'condition': ' by binding imperfectly to nucleotides in the seed sequence in the mRNA 3′ untranslated region'}]"
24
+ P81P9,Our results suggest that UCA1 knockdown reduces Akt activation and consequently improves sensitivity to radiation. The process of radiation resistance involves many molecular pathways. The expression and dysregulation of lncRNAs are highly cancer type specific. UCA1 may regulate therapy response in PCa tumors through its effects on different target genes. The selection of targets may also vary depending on physiological contexts or distinct tumor microenvironment.,"[{'e1': ' UCA1 ', 'e2': 'therapy response through its effects on different target genes', 'relation': 'may regulate ', 'condition': 'in PCa tumors'}]"
25
+ P70P4,"Paired analysis of single prostate cancer cells in blood and bone shows promise for clinical application and provides complementary information. The high prevalence and prognostic significance of tumor cell clusters, particularly in bone marrow aspirates, suggest that these structures are key mediators of prostate cancer's metastatic progression.","[{'e1': 'Paired analysis of single prostate cancer cells ', 'e2': 'clinical application ', 'relation': 'shows promise for ', 'condition': 'in blood and bone'}, {'e1': 'Paired analysis of single prostate cancer cells ', 'e2': 'complementary information', 'relation': 'provides ', 'condition': 'in blood and bone'}, {'e1': 'tumor cell clusters ', 'e2': ""prostate cancer's metastatic progression"", 'relation': 'are key mediators of ', 'condition': 'particularly in bone marrow aspirates, '}]"
26
+ P38P7,"A pre-specified aim of the original gene identification study conducted on RP specimens was to assess gene expression in NT adjacent to prostate tumor, where “adjacent” was defined as ≥3-mm distant from tumor. The goal of this analysis was to identify gene expression changes in NT that could predict clinical outcome and to compare the gene expression patterns from NT to tumor tissue. Additionally, post-hoc analyses were conducted to evaluate if GPS, developed using the tumor-containing tissue, was predictive of outcome when applied to gene expression derived from NT specimens. In this study we asked whether identification of genes in NT would provide evidence for a biologically meaningful field effect in the tumor-containing prostate and identify early markers of aggressive PCa assayable in non-tumor tissue.","[{'e1': 'the original gene identification study conducted on RP specimens ', 'e2': 'gene expression ', 'relation': 'was to assess ', 'condition': 'in NT adjacent to prostate tumor'}, {'e1': 'identification of genes in NT', 'e2': 'biologically meaningful field effect ', 'relation': ' would provide evidence for a ', 'condition': 'in the tumor-containing prostate '}, {'e1': 'identification of genes in NT', 'e2': 'aggressive PCa assayable', 'relation': 'would identify early markers of ', 'condition': ' in non-tumor tissue.'}]"
27
+ P79P5,"Chromosome 8p deletion is one of the most frequent alterations in many different cancer types. 8p deletions are typically large and often involve the entire short arm of the chromosome. This made the search for 8p deletion target genes difficult. Extensive studies searching for the underlying tumor suppressor gene have failed to identify a universal 8p tumor suppressor but have revealed multiple 8p genes with documented tumor suppressive properties, such as NKX3.1, CSMD1, DLC1, PPP2CB and PPP3CC, MSR1, TNFRSF10C and TNFRSF10D. Studies employing whole genome or exome sequencing have meanwhile clarified that 8p deletion is, in the vast majority of cases, not accompanied by a mutation of the coding area of any 8p gene. It is still possible that one or several 8p-deleted genes are completely silenced by epigenetic or other mechanisms. It is an appealing alternative, however, that reduced expression of a combination of 8p genes could exert biologically relevant consequences in case of heterozygous 8p deletion. Studies in murine models of hepatocellular carcinomas, another cancer type frequently affected by large 8p deletions, have shown that partial inactivation of several 8p genes can cooperatively drive cancer development, thus supporting a model of compound haplo-insufficiency which might also apply for 8p-deleted prostate cancers. A significant biologic impact of haplo-insufficiency has recently also been demonstrated for NKX3.1.","[{'e1': 'Chromosome 8p deletion ', 'e2': 'most frequent alterations ', 'relation': 'is one of the ', 'condition': 'in many different cancer types'}]"
28
+ P22P3,"Our comparison revealed 21 differentially expressed snoRNAs in the metastatic vs. non-metastatic xenografts. Of those, 12 were represented in clinical databases and were further analyzed. SNORA55 emerged as a predictor of shorter relapse-free survival (results confirmed in two independent databases). SNORA55 was reproducibly detectable in serum samples from PCa patients. SNORA55 silencing in PCa cell lines significantly inhibited cell proliferation and migration. Pathway analysis revealed that SNORA55 expression is significantly associated with growth factor signaling and pro-inflammatory cytokine expression in PCa. Our results demonstrate that SNORA55 up-regulation predicts PCa progression and that silencing this non-coding gene affects PCa cell proliferation and metastatic potential, thus positioning it as both a novel biomarker and therapeutic target.","[{'e1': 'Our comparison', 'e2': '21 differentially expressed snoRNAs ', 'relation': ' revealed ', 'condition': 'in the metastatic vs. non-metastatic xenografts'}, {'e1': 'SNORA55 silencing ', 'e2': 'cell proliferation and migration', 'relation': ' significantly inhibited ', 'condition': 'in PCa cell lines'}, {'e1': ' SNORA55 expression ', 'e2': ' growth factor signaling and pro-inflammatory cytokine expression ', 'relation': 'is significantly associated with', 'condition': 'in PCa'}]"
29
+ P25P4,"There are few investigations that have examined aberrant DNA methylation in African American PCa patients, and these mainly consist of candidate gene studies. For instance, Tang et al. reported that hypermethylation of RARB was significantly associated with a higher risk of PCa in African American men but not in men of European ancestry. Woodson et al. described hypermethylation of CD44 in tumor tissues from African Americans (43% compared to 25% in European Americans), and found that this was positively correlated with tumor grade. The one publication to date that focused on epigenome-wide DNA methylation in African American PCa patients analyzed only three tumors in this high-risk population. That study found that the promoter regions of several genes, including SNRPN, MST1R, and ABCG5, were hypermethylated in African Americans compared to European Americans.","[{'e1': ' few investigations ', 'e2': 'aberrant DNA methylation ', 'relation': 'that have examined ', 'condition': 'in African American PCa patients'}, {'e1': 'hypermethylation of RARB ', 'e2': 'a higher risk of PCa ', 'relation': 'was significantly associated with ', 'condition': 'in African American men'}]"
30
+ P36P7,"The androgen receptor (AR) is a ligand-activated transcription factor that is central to the initiation and progression of prostate cancer. The importance of AR signalling is underscored by the clinical utility of castration in producing symptomatic relief and objective responses in men with advanced prostate cancer. During prostate development, AR activation is known to increase the expression of growth factors, transcription factors and signalling peptides that are involved in cell proliferation, resistance to apoptosis, invasion and migration, processes which are necessary for successful organogenesis and are subsequently exploited by cancer. The expression of AR has been demonstrated to increase with increasing tumour grade and stage, as do serum levels of prostate specific antigen (PSA), the product of the prototypical androgen responsive gene KLK3. In fact, the positive relationship between increasing serum PSA and increasing tumour stage and grade informs all aspects of its usage in the clinical management of prostate cancer patients. However, it has been recognised for some time that there exists a small cohort of patients with primary prostate cancer that remains localised to the prostate, in whom serum PSA does not accurately reflect the extent of their disease burden. These ‘low-secreting’ tumours are reported to have a worse prognosis compared to grade- and stage-matched controls. This is supported by a number of studies indicating that the incidence of prostate cancer, including high-grade tumours, is significant in patients with serum PSA levels within the quoted normal range.","[{'e1': ' AR activation ', 'e2': 'expression of growth factors', 'relation': 'is known to increase the ', 'condition': 'During prostate development,'}, {'e1': ' AR activation ', 'e2': 'expression of transcription factors ', 'relation': 'is known to increase the ', 'condition': 'During prostate development,'}, {'e1': ' AR activation ', 'e2': 'expression of signalling peptides', 'relation': 'is known to increase the ', 'condition': 'During prostate development,'}, {'e1': 'clinical utility of castration', 'e2': 'symptomatic relief and objective responses ', 'relation': ' in producing ', 'condition': 'in men with advanced prostate cancer'}]"
31
+ P191P2,"Prostate cancer (PCa) is one of the most prevalent cancer types in men; in 2015, there were 60,300 newly diagnosed cases of PCa in China, resulting in 26,000 mortalities. Disease recurrence has been reported in a large proportion of patients following radical prostatectomy, and castration-resistant disease typically develops as a result. Although prognostic and clinical indicators were implemented, the prognostic effect was not fully understood. Thus, clinical biomarkers for PCa biochemical recurrence are required. Huang et al used long non-coding RNAs to develop a prediction model for biochemical recurrence; however, the analysis lacked validation datasets.","[{'e1': 'Disease recurrence ', 'e2': 'a large proportion of patients ', 'relation': 'has been reported in ', 'condition': 'following radical prostatectomy'}]"
32
+ P163P10,"PSA is commonly used as a tumour biomarker after RP in order to identify possible recurrences. Early (< 3 year) biochemical failure was identified as a significant predictor of metastatic progression and cancer related death, thus representing a useful marker in the clinical practice. We expect an improvement of early biochemical failure in the study arm compared to the control arm. The prognostic value of PSA nadir to predict PCa survival after 3 months of hormonal treatment and before EBRT was tested. PSA levels < 0.5 ng/ml can predict patient survival and this observation was also confirmed recently for PSA levels ‚â§ 0.3 ng/ml. PSA nadir before EBRT is, thus, an important biomarker of hormonal response and also a predictor of survival in this setting.","[{'e1': 'PSA ', 'e2': ' a tumour biomarker', 'relation': 'is commonly used as', 'condition': ' after RP'}]"
33
+ P17P5,"Individually, while FoxA1 has been well characterized, CREB1-mediated transcription remains largely unexplored in prostate cancer. This important second messenger-responsive transcription factor (TF), in addition to promoting cell cycle progression, has been implicated in several prostate cancer-relevant functions including steroidogenesis and bone metastasis . CREB1 is also emerging as a key mediator of metabolic programs in cancer cells, orchestrating the response to metabolic stress and multiple extracellular hormonal signals. Its kinase-inducible transactivation, minimally by Serine 133 phosphorylation resulting in CREB binding protein (CBP)/p300 recruitment to target gene loci, can be stimulated by multiple signaling pathways, some of which are deregulated in prostate cancer (ex. IGF-I and PI3K/Akt). Consequently, CREB1 signaling represents an attractive therapeutic candidate. Complete profiling of CREB1 target genes should therefore expand on these insights and provide a rationale for the development and use of direct or indirect CREB1-inhibiting compounds in prostate cancer prevention or therapy.","[{'e1': 'CREB1 ', 'e2': 'metabolic programs ', 'relation': 'is also emerging as a key mediator of ', 'condition': 'in cancer cells'}]"
34
+ P41P2,"In the United States, approximately 220,800 men are diagnosed with prostate cancer (PCa) and more than 27,000 men die from the disease annually. The optimal management strategy for this tumor is a subject of continuous debate. Physicians face many challenges in treating PCa, primarily because of the apparent heterogeneity of the disease, which acts differently in each patient. Although there is a concern of overdiagnosis and overtreatment of many men with low-risk tumors, many others with high-risk tumors are likely undertreated. Moreover, in cases in which active treatment is indicated, the optimal initial treatment strategy and the most appropriate sequence of treatments are not always clear. Likewise, the most appropriate management strategy for patients with metastatic and castration-resistant disease is a subject of controversy and continuous research.","[{'e1': ' approximately 220,800 men ', 'e2': 'prostate cancer (PCa) ', 'relation': 'are diagnosed with ', 'condition': 'In the United States,'}]"
35
+ P53P4,"To gain insight into the cellular factors controlling AR activity and potentially CRPC, we performed an unbiased, genome-wide siRNA screen for factors that reduced AR activity upon depletion using a Drosophila cell system. This was followed by functional analyses of homologous factors in human prostate cancer cells, revealing several new factors that regulate AR activity and prostate cancer cell proliferation.","[{'e1': 'an unbiased, genome-wide siRNA screen', 'e2': 'AR activity ', 'relation': ' for factors that reduced ', 'condition': 'upon depletion using a Drosophila cell system'}]"
36
+ P158P3,"HDDA10 showed significant performance for predicting metastasis and biochemical recurrence in the validation set, outperforming Gleason grade grouping for biochemical recurrence and with comparable performance for metastasis endpoint. HDDA10 prognostic significance was superior to any clinical–pathological parameter within grade group 2 and 3 patients for biochemical recurrence and also performed better for metastasis than Gleason pattern 4. HDDA10 remained significant for both biochemical recurrence and metastasis in multivariate analysis, suggesting that it can be used to increase accuracy in stratifying patients eligible for active surveillance.","[{'e1': 'HDDA10', 'e2': 'metastasis and biochemical recurrence ', 'relation': ' showed significant performance for predicting ', 'condition': 'in the validation set'}, {'e1': 'HDDA10 ', 'e2': 'both biochemical recurrence and metastasis ', 'relation': 'remained significant for ', 'condition': 'in multivariate analysis'}]"
37
+ P118P5,"Among the tumor types analyzed, bladder urothelial carcinoma had the highest mutation count, followed by adrenocortical carcinoma, papillary renal cell carcinoma, testis germ cell tumor, clear cell renal cell carcinoma, prostate adenocarcinoma, pheochromocytoma and paraganglioma, and chromophobe renal cell carcinoma. The tumor type with the highest fraction of the genome with copy number variation was chromophobe renal cell carcinoma, followed by adrenocortical carcinoma, testis germ cell tumor, bladder urothelial carcinoma, papillary renal cell carcinoma, pheochromocytoma and paraganglioma, clear cell renal cell carcinoma, and prostate adenocarcinoma. Mutation count was associated with higher tumor stage and grade in several cancers and with survival outcomes in chromophobe renal cell carcinoma. Copy number variation was associated with higher stage and grade in multiple cancers and with inferior survival outcomes in some tumor types.","[{'e1': 'Mutation count ', 'e2': 'higher tumor stage and grade ', 'relation': 'was associated with ', 'condition': 'in several cancers'}, {'e1': 'Mutation count ', 'e2': 'survival outcomes ', 'relation': 'was associated with ', 'condition': 'in chromophobe renal cell carcinoma'}, {'e1': 'Copy number variation ', 'e2': 'higher stage and grade ', 'relation': 'was associated with ', 'condition': 'in multiple cancers '}, {'e1': 'Copy number variation ', 'e2': 'inferior survival outcomes ', 'relation': 'was associated with ', 'condition': 'in some tumor types.'}]"
38
+ P154P6,"Of the 11 candidate genes that scored in both the in vitro and in vivo assays, asparagine synthetase had the most robust clinical evidence supporting its relevance to disease progression. Expression levels of the human orthologue, ASNS, were predictive of general and lung-specific relapse in two datasets of patients with breast cancer. Also, when a small collection of matched tumour and lung metastases were transcriptionally profiled, ASNS was found to be more highly expressed in secondary lesions. ASNS is more highly expressed in aggressive tumour subtypes and it is more highly expressed in patients with relapse to the lymph node, brain, liver, and lungs compared with relapse-free survivors. Subsequent analyses identified ASNS as predictive of survival in three additional datasets of patients with breast cancer. In addition to breast tumours, ASNS is negatively correlated with survival in four out of the ten other solid tumours in The Cancer Genome Atlas Pan-Cancer dataset and is a globally predictive biomarker for solid tumours. Previous research has shown that asparagine is an important regulator of cellular metabolism and adaptation.","[{'e1': 'ASNS ', 'e2': 'survival ', 'relation': 'is negatively correlated with ', 'condition': 'in four out of the ten other solid tumours in The Cancer Genome Atlas Pan-Cancer dataset'}]"
39
+ P157P3,"Metastatic castration-resistant prostate cancer is associated with poor prognosis with a mean survival time of 16–18 months. The U.S. Food and Drug Administration-approved therapies for metastatic castration-resistant prostate cancer include chemotherapy agents, second-generation hormonal therapies, immunotherapy, and radium-223. Androgen receptor point mutations and amplifications have led to resistance to first-line androgen deprivation therapy treatments, and since androgen receptor remains active in metastatic castration-resistant prostate cancer, these patients respond to abiraterone acetate and enzalutamide, but with a modest increase in overall survival of 3–4 months. A major resistance mechanism to abiraterone acetate and enzalutamide involve the presence of androgen receptor splice variants, such as ARv7, possibly explaining the modest overall survival benefit of these agents in an unselected population. Androgen receptor splice variants are truncated forms of wild-type androgen receptor where the ligand-binding domain is lost, activation is ligand independent, and these variants are constitutively active. It was recently shown that ARv7 mRNA detection in circulating tumor cells correlated with poor outcomes in patients with metastatic castration-resistant prostate cancer who were treated with abiraterone acetate and enzalutamide. It is still unclear if androgen receptor splice variants are functionally contributing to treatment resistance, but ARv7 has developed into an important predictive biomarker for metastatic castration-resistant prostate cancer patients taking either abiraterone acetate or enzalutamide. Another result of resistance to prolonged administration of abiraterone acetate and enzalutamide is the development of a lethal variant of metastatic castration-resistant prostate cancer termed aggressive variant prostate cancer. Indeed, aggressive variant prostate cancer was classified in 15% of metastatic castration-resistant prostate cancers prior to the approval of abiraterone acetate and enzalutamide; however, this population shifted to 31% aggressive variant prostate cancer post-abiraterone acetate and enzalutamide. Several great reviews have been written on this disease variant, and recent work has classified aggressive variant prostate cancer into two distinct subtypes: androgen receptor-null expressing neuroendocrine differentiation markers and androgen receptor-null lacking markers of neuroendocrine differentiation. Aggressive variant prostate cancer is characterized by several clinical and genetic features to include low prostate-specific antigen and androgen receptor protein expression, loss of retinoblastoma, TP53 mutations, overexpression of Aurora kinase A, and amplification of N-Myc. Survival is typically less than a year with limited treatment options to include platinum-based chemotherapy. Based on the recent literature, it is becoming apparent that androgen receptor-independent pathways such as activated MAPK and FGFR kinase pathways are responsible for aggressive variant prostate cancer development and progression. Indeed, several clinical trials investigating androgen receptor-independent pathways are underway in prostate cancer including agents that target MEK and/or SRC, Aurora kinase A, PI3K/mammalian target of rapamycin, and DNAPK, although not all of these trials focus on aggressive variant prostate cancer.","[{'e1': 'ARv7 mRNA detection in circulating tumor cells', 'e2': ' poor outcomes ', 'relation': ' correlated with', 'condition': 'in patients with metastatic castration-resistant prostate cancer who were treated with abiraterone acetate and enzalutamide'}, {'e1': 'aggressive variant prostate cancer ', 'e2': '15% of metastatic castration-resistant prostate cancers', 'relation': 'was classified in ', 'condition': ' prior to the approval of abiraterone acetate and enzalutamide'}]"
40
+ P76P8,We have very recently shown that promoter methylation of the immune checkpoint receptor PD-1 is an independent prognostic biomarker for biochemical recurrence-free survival in PCa patients following radical prostatectomy. The aim of the present study was to quantify PD-L1 DNA methylation in prostate tissue samples and to evaluate its potential role as a prognostic biomarker in PCa.,"[{'e1': 'promoter methylation of the immune checkpoint receptor PD-1', 'e2': 'independent prognostic biomarker for biochemical recurrence-free survival ', 'relation': ' is an ', 'condition': 'in PCa patients following radical prostatectomy'}, {'e1': 'The aim of the present study ', 'e2': 'PD-L1 DNA methylation ', 'relation': 'was to quantify ', 'condition': 'in prostate tissue samples '}, {'e1': 'The aim of the present study ', 'e2': 'its potential role as a prognostic biomarker ', 'relation': 'was to evaluate ', 'condition': 'in PCa.'}]"
41
+ P157P2,"The male prostate, as well as early stage prostate cancer, is dependent on androgens activating the androgen receptor for survival, growth, and proliferation. Prostate-specific antigen is a serine protease that is secreted from the prostate and is transcriptionally regulated by androgen receptor. Thus, along with digital rectal exams, prostate-specific antigen-based screening is routinely used for early detection of prostate cancer, although the magnitude of benefit from prostate-specific antigen screening continues to be debated. Biopsies are typically done to confirm prostate cancer, and if diagnosed with clinically significant disease, a patient most commonly has external beam radiation therapy or radical prostatectomy. Adjuvant androgen deprivation with radiation or adjuvant radiation after surgery may be administered in the setting of tumors with high risk of recurrence. Androgen deprivation therapy that suppresses testicular function is typically first-line therapy for androgen-sensitive prostate cancer. A small additional survival benefit may be seen when first-generation oral androgen receptor inhibitors such as bicalutamide and flutamide are combined with androgen deprivation therapy. Initial positive response to androgen deprivation therapy is common by evidence of decline prostate-specific antigen levels in 90% of patients and duration of response to therapy varies, with 5–10% of patients surviving 10 years after initiating androgen deprivation therapy. In two recent phase III clinical trials, hormone naive patients with locally advanced or oligometastatic disease starting first-line long-term androgen deprivation therapy treatment were also given abiraterone acetate and prednisone. Abiraterone acetate is a potent, second-generation inhibitor that blocks androgen synthesis, significantly decreasing circulating androgen below levels achieved with testicular suppression alone. In the STAMPEDE trial, inclusion of abiraterone acetate early in the treatment protocol resulted in a lower risk of death by 37%. The 3-year survival rate was 76% with standard androgen deprivation therapy treatment alone and 83% with the standard care in combination with abiraterone acetate as well as a 14-month failure-free survival advantage. The results were also verified in a separate LATITUDE trial. In another phase III clinical trial, patients with hormone-sensitive metastatic prostate cancer were given docetaxel in combination with first-line androgen deprivation therapy treatment. The median overall survival with combination treatment was 13.6 months longer than with androgen deprivation therapy alone, nearly identical to the STAMPEDE and LATITUDE trials. A decrease in prostate-specific antigen to less than 0.2 ng/ml at 12 months was 27.7% for the combination group compared to 16.8% for the androgen deprivation therapy only group, and the median time for development of castration-resistant prostate cancer was increased. The results of these exciting clinical trials have prompted earlier use of docetaxel or abiraterone acetate plus standard androgen deprivation therapy to delay time of metastatic castration-resistant prostate cancer and ultimately death.","[{'e1': ' inclusion of abiraterone acetate early in the treatment protocol ', 'e2': 'a lower risk of death by 37%', 'relation': 'resulted in ', 'condition': 'In the STAMPEDE trial'}]"
42
+ P81P3,"Long non-coding RNAs (lncRNAs) are a group of non-coding transcripts of more than 200 nucleotides that function in a broad range of cellular processes, such as cell growth, survival, migration, invasion, and differentiation. They are also involved in tumorigenesis and metastasis as well as radiotherapy and chemotherapy resistance. LncRNAs are highly deregulated in tumors and have been found to act as tumor suppressors or oncogenes. Recent studies indicate that lncRNAs play important biological and clinical roles in PCa; and overexpression of oncogenic lncRNAs may promote tumor cell proliferation and metastasis.","[{'e1': 'lncRNAs ', 'e2': 'important biological and clinical roles ', 'relation': 'play ', 'condition': 'in PCa'}]"
43
+ P28P1,"Radiation therapy (RT) is one of the mainstay treatments for prostate cancer (PCa). The potentially curative approaches can provide satisfactory results for many patients with non-metastatic PCa; however, a considerable number of individuals may present disease recurrence and die from the disease. Exploiting the rich molecular biology of PCa will provide insights into how the most resistant tumor cells can be eradicated to improve treatment outcomes. Important for this biology-driven individualized treatment is a robust selection procedure. The development of predictive biomarkers for RT efficacy is therefore of utmost importance for a clinically exploitable strategy to achieve tumor-specific radiosensitization. This review highlights the current status and possible opportunities in the modulation of four key processes to enhance radiation response in PCa by targeting the: (1) androgen signaling pathway; (2) hypoxic tumor cells and regions; (3) DNA damage response (DDR) pathway; and (4) abnormal extra-/intracell signaling pathways. In addition, we discuss how and which patients should be selected for biomarker-based clinical trials exploiting and validating these targeted treatment strategies with precision RT to improve cure rates in non-indolent, localized PCa.","[{'e1': ' targeted treatment strategies with precision RT ', 'e2': 'cure rates ', 'relation': 'to improve ', 'condition': 'in non-indolent, localized PCa.'}]"
44
+ P185P5,"To further explore the biomarker value of the Mucin 1 network, we examined the transcriptome of the 9-gene Mucin 1 genomic signature using the TCGA Provisional dataset within cBioPortal, and established 696 differentially expressed genes. From these differentially expressed genes, a 15-gene panel and multiple subpanels were constructed. These signatures robustly associate with reductions in disease-free survival following radical prostatectomy in two independent prostate cancer datasets. Cutpoints have been derived, which not only enhance the power of these signatures in the stratification of men with higher risk of biochemical recurrence but also provide a guideline for the subsequent validation and clinical application. Taken together, we have constructed a set of novel and robust signatures to assess prostate cancer recurrence following radical prostatectomy.","[{'e1': 'These signatures ', 'e2': ' reductions in disease-free survival', 'relation': 'robustly associate with', 'condition': ' following radical prostatectomy in two independent prostate cancer datasets'}]"
45
+ P44P4,"In conclusion, HELLS and ZIC5 might be promising candidate markers for selection of biopsy GS 6 prostate cancer being at risk for up-grading at prostatectomy.","[{'e1': 'HELLS and ZIC5', 'e2': 'selection of biopsy GS 6 prostate cancer being at risk for up-grading ', 'relation': ' might be promising candidate markers for ', 'condition': 'at prostatectomy.'}]"
46
+ P47P4,SPINK1 over expression is associated with prostate cancer specific mortality in at risk men with biochemical and clinical recurrence after prostatectomy. ERG-ETS alterations are not prognostic for outcome.,"[{'e1': 'SPINK1 over expression ', 'e2': 'prostate cancer specific mortality ', 'relation': 'is associated with ', 'condition': 'in at risk men with biochemical and clinical recurrence after prostatectomy'}, {'e1': 'SPINK1 over expression ', 'e2': 'prostate cancer specific mortality in at risk men with biochemical and clinical recurrence ', 'relation': 'is associated with ', 'condition': 'after prostatectomy'}]"
47
+ P127P7,"To the best of our knowledge, this is the largest study of TFF3 promoter methylation and RNA expression in PC to date. We found that the TFF3 gene promoter was frequently hypomethylated in PC compared to non-malignant prostate tissue samples, suggesting diagnostic biomarker potential for PC. Additionally, TFF3 RNA expression levels were significantly increased in PC tissue samples and correlated inversely with TFF3 promoter methylation, consistent with epigenetic regulation of gene activity. Furthermore, low TFF3 RNA levels were significantly associated with high ERG expression, high Gleason score, advanced pT-stage, and early prostate-specific antigen recurrence after radical prostatectomy. Together, our results demonstrate diagnostic biomarker potential of TFF3 promoter hypomethylation as well as prognostic biomarker potential of TFF3 RNA expression for clinically localized PC.","[{'e1': 'low TFF3 RNA levels ', 'e2': 'high ERG expression', 'relation': 'were significantly associated with ', 'condition': 'after radical prostatectomy'}, {'e1': 'low TFF3 RNA levels ', 'e2': 'high Gleason score', 'relation': 'were significantly associated with ', 'condition': 'after radical prostatectomy'}, {'e1': 'low TFF3 RNA levels ', 'e2': ' advanced pT-stage ', 'relation': 'were significantly associated with ', 'condition': 'after radical prostatectomy'}, {'e1': 'low TFF3 RNA levels ', 'e2': 'early prostate-specific antigen recurrence ', 'relation': 'were significantly associated with ', 'condition': 'after radical prostatectomy'}]"
48
+ P93P7,"Our immunohistochemical analysis revealed membranous ADAM15 staining of variable intensity, typically located at the apical cell pole, in a small fraction of our 9826 analyzable prostate cancers, while normal prostate epithelium and other non-malignant cells were negative under the selected experimental conditions. Absence of ADAM15 expression in normal prostatic epithelium was also described in one earlier study. High-level ADAM15 staining was strongly linked to adverse phenotypical features of prostate cancer and early PSA recurrence in our study. Similar findings were made by Kuefer et al. using a different scoring scheme that does not disclose the fraction of positive cancer samples. That a statistical association was not found in this study might be due to a relatively low number of cases. Overall, these findings from our study provide strong in vivo evidence for a role of ADAM15 expression in development and progression of prostate cancer. This assumption is strongly supported by earlier in vivo evidence from functional studies using prostate cancer cell lines. These data had suggested that ADAM15 overexpression contributes to the metastatic cascade by prostate tumor cell interaction with vascular endothelium and thus facilitating blood vessel invasion.","[{'e1': ' High-level ADAM15 staining ', 'e2': 'adverse phenotypical features of prostate cancer and early PSA recurrence ', 'relation': 'was strongly linked to ', 'condition': 'in our study'}, {'e1': 'ADAM15 overexpression ', 'e2': 'the metastatic cascade ', 'relation': 'contributes to ', 'condition': 'by prostate tumor cell interaction with vascular endothelium and thus facilitating blood vessel invasion.'}]"
49
+ P58P1,"Patients with prostate cancer (PCa) have a variable prognosis. It is challenging to recognize the progressive disease. In this study, we focused on TSPAN1, a new member of the tetraspanin family. Its expression was decreased in progressive PCa and was an independent prognosis factor of biochemical recurrence after radical prostatectomy. In vitro, knockdown and overexpression of TSPAN1 in PCa cell lines showed that TSPAN1 could inhibit cell proliferation and migration. TSPAN1 was positive related to PTEN in both clinical specimen and mouse models. The combination of these two markers could increase their prognosis value especially in low risk patients. In vitro TSPAN1 knockdown resulted in increased Akt phosphorylation and caused evident cell cycle transition from G1 to S phase. Our data suggests that TSPAN1 is a valuable marker to recognize more progressive PCa.","[{'e1': 'TSPAN1', 'e2': 'of biochemical recurrence ', 'relation': 'was an independent prognosis factor ', 'condition': 'after radical prostatectomy'}, {'e1': 'TSPAN1', 'e2': 'PTEN ', 'relation': ' was positive related to ', 'condition': 'in clinical specimen '}, {'e1': 'TSPAN1', 'e2': 'PTEN ', 'relation': ' was positive related to ', 'condition': 'in mouse models'}, {'e1': ' The combination of these two markers ', 'e2': ' their prognosis value ', 'relation': 'could increase', 'condition': 'especially in low risk patients'}]"
50
+ P71P1,"Prostate cancer management is complicated by extreme disease heterogeneity, which is further limited by availability of prognostic biomarkers. Recognition of prostate cancer as a genetic disease has prompted a focus on the nuclear genome for biomarker discovery, with little attention given to the mitochondrial genome. While it is evident that mitochondrial DNA (mtDNA) mutations are acquired during prostate tumorigenesis, no study has evaluated the prognostic value of mtDNA variation. Here we used next-generation sequencing to interrogate the mitochondrial genomes from prostate tissue biopsies and matched blood of 115 men having undergone a radical prostatectomy for which there was a mean of 107 months clinical follow-up. We identified 74 unique prostate cancer specific somatic mtDNA variants in 50 patients, providing significant expansion to the growing catalog of prostate cancer mtDNA mutations. While no single variant or variant cluster showed recurrence across multiple patients, we observe a significant positive correlation between the total burden of acquired mtDNA variation and elevated Gleason Score at diagnosis and biochemical relapse. We add to accumulating evidence that total acquired genomic burden, rather than specific mtDNA mutations, has diagnostic value. This is the first study to demonstrate the prognostic potential of mtDNA mutational burden in prostate cancer.","[{'e1': '74 unique prostate cancer specific somatic mtDNA variants ', 'e2': 'growing catalog of prostate cancer mtDNA mutations', 'relation': 'providing significant expansion to the ', 'condition': 'in 50 patients'}]"
51
+ P39P9,"In localized PC treated by radical prostatectomy, Ki67 PI provides independent prognostic value for RFS, DSS and OS beyond Gleason score, pathological stage and PSA levels. In our large, multi-institutional cohort, Ki67 PI performed best as a continuous variable and could be incorporated into existing or new predictive nomograms. Additionally, our study suggests that risk stratification for localized PC could be achieved with Ki67 as a dichotomous variable at 5% cutoff. These findings strongly suggest that Ki67 PI should be further tested as a prognostic biomarker in other clinically relevant cohorts such as patients on active surveillance, and possibly in patients undergoing image guided biopsies.","[{'e1': 'Ki67 PI ', 'e2': ' RFS', 'relation': 'provides independent prognostic value for', 'condition': 'In localized PC treated by radical prostatectomy,'}, {'e1': 'Ki67 PI ', 'e2': 'DSS and OS beyond Gleason score', 'relation': 'provides independent prognostic value for', 'condition': 'In localized PC treated by radical prostatectomy,'}, {'e1': 'Ki67 PI ', 'e2': 'pathological stage ', 'relation': 'provides independent prognostic value for', 'condition': 'In localized PC treated by radical prostatectomy,'}, {'e1': 'Ki67 PI ', 'e2': 'PSA levels', 'relation': 'provides independent prognostic value for', 'condition': 'In localized PC treated by radical prostatectomy,'}, {'e1': ' Ki67 PI', 'e2': ' a prognostic biomarker ', 'relation': ' should be further tested as', 'condition': 'in other clinically relevant cohorts such as patients on active surveillance'}, {'e1': ' Ki67 PI', 'e2': ' a prognostic biomarker ', 'relation': ' should be further tested as', 'condition': ' in patients undergoing image guided biopsies.'}]"
52
+ P187P7,"Human RNase κ is an endoribonuclease, coding by a gene that consists of three exons and two intervening introns. Recently, our group demonstrated that RNase κ is subjected to alternative splicing, within the first intron, producing two transcript variants, RNase κ-01 and RNase κ-02, which code for two structurally different protein isoforms. The high percentage of amino acid conservation of human RNase κ along with its expression in a wide spectrum of tissues and developmental stages, denote its significant, but yet largely obscure, biological function. Moreover, RNase κ exhibits increased or decreased expression levels in several cancer types, suggesting its possible clinical utility as molecular cancer marker.","[{'e1': 'RNase κ ', 'e2': 'increased or decreased expression levels ', 'relation': 'exhibits ', 'condition': 'in several cancer types'}]"
53
+ P58P3,"Tetraspanins are a heterogeneous group of four transmembrane proteins, which are expressed across evolution from sponges to mammals. Studies have established that they can affect tumor metastasis by forming tetraspanin-enriched membrane micro-domains (TEMs) with other tetraspanins and with a variety of trans-membrane and cytosolic proteins through different mechanisms. For example, CD82 is recognized as a typical metastasis suppressor. It can interact with integrin and then form a protein complex with c-Met. Through the recruitment of regulation cofactors, CD82 influences the protein complex function, which results in promoting matrix adhesion and inducing senescence. On the other hand, CD151 and tetraspanin8 are shown to promote metastasis by supporting cell motility. The controversial role of tetraspanins in tumor progression may be due to their function of serving as a scaffold to interact with various proteins.","[{'e1': 'Tetraspanins', 'e2': 'tumor metastasis ', 'relation': 'can affect ', 'condition': 'by forming tetraspanin-enriched membrane micro-domains (TEMs) with other tetraspanins '}]"
54
+ P45P8,"DNA methylation can also be actively “erased,” presumably independent of DNA replication. Such active reversal of DNA methylation has been suggested to play an important role in mediating plasticity and dynamic epigenetic regulation, particularly in certain cell types such as neurons and embryonic stem cells. Recent work has implicated oxidation of 5-methylcytosine to 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosine by ten-eleven translocation family proteins, encoded by three distinct genes such as TET1, TET2, and TET3. Although the precise mechanism of active demethylation by such oxidation has not been fully worked out, it appears that the oxidized forms are either directly excised by DNA glycosylases such as TDG and replaced with unmethylated cytosine by base excision repair machinery or are first deaminated prior to excision and base excision repair. Haffner and colleagues were the first to show robustly that when compared to normal differentiated or effector cells in many tissue types, the abundance of 5-hydroxymethylcytosine, which is the major oxidized form of 5-methylcytosine, is profoundly reduced in human cancers, including prostate cancer, and stem or progenitor cell compartments. This finding has now been reproduced by numerous labs for a multitude of cancer types. We speculate that this loss of 5-hydroxymethylcytosine in cancer cells might indicate a reduced plasticity of DNA methylation alterations in human cancer.","[{'e1': 'loss of 5-hydroxymethylcytosine in cancer cells ', 'e2': 'DNA methylation alterations', 'relation': 'might indicate a reduced plasticity of ', 'condition': ' in human cancer.'}]"
55
+ P60P2,"Early detection of prostate cancer, largely facilitated by the advent of PSA screening, has also been attributed to over-diagnosis and overtreatment of this disease. While coupling PSA screening with other biomarkers such as the long non-coding RNA transcript PCA3 or gene fusions events have increased specificity of cancer diagnosis, these biomarkers have limited utility in stratifying patients in terms of prognosis. While stratifying patients into risk groups based on clinicopathologic features is currently used to guide treatment decisions, it is clear that current stratification approaches need to be further refined to allow better personalization of therapy. Thus, identifying molecular biomarkers to distinguish indolent versus aggressive disease would address an unmet need in the clinical management of prostate cancer.","[{'e1': 'identifying molecular biomarkers ', 'e2': ' indolent versus aggressive disease would address an unmet need', 'relation': 'to distinguish', 'condition': ' in the clinical management of prostate cancer.'}]"
56
+ P83P8,"Using genetic inducible fate mapping, we traced the fate of ACTA2-expressing cells in vivo during mouse tumor progression and found that the labeled cells are largely lost in PB-MYC tumors without changing fate and giving rise to cancer reactive stroma. In TRAMP tumors, in contrast, labeled SMCs not only expand the smooth muscle layers, but also contribute to cancer stromal cells, specifically in IAS and not between ducts. Thus, in TRAMP tumors, some labeled SMCs change their fate to fibroblasts and/or myofibroblast-like cells and migrate into IASs. However, SMCs in TRAMP tumors, as in PB-MYC tumors, do not contribute to interductal stromal cells. We propose that the fate of SMC is likely determined by the molecular character of the tumor epithelial cells. It will be interesting to determine if the cell of origin of interductal stroma is the stem or progenitor cell that a fate-mapping study indicates is restricted to the interductal fibroblast lineage. Furthermore, if each stromal lineage has a distinct expression signature, it should be possible to predict the cell of origin of reactive stroma in human PCa samples.","[{'e1': ' labeled SMCs ', 'e2': ' cancer stromal cells, ', 'relation': 'not only expand the smooth muscle layers but also contribute to', 'condition': 'specifically in IAS and not between ducts In TRAMP tumors'}, {'e1': ' some labeled SMCs ', 'e2': ' fibroblasts and/or myofibroblast-like cells and migrate into IASs', 'relation': 'change their fate to', 'condition': 'in TRAMP tumors'}]"
57
+ P85P6,"An estimated 50,000 radical prostatectomies are performed each year in the US, and about 15,000 of these patients will experience biochemical recurrence. Here we show that a four-gene signature based on HBEGF, HOXC13, IGFBP2, and SATB1 was able to identify patients whose prostate cancer recurred. The prediction algorithm that incorporated surgical information provided accurate prognostic information on patient outcomes with 83% accuracy. Most patients undergoing radical prostatectomy receive no additional treatment beyond regular monitoring of PSA. Adjuvant radiotherapy administered immediately after radical prostatectomy could improve outcomes for patients identified using the CRG signature to be at high risk for recurrence.","[{'e1': 'Adjuvant radiotherapy administered ', 'e2': 'patients identified using the CRG signature to be at high risk for recurrence.', 'relation': 'could improve outcomes for ', 'condition': 'immediately after radical prostatectomy '}]"
58
+ P22P6,"On the contrary, snoRNAs are a poorly investigated class of non-coding RNAs that are encoded by at least 400 distinct genomic regions. They have traditionally been considered “housekeeping” genes, mainly involved in alternative splicing and ribosomal RNA (rRNA) modifications. In light of their presumptive stable expression, some snoRNAs have been selected as reference genes in studies investigating the expression of microRNAs in human neoplasm. However, recent findings have challenged these assumptions, revealing that snoRNAs can migrate to the cytoplasm and modulate a wide range of cellular functions. At the same time, it has become evident that snoRNA expression patterns are deregulated in cancer cells and in serum samples from cancer patients. In addition, some snoRNAs are emerging as critical mediators of cancer progression. For example SNORA42 is often amplified in lung cancer, and its silencing leads to cancer cell apoptosis, thereby impairing in vivo cancer growth. SNORD50A is frequently deleted and acts as a tumor suppressor in breast cancer and PCa. This gene also represents, to date, the only functionally characterized snoRNA in PCa.","[{'e1': ' some snoRNAs ', 'e2': 'reference genes ', 'relation': 'have been selected as ', 'condition': 'in studies investigating the expression of microRNAs in human neoplasm'}]"
59
+ P50P6,"This study presents a distinct metabolic profile with concordant alterations of gene expression levels of key metabolic enzymes in prostate tissue samples with the presence of TMPRSS2-ERG. The metabolic profile was especially connected to the metabolism of polyamines and citrate, but also glycolysis and fatty acid metabolism. Our results indicate that TMPRSS2-ERG differentiates towards a phenotype that is associated with characteristics of an aggressive phenotype of prostate cancer. Additionally, the observed metabolic alterations can be translated to in vivo patient MRSI.","[{'e1': 'distinct metabolic profile ', 'e2': 'key metabolic enzymes ', 'relation': 'with concordant alterations of gene expression levels of ', 'condition': 'in prostate tissue samples with the presence of TMPRSS2-ERG'}]"
60
+ P123P3,"DNA methylation plays an important role in tumorigenesis and cancer progression. DNA hypermethylation is frequently observed in the promoter regions of tumor suppressor genes, leading to gene silencing, while genome-wide global hypomethylation events are common in human cancer, causing genomic instability. Global hypomethylation in peripheral blood leukocyte DNA has been associated with increased risk of various cancers. However, no study has evaluated the role of global leukocyte DNA methylation in the prognosis of localized PCa patients.","[{'e1': 'Global hypomethylation ', 'e2': ' increased risk of various cancers', 'relation': 'has been associated with', 'condition': 'in peripheral blood leukocyte DNA'}]"
61
+ P186P5,Restoration of the expression of miR-195/-16 could enhance radiotherapy via activation of the T cell response in the tumor microenvironment by blocking the PD-L1 immune checkpoint. This synergy between radiotherapy and immunotherapy was accompanied by the proliferation of functional cytotoxic CD8+ T cells and inhibition of MDSCs and Tregs. This work indicates a biological and functional interaction between immunotherapy and radiotherapy through the miR-195/-16 family regulatory cascade.,"[{'e1': 'Restoration of the expression of miR-195/-16 ', 'e2': 'radiotherapy ', 'relation': 'could enhance ', 'condition': 'via activation of the T cell response in the tumor microenvironment '}, {'e1': 'Restoration of the expression of miR-195/-16 ', 'e2': 'radiotherapy via activation of the T cell response in the tumor microenvironment ', 'relation': 'could enhance ', 'condition': 'by blocking the PD-L1 immune checkpoint'}]"
62
+ P77P6,"In the present study, PD-1 mRNA content in PCa was independent from lymphocytic infiltration and from the stromal amount of the sample, which may potentially be due to a distinctive yet undefined role of PD-1 in PCa glands themselves. Tumor-intrinsic PD-1 expression, however, has only recently been characterized in malignant melanoma cells. This study shows that prostatic adenocarcinoma contains PD-1 mRNA and that PD-1 mRNA is subject to epigenetic PD-1 promoter control in the same way as it has been described for human T-lymphocytes, whose PD-1 expression underlies epigenetic control and is regulated by promoter methylation. This finding may be of significance for the future application of immunotherapies in PCa patients, since intrinsic PD-1 expression has been linked to tumor immune evasion and failure to anti-PD-1 treatment. The experience with PD-1 checkpoint inhibition in PCa is still limited, however, tumor-intrinsic PD-1 DNA methylation interfering with tumor-intrinsic PD-1 functions may have a predictive value for future treatment with checkpoint inhibitors in PCa. The present study bears the strength to combine the analysis of PD-1 promoter methylation in two independent cohorts and by two different molecular assays, indicating that the PD-1 gene is differentially methylated in local and advanced PCa. The University Hospital Bonn cohort revealed a significant association between lower PD-1 methylation and organ confined PCa, which may be due to the altogether higher number of localized tumors compared to the TCGA cohort. In addition, PD-1 methylation correlated with preoperative serum PSA levels in both cohorts. Both parameters are well known to determine the outcome of PCa patients. The latter fact supports the notion that PD-1 promoter methylation qualified as a prognostic biomarker in PCa. However, the prognostic power of PD-1 still needs to be validated in an independent cohort with sufficient follow-up information. Furthermore, the prognostic value should be analyzed with regard to more clinically relevant endpoints, i.e. PCa-specific survival which was unfortunately not available for the analyzed cohorts. In addition, the retrospective nature of the present study further adds to its major limitations.","[{'e1': ' PD-1 methylation ', 'e2': 'preoperative serum PSA levels ', 'relation': 'correlated with ', 'condition': 'in both cohorts'}]"
63
+ P196P7,"Here, we evaluate the validity of the 22-gene GC test performed on diagnostic biopsies, accounting for clinicopathologic NCCN risk grouping, for predicting biochemical and metastatic relapse in a cohort of IR-PCa treated with single-modality DE-IGRT at a tertiary cancer center. Of note, there has been only 1 prior study reporting on the utility of a biopsy-derived GC score; it focused on a mixed cohort of intermediate- and high-risk PCa treated with combined ADT and RT. We show that the GC score outperforms the NCCN criteria in distinguishing patients with IR-PCa with favorable outcomes after DE-IGRT without ADT from those who are at risk of metastatic relapse. The GC test may thus be useful for personalizing treatment strategies in IR-PCa, providing actionable information to identify men who should receive combination ADT and DE-IGRT.","[{'e1': ' GC score ', 'e2': 'the NCCN criteria ', 'relation': 'outperforms ', 'condition': 'in distinguishing patients with IR-PCa with favorable outcomes after DE-IGRT without ADT from those who are at risk of metastatic relapse'}, {'e1': 'The GC test ', 'e2': 'personalizing treatment strategies ', 'relation': 'may thus be useful for ', 'condition': 'in IR-PCa'}]"
64
+ P15P1,"Patients with clinically insignificant prostate cancer remain a major over-treated population. PTEN loss is one of the most recurrent alterations in prostate cancer associated with an aggressive phenotype; however, the occurrence of PTEN loss in insignificant prostate cancer has not been reported and its role in the separation of insignificant from significant prostate cancer is unclear. An integrated analysis of PTEN loss was, therefore, performed for structural variations, point mutations and protein expression in clinically insignificant (48 cases) and significant (76 cases) prostate cancers treated by radical prostatectomy. Whole-genome mate pair sequencing was performed on tumor cells isolated by laser capture microdissection to characterize PTEN structural alterations. Fluorescence in situ hybridization probes were constructed from the sequencing data to detect the spectrum of these PTEN alterations. PTEN loss by mate pair sequencing and fluorescence in situ hybridization occurred in 2% of insignificant, 13% of large volume Gleason score 6, and 46% of Gleason score 7 and higher cancers. In Gleason score 7 cancers with PTEN loss, PTEN alterations were detected in both Gleason pattern 3 and 4 in 57% of cases by mate pair sequencing, 75% by in situ hybridization and 86% by immunohistochemistry. PTEN loss by sequencing was strongly associated with TMPRSS2-ERG fusion, biochemical recurrence, PTEN loss by in situ hybridization and protein loss by immunohistochemistry. The complex nature of PTEN rearrangements was unveiled by sequencing, detailing the heterogeneous events leading to homozygous loss of PTEN. PTEN point mutation was present in 5% of clinically significant tumors and not in insignificant cancer or high-grade prostatic intraepithelial neoplasia. PTEN loss is infrequent in clinically insignificant prostate cancer, and is associated with higher grade tumors. Detection of PTEN loss in Gleason score 6 cancer in a needle biopsy specimen indicates a higher likelihood of clinically significant prostate cancer.","[{'e1': 'PTEN loss ', 'e2': 'recurrent alterations ', 'relation': 'is one of the most ', 'condition': 'in prostate cancer associated with an aggressive phenotype'}, {'e1': 'An integrated analysis of PTEN loss ', 'e2': ' structural variations ', 'relation': 'was performed for', 'condition': 'in clinically insignificant (48 cases) prostate cancers treated by radical prostatectomy.'}, {'e1': 'An integrated analysis of PTEN loss ', 'e2': 'point mutations', 'relation': 'was performed for', 'condition': 'in clinically insignificant (48 cases) prostate cancers treated by radical prostatectomy.'}, {'e1': 'An integrated analysis of PTEN loss ', 'e2': 'protein expression ', 'relation': 'was performed for', 'condition': 'in clinically insignificant (48 cases) prostate cancers treated by radical prostatectomy.'}, {'e1': 'An integrated analysis of PTEN loss ', 'e2': ' structural variations ', 'relation': 'was performed for', 'condition': 'in clinically significant (76 cases) prostate cancers treated by radical prostatectomy.'}, {'e1': 'An integrated analysis of PTEN loss ', 'e2': 'point mutations', 'relation': 'was performed for', 'condition': 'in clinically significant (76 cases) prostate cancers treated by radical prostatectomy.'}, {'e1': 'An integrated analysis of PTEN loss ', 'e2': 'protein expression ', 'relation': 'was performed for', 'condition': 'in clinically significant (76 cases) prostate cancers treated by radical prostatectomy.'}, {'e1': 'PTEN alterations ', 'e2': 'both Gleason pattern 3 and 4 ', 'relation': 'were detected in ', 'condition': 'in 57% of cases by mate pair sequencing'}, {'e1': 'PTEN alterations ', 'e2': 'both Gleason pattern 3 and 4 ', 'relation': 'were detected in ', 'condition': 'in 75% of cases by situ hybridization '}, {'e1': 'PTEN alterations ', 'e2': 'both Gleason pattern 3 and 4 ', 'relation': 'were detected in ', 'condition': 'in 86% of cases by immunohistochemistry'}]"
65
+ P188P6,"The analysis of these different types of liquid biopsy has been successfully applied in oncology research during the last two decades, closely linked to the development of ultrasensitive methods for their detection. In fact, the main limitation to working with liquid biopsy is the low quantity of tumour material present in circulation. For example, in metastatic patients, the mean circulating tumour cell level is 1 circulating tumour cell per 10^6 to 10^8 mononuclear cells, while circulating tumour DNA is normally less than 0.01%. Fortunately, nowadays we have highly sensitive techniques to tackle liquid biopsy analyses with enough guarantees.","[{'e1': 'The analysis of these different types of liquid biopsy ', 'e2': 'oncology research', 'relation': 'has been successfully applied in ', 'condition': ' during the last two decade'}]"
66
+ P94P5,"Evidence supporting the in vivo efficacy of targeting the AR NTD was shown by application of decoy AR1-558 molecules of AR NTD that inhibit the growth and hormonal progression of prostate cancer xenografts both in the presence and absence of androgen. Those studies applied two models: one model used cells that stably expressed decoy AR1-558 to grow tumors with decoy; and the other model applied lentivirus delivery of decoy to established tumors in non-castrated mice. Here we investigated the effects of decoy in established tumors combined with castration. This is a model that better reflects the clinical representation of patients that undergo androgen deprivation therapy and develop castration-recurrent disease. Non-transfected LNCaP tumors were first established in NOD-SCID mice prior to castration and lentivirus delivery of the decoys. PSA nadir, time for PSA to reach pre-castration levels, and the time for the tumor to double in volume after therapy were all measured as an indication of tumor progression as reported in clinical studies. Patients have a better prognosis when their PSA nadir reaches very low levels, or with long periods of the time required for rises in PSA or for their tumor volume to double. Our studies showed that the delivery of decoys to established tumors leads to a lower nadir, increased time for the tumor to double in volume as well as for PSA to reach the pre-castrate levels. These data concur with delayed hormonal progression in xenografts of LNCaP cells stably expressing decoy in castrated mice and suggests that tumor progression is at least in part dependent on the AR NTD.","[{'e1': 'decoy AR1-558 molecules of AR NTD ', 'e2': 'the growth and hormonal progression of prostate cancer xenografts ', 'relation': 'inhibit', 'condition': 'in the presence of androgen'}, {'e1': 'decoy AR1-558 molecules of AR NTD ', 'e2': 'the growth and hormonal progression of prostate cancer xenografts ', 'relation': 'inhibit', 'condition': 'in the absence of androgen'}]"
67
+ P78P7,"Deletions of 18q were significantly associated with advanced tumor stage, high Gleason grade and increased risk of biochemical recurrence. These findings are in line with earlier studies on 23–46 prostate cancers reporting higher frequencies of loss of heterozygosity at 18q21 in tumors with advanced stage, high Gleason grade and metastatic growth. That the prognostic impact of 18q deletions was independent of established prognostic features, both in preoperative and in postoperative scenarios, highlights the potential clinical applicability of 18q deletion measurement. The Gleason grade is the strongest known prognostic parameter in prostate cancer. A comparison with established prognostic Gleason grade groups revealed that 18q deletion was even able to distinguish prognostic subgroups within Gleason 3 + 3 and 3 + 4 cancers. This is of particular interest because these are the low and intermediate risk tumors where the clinical decision making is most difficult and where the therapeutic options often range from active surveillance to radical prostatectomy.","[{'e1': 'the prognostic impact of 18q deletions', 'e2': ' established prognostic features', 'relation': ' was independent of', 'condition': 'in preoperative '}, {'e1': 'the prognostic impact of 18q deletions', 'e2': ' established prognostic features', 'relation': ' was independent of', 'condition': 'in postoperative scenarios'}]"
68
+ P77P4,"Epigenetic alterations are involved in the regulation of gene expression in key biological processes, i.e. development, differentiation, alternative splicing, and genetic imprinting. In addition, promoter hypermethylation also plays a major role in carcinogenesis altering the expression levels of critical growth regulators. Thereby, gene methylation has turned out to be a potential prognostic biomarker in different tumor entities. Of note, PD-1 DNA methylation had a significant impact on the course of prostate adenocarcinoma in the current study. While PD-1 mRNA expression was highly variable in PCa and did not serve as a prognostic factor in the cohort under investigation, high PD-1 DNA methylation was linked to a BCR 7 months earlier compared to patients with low PD-1 methylation levels. In multivariate Cox proportional hazards analysis, PD-1 DNA methylation furthermore served as a significant prognostic factor in PCa.","[{'e1': 'gene methylation ', 'e2': 'a potential prognostic biomarker ', 'relation': 'has turned out to be ', 'condition': 'in different tumor entities'}, {'e1': 'PD-1 DNA methylation', 'e2': 'prostate adenocarcinoma ', 'relation': ' had a significant impact on the course of ', 'condition': 'in the current study'}, {'e1': 'PD-1 DNA methylation ', 'e2': 'significant prognostic factor ', 'relation': 'served as a ', 'condition': 'in PCa.'}]"
69
+ P79P10,"Our data suggest PTEN inactivation as a possible candidate for a molecular aberration that could particularly efficiently interplay with 8p deletion. PTEN deletion is the strongest single molecular prognostic feature in prostate cancer known as yet. The strong statistical association between PTEN and 8p deletions and the particularly poor clinical course in case of a co-deletion of PTEN and 8p argues for synergistic effects between these lesions. The 8p genes possibly involved in such an interaction remain unclear. However, mouse models suggest that PTEN loss could drive invasion and metastasis in cooperation with loss of NKX3.1. Earlier studies had demonstrated that the panel of chromosomal deletions occurring in prostate cancer is largely dependent on the ERG status. Deletions of PTEN, 16q, and 3p13 are tightly linked to ERG expression while deletions of 6q15 and 5q21 are largely restricted to ERG-negative cancers. The data of the present study delineate 8p deletion as the exceptional case of an “ERG-independent” deletion. This is also supported by CGH array data from a cohort of 181 prostate cancers, where no significant link between 8p deletion and ERG fusion was reported. Our data demonstrate that the slightly higher rate of 8p deletions in ERG-positive than in ERG-negative cancers is entirely driven by its strong association with the ERG-linked PTEN deletion.","[{'e1': 'PTEN loss ', 'e2': 'invasion and metastasis ', 'relation': 'could drive ', 'condition': 'in cooperation with loss of NKX3.1'}, {'e1': ' panel of chromosomal deletions ', 'e2': 'the ERG status', 'relation': ' is largely dependent on ', 'condition': 'in prostate cancer'}, {'e1': ' slightly higher rate of 8p deletions', 'e2': 'its strong association with the ERG-linked PTEN deletion.', 'relation': ' is entirely driven by ', 'condition': 'in ERG-positive than in ERG-negative cancers '}]"
data/splits/extraction/domain_exp3_1_extraction_splits/reddit/reddit_exp3_1_extraction_test.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/splits/extraction/domain_exp3_1_extraction_splits/reddit/reddit_exp3_1_extraction_train.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/splits/extraction/domain_exp3_1_extraction_splits/reddit/reddit_exp3_1_extraction_validation.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/splits/extraction/domain_exp3_1_extraction_splits/synthetic/synthetic_exp3_1_extraction_test.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/splits/extraction/domain_exp3_1_extraction_splits/synthetic/synthetic_exp3_1_extraction_train.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/splits/extraction/domain_exp3_1_extraction_splits/synthetic/synthetic_exp3_1_extraction_validation.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/splits/probes/pubmed/pubmed_exp3_2_probe_test.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/splits/probes/pubmed/pubmed_exp3_2_probe_train.csv ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:5e906242bedaa4c5aeee85155f2c2df08c5fdcdbcfc6c8dcb562748fce1383be
3
+ size 14320478
data/splits/probes/pubmed/pubmed_exp3_2_probe_validation.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/splits/probes/pubmed/split_assignments.csv ADDED
@@ -0,0 +1,679 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ Paragraph_id,split
2
+ P153P3,train
3
+ P55P4,train
4
+ P16P2,train
5
+ P36P7,train
6
+ P19P2,train
7
+ P72P6,train
8
+ P87P3,train
9
+ P179P2,train
10
+ P99P14,train
11
+ P104P2,train
12
+ P38P2,train
13
+ P57P9,train
14
+ P108P7,train
15
+ P35P4,train
16
+ P185P4,train
17
+ P159P7,train
18
+ P56P2,train
19
+ P179P4,train
20
+ P34P2,train
21
+ P17P11,train
22
+ P83P2,train
23
+ P59P3,train
24
+ P23P8,train
25
+ P121P5,train
26
+ P24P1,train
27
+ P66P1,train
28
+ P84P1,train
29
+ P194P3,train
30
+ P60P1,train
31
+ P12PR4,train
32
+ P48P4,train
33
+ P39P4,train
34
+ P168P1,train
35
+ P104P6,train
36
+ P61P1,train
37
+ P20P2,train
38
+ P13P6,train
39
+ P13P13,train
40
+ P77P1,train
41
+ P91P7,train
42
+ P39P9,train
43
+ P192P1,train
44
+ P184P14,train
45
+ P20P7,train
46
+ P86P19,train
47
+ P57P1,train
48
+ P70P12,train
49
+ P77P4,train
50
+ P37P7,train
51
+ P76P7,train
52
+ P106P10,train
53
+ P47P6,train
54
+ P24P3,train
55
+ P72P10,train
56
+ P86P3,train
57
+ P59P1,train
58
+ P163P9,train
59
+ P77P5,train
60
+ P115P10,train
61
+ P127P15,train
62
+ P81P1,train
63
+ P121P1,train
64
+ P77P9,train
65
+ P157P3,train
66
+ P57P10,train
67
+ P190P3,train
68
+ P35P3,train
69
+ P90P13,train
70
+ P124P8,train
71
+ P83P4,train
72
+ P172P4,train
73
+ P118P14,train
74
+ P145P5,train
75
+ P20P4,train
76
+ P186P5,train
77
+ P118P17,train
78
+ P195P6,train
79
+ P58P1,train
80
+ P104P4,train
81
+ P114P2,train
82
+ P27P3,train
83
+ P139P6,train
84
+ P83P3,train
85
+ P88P10,train
86
+ P197P1,train
87
+ P154P1,train
88
+ P87P15,train
89
+ P18P5,train
90
+ P69P1,train
91
+ P52P1,train
92
+ P62P1,train
93
+ P111P8,train
94
+ P72P11,train
95
+ P17P5,train
96
+ P30P4,train
97
+ P50P6,train
98
+ P46P2,train
99
+ P194P8,train
100
+ P87P22,train
101
+ P188P7,train
102
+ P139P7,train
103
+ P54P4,train
104
+ P35P5,train
105
+ P103P7,train
106
+ P12PR11,train
107
+ P127P1,train
108
+ P200P7,train
109
+ P160P6,train
110
+ P112P8,train
111
+ P183P6,train
112
+ P90P9,train
113
+ P194P4,train
114
+ P90P10,train
115
+ P33P4,train
116
+ P12PR3,train
117
+ P75P12,train
118
+ P82P10,train
119
+ P20P3,train
120
+ P27P1,train
121
+ P84P3,train
122
+ P186P4,train
123
+ P103P4,train
124
+ P190P8,train
125
+ P28P4,train
126
+ P112P9,train
127
+ P163P10,train
128
+ P133P1,train
129
+ P95P3,train
130
+ P177P6,train
131
+ P104P11,train
132
+ P28P7,train
133
+ P90P16,train
134
+ P118P16,train
135
+ P178P2,train
136
+ P74P9,train
137
+ P17P3,train
138
+ P29P9,train
139
+ P161P6,train
140
+ P163P11,train
141
+ P115P1,train
142
+ P157P2,train
143
+ P95P8,train
144
+ P36P3,train
145
+ P139P1,train
146
+ P13P4,train
147
+ P131P1,train
148
+ P161P4,train
149
+ P187P9,train
150
+ P33P2,train
151
+ P115P5,train
152
+ P40P7,train
153
+ P78P7,train
154
+ P45P2,train
155
+ P115P8,train
156
+ P151P6,train
157
+ P12PR6,train
158
+ P76P4,train
159
+ P104P7,train
160
+ P127P11,train
161
+ P38P3,train
162
+ P37P8,train
163
+ P149P4,train
164
+ P31P4,train
165
+ P99P15,train
166
+ P83P7,train
167
+ P11PR13,train
168
+ P178P4,train
169
+ P130P4,train
170
+ P103P10,train
171
+ P113P26,train
172
+ P87P10,train
173
+ P139P3,train
174
+ P29P10,train
175
+ P192P2,train
176
+ P58P3,train
177
+ P32P4,train
178
+ P104P1,train
179
+ P31P3,train
180
+ P73P10,train
181
+ P109P11,train
182
+ P41P5,train
183
+ P187P4,train
184
+ P76P11,train
185
+ P173P5,train
186
+ P95P10,train
187
+ P170P1,train
188
+ P59P5,train
189
+ P121P2,train
190
+ P46P4,train
191
+ P67P1,train
192
+ P169P9,train
193
+ P169P10,train
194
+ P124P13,train
195
+ P91P1,train
196
+ P66P5,train
197
+ P134P8,train
198
+ P58P4,train
199
+ P130P18,train
200
+ P54P6,train
201
+ P68P3,train
202
+ P23P6,train
203
+ P66P2,train
204
+ P57P4,train
205
+ P80P1,train
206
+ P143P4,train
207
+ P76P2,train
208
+ P185P1,train
209
+ P145P7,train
210
+ P87P1,train
211
+ P91P6,train
212
+ P13P15,train
213
+ P73P8,train
214
+ P76P5,train
215
+ P12PR9,train
216
+ P24P4,train
217
+ P48P3,train
218
+ P11PR3,train
219
+ P183P3,train
220
+ P184P13,train
221
+ P87P2,train
222
+ P81P12,train
223
+ P56P12,train
224
+ P124P14,train
225
+ P11PR11,train
226
+ P84P4,train
227
+ P102P2,train
228
+ P116P2,train
229
+ P153P1,train
230
+ P133P3,train
231
+ P61P2,train
232
+ P69P5,train
233
+ P147P6,train
234
+ P70P7,train
235
+ P128P8,train
236
+ P31P5,train
237
+ P39P6,train
238
+ P113P28,train
239
+ P70P6,train
240
+ P101P7,train
241
+ P15P3,train
242
+ P125P14,train
243
+ P73P4,train
244
+ P139P4,train
245
+ P154P18,train
246
+ P70P13,train
247
+ P74P2,train
248
+ P18P9,train
249
+ P102P10,train
250
+ P117P9,train
251
+ P25P4,train
252
+ P117P6,train
253
+ P156P4,train
254
+ P193P2,train
255
+ P102P5,train
256
+ P117P10,train
257
+ P86P4,train
258
+ P27P2,train
259
+ P74P4,train
260
+ P85P9,train
261
+ P88P17,train
262
+ P19P4,train
263
+ P117P7,train
264
+ P62P2,train
265
+ P72P3,train
266
+ P81P7,train
267
+ P173P1,train
268
+ P85P6,train
269
+ P124P3,train
270
+ P124P10,train
271
+ P185P5,train
272
+ P44P6,train
273
+ P116P9,train
274
+ P82P2,train
275
+ P56P4,train
276
+ P128P1,train
277
+ P172P3,train
278
+ P61P3,train
279
+ P108P11,train
280
+ P104P8,train
281
+ P75P2,train
282
+ P11PR7,train
283
+ P197P3,train
284
+ P22P5,train
285
+ P67P7,train
286
+ P54P3,train
287
+ P144P2,train
288
+ P74P8,train
289
+ P14P2,train
290
+ P94P4,train
291
+ P77P3,train
292
+ P36P4,train
293
+ P81P3,train
294
+ P194P5,train
295
+ P87P8,train
296
+ P72P1,train
297
+ P87P5,train
298
+ P185P3,train
299
+ P81P4,train
300
+ P177P8,train
301
+ P21P7,train
302
+ P71P4,train
303
+ P46P6,train
304
+ P113P25,train
305
+ P40P5,train
306
+ P189P7,train
307
+ P171P3,train
308
+ P70P3,train
309
+ P88P13,train
310
+ P154P16,train
311
+ P139P5,train
312
+ P14P7,train
313
+ P76P9,train
314
+ P183P5,train
315
+ P89P22,train
316
+ P127P5,train
317
+ P62P3,train
318
+ P118P12,train
319
+ P56P10,train
320
+ P78P1,train
321
+ P124P7,train
322
+ P59P2,train
323
+ P182P6,train
324
+ P33P1,train
325
+ P67P2,train
326
+ P45P8,train
327
+ P131P5,train
328
+ P130P10,train
329
+ P109P16,train
330
+ P57P3,train
331
+ P113P22,train
332
+ P62P5,train
333
+ P90P17,train
334
+ P182P1,train
335
+ P47P3,train
336
+ P191P2,train
337
+ P123P8,train
338
+ P197P6,train
339
+ P187P7,train
340
+ P17P4,train
341
+ P129P8,train
342
+ P94P5,train
343
+ P108P19,train
344
+ P55P2,train
345
+ P93P8,train
346
+ P41P3,train
347
+ P90P4,train
348
+ P47P8,train
349
+ P65P1,train
350
+ P60P3,train
351
+ P119P8,train
352
+ P76P10,train
353
+ P11PR9,train
354
+ P113P7,train
355
+ P40P2,train
356
+ P117P13,train
357
+ P22P7,train
358
+ P67P8,train
359
+ P81P9,train
360
+ P11PR8,train
361
+ P44P4,train
362
+ P100P13,train
363
+ P28P2,train
364
+ P76P13,train
365
+ P97P8,train
366
+ P122P7,train
367
+ P187P2,train
368
+ P185P2,train
369
+ P14P6,train
370
+ P69P3,train
371
+ P23P5,train
372
+ P99P8,train
373
+ P17P2,train
374
+ P117P8,train
375
+ P37P9,train
376
+ P100P7,train
377
+ P139P8,train
378
+ P90P5,train
379
+ P109P6,train
380
+ P189P8,train
381
+ P198P3,train
382
+ P161P5,train
383
+ P119P13,train
384
+ P21P9,train
385
+ P113P15,train
386
+ P174P9,train
387
+ P75P8,train
388
+ P106P5,train
389
+ P188P2,train
390
+ P35P1,train
391
+ P63P8,train
392
+ P28P1,train
393
+ P128P6,train
394
+ P87P21,train
395
+ P49P2,train
396
+ P86P7,train
397
+ P105P8,train
398
+ P88P14,train
399
+ P11PR2,train
400
+ P134P5,train
401
+ P103P5,train
402
+ P71P8,train
403
+ P113P4,train
404
+ P29P1,train
405
+ P65P4,train
406
+ P86P9,train
407
+ P18P1,train
408
+ P12PR1,test
409
+ P35P6,test
410
+ P197P5,test
411
+ P32P1,test
412
+ P118P5,test
413
+ P96P3,test
414
+ P70P11,test
415
+ P118P15,test
416
+ P103P1,test
417
+ P54P2,test
418
+ P72P7,test
419
+ P21P8,test
420
+ P156P1,test
421
+ P13P14,test
422
+ P190P5,test
423
+ P121P4,test
424
+ P72P8,test
425
+ P69P4,test
426
+ P32P8,test
427
+ P93P3,test
428
+ P91P10,test
429
+ P163P7,test
430
+ P22P8,test
431
+ P106P2,test
432
+ P148P5,test
433
+ P79P10,test
434
+ P21P10,test
435
+ P113P13,test
436
+ P139P9,test
437
+ P184P11,test
438
+ P86P22,test
439
+ P107P1,test
440
+ P98P8,test
441
+ P140P3,test
442
+ P127P6,test
443
+ P32P7,test
444
+ P186P3,test
445
+ P153P4,test
446
+ P38P6,test
447
+ P191P1,test
448
+ P157P4,test
449
+ P81P13,test
450
+ P123P3,test
451
+ P17P10,test
452
+ P83P10,test
453
+ P155P7,test
454
+ P98P7,test
455
+ P25P1,test
456
+ P103P6,test
457
+ P38P1,test
458
+ P79P8,test
459
+ P187P3,test
460
+ P72P9,test
461
+ P62P6,test
462
+ P83P8,test
463
+ P34P4,test
464
+ P173P6,test
465
+ P47P7,test
466
+ P65P2,test
467
+ P73P9,test
468
+ P45P6,test
469
+ P87P20,test
470
+ P127P4,test
471
+ P189P5,test
472
+ P77P6,test
473
+ P59P4,test
474
+ P22P6,test
475
+ P188P6,test
476
+ P13P8,test
477
+ P198P7,test
478
+ P56P8,test
479
+ P193P4,test
480
+ P128P5,test
481
+ P116P1,test
482
+ P127P7,test
483
+ P41P7,test
484
+ P60P2,test
485
+ P32P5,test
486
+ P49P8,test
487
+ P31P2,test
488
+ P68P6,test
489
+ P57P8,test
490
+ P142P2,test
491
+ P118P11,test
492
+ P142P9,test
493
+ P76P8,test
494
+ P22P3,test
495
+ P47P4,test
496
+ P132P1,test
497
+ P65P8,test
498
+ P138P6,test
499
+ P200P12,test
500
+ P113P11,test
501
+ P79P3,test
502
+ P125P10,test
503
+ P58P5,test
504
+ P124P11,test
505
+ P161P1,test
506
+ P19P3,test
507
+ P74P1,test
508
+ P70P9,test
509
+ P32P6,test
510
+ P58P6,test
511
+ P46P3,test
512
+ P83P6,test
513
+ P105P1,test
514
+ P116P4,test
515
+ P188P1,test
516
+ P50P1,test
517
+ P50P2,test
518
+ P11PR1,test
519
+ P200P4,test
520
+ P181P5,test
521
+ P56P9,test
522
+ P81P6,test
523
+ P185P6,test
524
+ P130P6,test
525
+ P200P9,test
526
+ P35P9,test
527
+ P18P10,test
528
+ P179P3,test
529
+ P65P3,test
530
+ P83P1,test
531
+ P134P6,test
532
+ P163P13,test
533
+ P13P7,test
534
+ P27P4,test
535
+ P86P8,test
536
+ P15P1,test
537
+ P105P7,test
538
+ P84P5,test
539
+ P71P1,test
540
+ P81P11,test
541
+ P184P12,test
542
+ P102P3,test
543
+ P81P10,test
544
+ P13P3,test
545
+ P179P1,test
546
+ P78P8,test
547
+ P145P6,test
548
+ P121P6,test
549
+ P124P4,test
550
+ P183P8,test
551
+ P96P11,test
552
+ P78P2,test
553
+ P37P6,test
554
+ P190P2,test
555
+ P125P11,test
556
+ P20P6,test
557
+ P16P3,test
558
+ P196P5,test
559
+ P81P8,test
560
+ P11PR12,test
561
+ P167P7,test
562
+ P53P4,test
563
+ P22P11,test
564
+ P175P6,test
565
+ P41P2,test
566
+ P154P6,test
567
+ P165P10,test
568
+ P94P1,test
569
+ P32P2,test
570
+ P192P5,test
571
+ P111P9,test
572
+ P65P7,test
573
+ P167P6,test
574
+ P98P5,test
575
+ P50P3,test
576
+ P26P5,test
577
+ P45P9,test
578
+ P115P4,test
579
+ P17P6,test
580
+ P71P9,test
581
+ P30P5,test
582
+ P125P8,test
583
+ P81P5,test
584
+ P105P5,test
585
+ P128P2,test
586
+ P113P30,test
587
+ P75P1,test
588
+ P113P3,test
589
+ P38P5,test
590
+ P65P6,test
591
+ P90P12,test
592
+ P188P8,test
593
+ P75P9,test
594
+ P60P4,test
595
+ P24P2,test
596
+ P171P1,test
597
+ P171P2,test
598
+ P181P2,test
599
+ P90P7,test
600
+ P119P10,test
601
+ P186P1,test
602
+ P39P3,test
603
+ P84P9,test
604
+ P163P6,test
605
+ P76P12,test
606
+ P87P23,test
607
+ P96P13,test
608
+ P62P4,test
609
+ P73P2,test
610
+ P69P6,test
611
+ P127P3,test
612
+ P87P4,val
613
+ P85P7,val
614
+ P68P4,val
615
+ P71P7,val
616
+ P158P3,val
617
+ P190P7,val
618
+ P87P11,val
619
+ P61P4,val
620
+ P140P1,val
621
+ P177P7,val
622
+ P74P10,val
623
+ P70P8,val
624
+ P90P3,val
625
+ P57P7,val
626
+ P198P6,val
627
+ P93P1,val
628
+ P135P7,val
629
+ P196P7,val
630
+ P173P3,val
631
+ P175P3,val
632
+ P56P11,val
633
+ P117P1,val
634
+ P12PR8,val
635
+ P72P12,val
636
+ P102P1,val
637
+ P70P4,val
638
+ P86P5,val
639
+ P66P4,val
640
+ P138P7,val
641
+ P38P7,val
642
+ P45P10,val
643
+ P196P3,val
644
+ P125P2,val
645
+ P127P10,val
646
+ P54P1,val
647
+ P182P9,val
648
+ P40P8,val
649
+ P54P5,val
650
+ P94P3,val
651
+ P96P14,val
652
+ P26P3,val
653
+ P123P7,val
654
+ P113P16,val
655
+ P37P5,val
656
+ P91P14,val
657
+ P79P5,val
658
+ P90P1,val
659
+ P123P6,val
660
+ P124P12,val
661
+ P101P11,val
662
+ P15P4,val
663
+ P55P3,val
664
+ P100P1,val
665
+ P172P5,val
666
+ P193P5,val
667
+ P30P3,val
668
+ P28P3,val
669
+ P113P1,val
670
+ P67P4,val
671
+ P93P7,val
672
+ P165P6,val
673
+ P44P7,val
674
+ P85P8,val
675
+ P153P2,val
676
+ P87P26,val
677
+ P116P3,val
678
+ P88P18,val
679
+ P113P14,val
data/splits/probes/reddit/reddit_exp3_2_probe_test.csv ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:b928ef2d95c3f75e50497619628330b86b75c368685b2c0394cde0e97c4f2c19
3
+ size 15940795
data/splits/probes/reddit/reddit_exp3_2_probe_train.csv ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:52492e88a565ec9e48a47ae50220b92b3bf5a7069758f172973823161201c3aa
3
+ size 32189055
data/splits/probes/reddit/reddit_exp3_2_probe_validation.csv ADDED
The diff for this file is too large to render. See raw diff
 
data/splits/probes/reddit/split_assignments.csv ADDED
@@ -0,0 +1,682 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ Document_ID,Paragraph_ID,split
2
+ ,P0002,train
3
+ ,P0003,train
4
+ ,P0005,train
5
+ ,P0007,train
6
+ ,P0008,train
7
+ ,P0010,train
8
+ ,P0012,train
9
+ ,P0013,train
10
+ ,P0014,train
11
+ ,P0016,train
12
+ ,P0017,train
13
+ ,P0018,train
14
+ ,P0019,train
15
+ ,P0020,train
16
+ ,P0021,train
17
+ ,P0022,train
18
+ ,P0023,train
19
+ ,P0027,train
20
+ ,P0028,train
21
+ ,P0030,train
22
+ ,P0032,train
23
+ ,P0033,train
24
+ ,P0034,train
25
+ ,P0035,train
26
+ ,P0036,train
27
+ ,P0037,train
28
+ ,P0038,train
29
+ ,P0040,train
30
+ ,P0041,train
31
+ ,P0046,train
32
+ ,P0048,train
33
+ ,P0049,train
34
+ ,P0050,train
35
+ ,P0051,train
36
+ ,P0054,train
37
+ ,P0055,train
38
+ ,P0056,train
39
+ ,P0057,train
40
+ ,P0058,train
41
+ ,P0060,train
42
+ ,P0061,train
43
+ ,P0063,train
44
+ ,P0066,train
45
+ ,P0068,train
46
+ ,P0069,train
47
+ ,P0070,train
48
+ ,P0071,train
49
+ ,P0072,train
50
+ ,P0073,train
51
+ ,P0075,train
52
+ ,P0076,train
53
+ ,P0078,train
54
+ ,P0079,train
55
+ ,P0082,train
56
+ ,P0083,train
57
+ ,P0085,train
58
+ ,P0087,train
59
+ ,P0088,train
60
+ ,P0089,train
61
+ ,P0090,train
62
+ ,P0091,train
63
+ ,P0092,train
64
+ ,P0093,train
65
+ ,P0094,train
66
+ ,P0096,train
67
+ ,P0098,train
68
+ ,P0102,train
69
+ ,P0104,train
70
+ ,P0107,train
71
+ ,P0108,train
72
+ ,P0109,train
73
+ ,P0111,train
74
+ ,P0112,train
75
+ ,P0115,train
76
+ ,P0118,train
77
+ ,P0120,train
78
+ ,P0121,train
79
+ ,P0124,train
80
+ ,P0127,train
81
+ ,P0130,train
82
+ ,P0131,train
83
+ ,P0132,train
84
+ ,P0134,train
85
+ ,P0135,train
86
+ ,P0136,train
87
+ ,P0137,train
88
+ ,P0139,train
89
+ ,P0140,train
90
+ ,P0141,train
91
+ ,P0142,train
92
+ ,P0144,train
93
+ ,P0145,train
94
+ ,P0147,train
95
+ ,P0148,train
96
+ ,P0149,train
97
+ ,P0151,train
98
+ ,P0155,train
99
+ ,P0156,train
100
+ ,P0157,train
101
+ ,P0158,train
102
+ ,P0159,train
103
+ ,P0160,train
104
+ ,P0161,train
105
+ ,P0164,train
106
+ ,P0166,train
107
+ ,P0168,train
108
+ ,P0169,train
109
+ ,P0176,train
110
+ ,P0177,train
111
+ ,P0178,train
112
+ ,P0180,train
113
+ ,P0181,train
114
+ ,P0183,train
115
+ ,P0184,train
116
+ ,P0185,train
117
+ ,P0186,train
118
+ ,P0187,train
119
+ ,P0188,train
120
+ ,P0190,train
121
+ ,P0192,train
122
+ ,P0193,train
123
+ ,P0194,train
124
+ ,P0198,train
125
+ ,P0199,train
126
+ ,P0200,train
127
+ ,P0203,train
128
+ ,P0205,train
129
+ ,P0207,train
130
+ ,P0209,train
131
+ ,P0210,train
132
+ ,P0211,train
133
+ ,P0212,train
134
+ ,P0213,train
135
+ ,P0217,train
136
+ ,P0219,train
137
+ ,P0222,train
138
+ ,P0223,train
139
+ ,P0224,train
140
+ ,P0225,train
141
+ ,P0227,train
142
+ ,P0230,train
143
+ ,P0231,train
144
+ ,P0232,train
145
+ ,P0234,train
146
+ ,P0236,train
147
+ ,P0238,train
148
+ ,P0241,train
149
+ ,P0243,train
150
+ ,P0244,train
151
+ ,P0245,train
152
+ ,P0247,train
153
+ ,P0249,train
154
+ ,P0251,train
155
+ ,P0252,train
156
+ ,P0253,train
157
+ ,P0254,train
158
+ ,P0255,train
159
+ ,P0259,train
160
+ ,P0260,train
161
+ ,P0262,train
162
+ ,P0263,train
163
+ ,P0264,train
164
+ ,P0268,train
165
+ ,P0269,train
166
+ ,P0270,train
167
+ ,P0271,train
168
+ ,P0272,train
169
+ ,P0273,train
170
+ ,P0274,train
171
+ ,P0278,train
172
+ ,P0279,train
173
+ ,P0280,train
174
+ ,P0282,train
175
+ ,P0283,train
176
+ ,P0284,train
177
+ ,P0286,train
178
+ ,P0288,train
179
+ ,P0291,train
180
+ ,P0292,train
181
+ ,P0293,train
182
+ ,P0295,train
183
+ ,P0296,train
184
+ ,P0298,train
185
+ ,P0301,train
186
+ ,P0303,train
187
+ ,P0304,train
188
+ ,P0306,train
189
+ ,P0307,train
190
+ ,P0308,train
191
+ ,P0310,train
192
+ ,P0311,train
193
+ ,P0312,train
194
+ ,P0313,train
195
+ ,P0314,train
196
+ ,P0317,train
197
+ ,P0318,train
198
+ ,P0322,train
199
+ ,P0323,train
200
+ ,P0328,train
201
+ ,P0330,train
202
+ ,P0333,train
203
+ ,P0335,train
204
+ ,P0336,train
205
+ ,P0337,train
206
+ ,P0339,train
207
+ ,P0341,train
208
+ ,P0344,train
209
+ ,P0347,train
210
+ ,P0349,train
211
+ ,P0351,train
212
+ ,P0352,train
213
+ ,P0353,train
214
+ ,P0356,train
215
+ ,P0357,train
216
+ ,P0360,train
217
+ ,P0361,train
218
+ ,P0363,train
219
+ ,P0364,train
220
+ ,P0365,train
221
+ ,P0367,train
222
+ ,P0368,train
223
+ ,P0370,train
224
+ ,P0371,train
225
+ ,P0372,train
226
+ ,P0373,train
227
+ ,P0374,train
228
+ ,P0376,train
229
+ ,P0379,train
230
+ ,P0380,train
231
+ ,P0381,train
232
+ ,P0383,train
233
+ ,P0384,train
234
+ ,P0387,train
235
+ ,P0389,train
236
+ ,P0390,train
237
+ ,P0391,train
238
+ ,P0392,train
239
+ ,P0393,train
240
+ ,P0394,train
241
+ ,P0395,train
242
+ ,P0396,train
243
+ ,P0398,train
244
+ ,P0399,train
245
+ ,P0402,train
246
+ ,P0403,train
247
+ ,P0404,train
248
+ ,P0406,train
249
+ ,P0407,train
250
+ ,P0408,train
251
+ ,P0410,train
252
+ ,P0411,train
253
+ ,P0413,train
254
+ ,P0418,train
255
+ ,P0419,train
256
+ ,P0420,train
257
+ ,P0422,train
258
+ ,P0424,train
259
+ ,P0430,train
260
+ ,P0432,train
261
+ ,P0433,train
262
+ ,P0435,train
263
+ ,P0440,train
264
+ ,P0441,train
265
+ ,P0442,train
266
+ ,P0444,train
267
+ ,P0446,train
268
+ ,P0447,train
269
+ ,P0448,train
270
+ ,P0450,train
271
+ ,P0451,train
272
+ ,P0455,train
273
+ ,P0460,train
274
+ ,P0463,train
275
+ ,P0465,train
276
+ ,P0467,train
277
+ ,P0468,train
278
+ ,P0469,train
279
+ ,P0470,train
280
+ ,P0471,train
281
+ ,P0474,train
282
+ ,P0475,train
283
+ ,P0477,train
284
+ ,P0479,train
285
+ ,P0480,train
286
+ ,P0481,train
287
+ ,P0482,train
288
+ ,P0486,train
289
+ ,P0487,train
290
+ ,P0488,train
291
+ ,P0491,train
292
+ ,P0492,train
293
+ ,P0493,train
294
+ ,P0495,train
295
+ ,P0496,train
296
+ ,P0498,train
297
+ ,P0500,train
298
+ ,P0502,train
299
+ ,P0503,train
300
+ ,P0504,train
301
+ ,P0505,train
302
+ ,P0506,train
303
+ ,P0509,train
304
+ ,P0514,train
305
+ ,P0515,train
306
+ ,P0516,train
307
+ ,P0518,train
308
+ ,P0519,train
309
+ ,P0520,train
310
+ ,P0521,train
311
+ ,P0524,train
312
+ ,P0525,train
313
+ ,P0526,train
314
+ ,P0527,train
315
+ ,P0528,train
316
+ ,P0530,train
317
+ ,P0532,train
318
+ ,P0534,train
319
+ ,P0535,train
320
+ ,P0536,train
321
+ ,P0540,train
322
+ ,P0541,train
323
+ ,P0545,train
324
+ ,P0546,train
325
+ ,P0550,train
326
+ ,P0551,train
327
+ ,P0554,train
328
+ ,P0557,train
329
+ ,P0558,train
330
+ ,P0559,train
331
+ ,P0561,train
332
+ ,P0562,train
333
+ ,P0565,train
334
+ ,P0566,train
335
+ ,P0567,train
336
+ ,P0568,train
337
+ ,P0569,train
338
+ ,P0571,train
339
+ ,P0572,train
340
+ ,P0574,train
341
+ ,P0575,train
342
+ ,P0576,train
343
+ ,P0577,train
344
+ ,P0579,train
345
+ ,P0580,train
346
+ ,P0581,train
347
+ ,P0583,train
348
+ ,P0587,train
349
+ ,P0589,train
350
+ ,P0590,train
351
+ ,P0595,train
352
+ ,P0597,train
353
+ ,P0598,train
354
+ ,P0599,train
355
+ ,P0601,train
356
+ ,P0602,train
357
+ ,P0605,train
358
+ ,P0608,train
359
+ ,P0609,train
360
+ ,P0612,train
361
+ ,P0616,train
362
+ ,P0617,train
363
+ ,P0621,train
364
+ ,P0623,train
365
+ ,P0627,train
366
+ ,P0628,train
367
+ ,P0629,train
368
+ ,P0631,train
369
+ ,P0632,train
370
+ ,P0633,train
371
+ ,P0635,train
372
+ ,P0636,train
373
+ ,P0637,train
374
+ ,P0638,train
375
+ ,P0639,train
376
+ ,P0641,train
377
+ ,P0642,train
378
+ ,P0644,train
379
+ ,P0645,train
380
+ ,P0647,train
381
+ ,P0648,train
382
+ ,P0650,train
383
+ ,P0651,train
384
+ ,P0652,train
385
+ ,P0653,train
386
+ ,P0655,train
387
+ ,P0656,train
388
+ ,P0657,train
389
+ ,P0659,train
390
+ ,P0660,train
391
+ ,P0661,train
392
+ ,P0662,train
393
+ ,P0665,train
394
+ ,P0666,train
395
+ ,P0668,train
396
+ ,P0669,train
397
+ ,P0670,train
398
+ ,P0671,train
399
+ ,P0672,train
400
+ ,P0677,train
401
+ ,P0683,train
402
+ ,P0684,train
403
+ ,P0685,train
404
+ ,P0686,train
405
+ ,P0688,train
406
+ ,P0689,train
407
+ ,P0693,train
408
+ ,P0694,train
409
+ ,P0695,train
410
+ ,P0009,test
411
+ ,P0011,test
412
+ ,P0015,test
413
+ ,P0024,test
414
+ ,P0025,test
415
+ ,P0026,test
416
+ ,P0029,test
417
+ ,P0031,test
418
+ ,P0039,test
419
+ ,P0043,test
420
+ ,P0044,test
421
+ ,P0052,test
422
+ ,P0053,test
423
+ ,P0059,test
424
+ ,P0062,test
425
+ ,P0065,test
426
+ ,P0074,test
427
+ ,P0077,test
428
+ ,P0080,test
429
+ ,P0081,test
430
+ ,P0084,test
431
+ ,P0086,test
432
+ ,P0095,test
433
+ ,P0097,test
434
+ ,P0099,test
435
+ ,P0105,test
436
+ ,P0110,test
437
+ ,P0113,test
438
+ ,P0114,test
439
+ ,P0117,test
440
+ ,P0122,test
441
+ ,P0123,test
442
+ ,P0125,test
443
+ ,P0126,test
444
+ ,P0128,test
445
+ ,P0129,test
446
+ ,P0133,test
447
+ ,P0143,test
448
+ ,P0146,test
449
+ ,P0150,test
450
+ ,P0153,test
451
+ ,P0163,test
452
+ ,P0165,test
453
+ ,P0167,test
454
+ ,P0170,test
455
+ ,P0171,test
456
+ ,P0173,test
457
+ ,P0174,test
458
+ ,P0175,test
459
+ ,P0179,test
460
+ ,P0182,test
461
+ ,P0191,test
462
+ ,P0195,test
463
+ ,P0196,test
464
+ ,P0197,test
465
+ ,P0201,test
466
+ ,P0204,test
467
+ ,P0208,test
468
+ ,P0214,test
469
+ ,P0215,test
470
+ ,P0216,test
471
+ ,P0218,test
472
+ ,P0221,test
473
+ ,P0226,test
474
+ ,P0228,test
475
+ ,P0229,test
476
+ ,P0233,test
477
+ ,P0239,test
478
+ ,P0242,test
479
+ ,P0248,test
480
+ ,P0250,test
481
+ ,P0256,test
482
+ ,P0257,test
483
+ ,P0258,test
484
+ ,P0261,test
485
+ ,P0266,test
486
+ ,P0267,test
487
+ ,P0275,test
488
+ ,P0276,test
489
+ ,P0277,test
490
+ ,P0281,test
491
+ ,P0285,test
492
+ ,P0287,test
493
+ ,P0289,test
494
+ ,P0290,test
495
+ ,P0294,test
496
+ ,P0297,test
497
+ ,P0299,test
498
+ ,P0300,test
499
+ ,P0305,test
500
+ ,P0309,test
501
+ ,P0315,test
502
+ ,P0321,test
503
+ ,P0327,test
504
+ ,P0331,test
505
+ ,P0332,test
506
+ ,P0334,test
507
+ ,P0338,test
508
+ ,P0340,test
509
+ ,P0342,test
510
+ ,P0345,test
511
+ ,P0346,test
512
+ ,P0348,test
513
+ ,P0350,test
514
+ ,P0354,test
515
+ ,P0355,test
516
+ ,P0359,test
517
+ ,P0362,test
518
+ ,P0369,test
519
+ ,P0375,test
520
+ ,P0382,test
521
+ ,P0385,test
522
+ ,P0386,test
523
+ ,P0388,test
524
+ ,P0400,test
525
+ ,P0401,test
526
+ ,P0405,test
527
+ ,P0409,test
528
+ ,P0412,test
529
+ ,P0414,test
530
+ ,P0415,test
531
+ ,P0421,test
532
+ ,P0423,test
533
+ ,P0426,test
534
+ ,P0427,test
535
+ ,P0428,test
536
+ ,P0429,test
537
+ ,P0434,test
538
+ ,P0436,test
539
+ ,P0443,test
540
+ ,P0445,test
541
+ ,P0452,test
542
+ ,P0453,test
543
+ ,P0454,test
544
+ ,P0456,test
545
+ ,P0457,test
546
+ ,P0458,test
547
+ ,P0459,test
548
+ ,P0461,test
549
+ ,P0464,test
550
+ ,P0476,test
551
+ ,P0478,test
552
+ ,P0484,test
553
+ ,P0485,test
554
+ ,P0489,test
555
+ ,P0490,test
556
+ ,P0494,test
557
+ ,P0497,test
558
+ ,P0501,test
559
+ ,P0507,test
560
+ ,P0510,test
561
+ ,P0511,test
562
+ ,P0513,test
563
+ ,P0517,test
564
+ ,P0522,test
565
+ ,P0533,test
566
+ ,P0537,test
567
+ ,P0538,test
568
+ ,P0539,test
569
+ ,P0544,test
570
+ ,P0547,test
571
+ ,P0549,test
572
+ ,P0553,test
573
+ ,P0555,test
574
+ ,P0556,test
575
+ ,P0560,test
576
+ ,P0563,test
577
+ ,P0564,test
578
+ ,P0573,test
579
+ ,P0578,test
580
+ ,P0582,test
581
+ ,P0584,test
582
+ ,P0585,test
583
+ ,P0586,test
584
+ ,P0588,test
585
+ ,P0591,test
586
+ ,P0592,test
587
+ ,P0594,test
588
+ ,P0596,test
589
+ ,P0600,test
590
+ ,P0603,test
591
+ ,P0604,test
592
+ ,P0606,test
593
+ ,P0607,test
594
+ ,P0610,test
595
+ ,P0611,test
596
+ ,P0613,test
597
+ ,P0614,test
598
+ ,P0615,test
599
+ ,P0620,test
600
+ ,P0624,test
601
+ ,P0630,test
602
+ ,P0634,test
603
+ ,P0643,test
604
+ ,P0649,test
605
+ ,P0664,test
606
+ ,P0673,test
607
+ ,P0675,test
608
+ ,P0678,test
609
+ ,P0680,test
610
+ ,P0681,test
611
+ ,P0682,test
612
+ ,P0687,test
613
+ ,P0690,test
614
+ ,P0691,test
615
+ ,P0001,val
616
+ ,P0004,val
617
+ ,P0006,val
618
+ ,P0042,val
619
+ ,P0045,val
620
+ ,P0047,val
621
+ ,P0064,val
622
+ ,P0067,val
623
+ ,P0100,val
624
+ ,P0101,val
625
+ ,P0106,val
626
+ ,P0116,val
627
+ ,P0119,val
628
+ ,P0138,val
629
+ ,P0152,val
630
+ ,P0154,val
631
+ ,P0172,val
632
+ ,P0189,val
633
+ ,P0202,val
634
+ ,P0206,val
635
+ ,P0220,val
636
+ ,P0235,val
637
+ ,P0237,val
638
+ ,P0240,val
639
+ ,P0246,val
640
+ ,P0265,val
641
+ ,P0302,val
642
+ ,P0316,val
643
+ ,P0320,val
644
+ ,P0326,val
645
+ ,P0329,val
646
+ ,P0366,val
647
+ ,P0377,val
648
+ ,P0378,val
649
+ ,P0417,val
650
+ ,P0431,val
651
+ ,P0437,val
652
+ ,P0438,val
653
+ ,P0462,val
654
+ ,P0466,val
655
+ ,P0472,val
656
+ ,P0473,val
657
+ ,P0483,val
658
+ ,P0499,val
659
+ ,P0523,val
660
+ ,P0529,val
661
+ ,P0531,val
662
+ ,P0542,val
663
+ ,P0543,val
664
+ ,P0548,val
665
+ ,P0552,val
666
+ ,P0570,val
667
+ ,P0593,val
668
+ ,P0618,val
669
+ ,P0619,val
670
+ ,P0622,val
671
+ ,P0625,val
672
+ ,P0626,val
673
+ ,P0640,val
674
+ ,P0646,val
675
+ ,P0654,val
676
+ ,P0658,val
677
+ ,P0663,val
678
+ ,P0667,val
679
+ ,P0674,val
680
+ ,P0676,val
681
+ ,P0679,val
682
+ ,P0692,val
data/splits/probes/synthetic/README_exp3_2_probe_splits.txt ADDED
@@ -0,0 +1,16 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ Exp3.2 Probe fine-tuning splits
2
+
3
+ These files use the exact Paragraph_ID split from Exp3.1 extraction fine-tuning.
4
+ Train = 60%, Test = 30%, Validation = 10% by unique Paragraph_ID.
5
+
6
+ Columns kept in train/test/validation CSVs:
7
+ - Paragraph_ID
8
+ - Tuple_ID
9
+ - ProbeID
10
+ - Probe_Number
11
+ - Probe_Type
12
+ - Paragraph
13
+ - Probe_Question
14
+ - Gold_Label
15
+
16
+ Dropped columns include raw tuple fields, claim text, validation status, and validation notes to keep the files light for SageMaker training.
data/splits/probes/synthetic/exp3_2_probe_split_assignments.csv ADDED
@@ -0,0 +1,3001 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ Paragraph_ID,Split
2
+ P0001,train
3
+ P0006,train
4
+ P0007,train
5
+ P0010,train
6
+ P0011,train
7
+ P0015,train
8
+ P0016,train
9
+ P0017,train
10
+ P0021,train
11
+ P0022,train
12
+ P0023,train
13
+ P0026,train
14
+ P0027,train
15
+ P0032,train
16
+ P0034,train
17
+ P0035,train
18
+ P0036,train
19
+ P0037,train
20
+ P0038,train
21
+ P0039,train
22
+ P0042,train
23
+ P0043,train
24
+ P0044,train
25
+ P0047,train
26
+ P0048,train
27
+ P0049,train
28
+ P0050,train
29
+ P0052,train
30
+ P0053,train
31
+ P0055,train
32
+ P0056,train
33
+ P0057,train
34
+ P0058,train
35
+ P0060,train
36
+ P0061,train
37
+ P0062,train
38
+ P0063,train
39
+ P0064,train
40
+ P0065,train
41
+ P0066,train
42
+ P0068,train
43
+ P0070,train
44
+ P0071,train
45
+ P0072,train
46
+ P0073,train
47
+ P0074,train
48
+ P0076,train
49
+ P0077,train
50
+ P0078,train
51
+ P0080,train
52
+ P0081,train
53
+ P0082,train
54
+ P0084,train
55
+ P0088,train
56
+ P0091,train
57
+ P0093,train
58
+ P0094,train
59
+ P0095,train
60
+ P0096,train
61
+ P0099,train
62
+ P0100,train
63
+ P0101,train
64
+ P0104,train
65
+ P0105,train
66
+ P0106,train
67
+ P0107,train
68
+ P0109,train
69
+ P0111,train
70
+ P0112,train
71
+ P0113,train
72
+ P0115,train
73
+ P0116,train
74
+ P0117,train
75
+ P0119,train
76
+ P0120,train
77
+ P0121,train
78
+ P0122,train
79
+ P0125,train
80
+ P0126,train
81
+ P0128,train
82
+ P0129,train
83
+ P0131,train
84
+ P0132,train
85
+ P0135,train
86
+ P0136,train
87
+ P0137,train
88
+ P0139,train
89
+ P0140,train
90
+ P0141,train
91
+ P0144,train
92
+ P0145,train
93
+ P0146,train
94
+ P0150,train
95
+ P0152,train
96
+ P0155,train
97
+ P0156,train
98
+ P0157,train
99
+ P0158,train
100
+ P0159,train
101
+ P0160,train
102
+ P0163,train
103
+ P0164,train
104
+ P0167,train
105
+ P0168,train
106
+ P0169,train
107
+ P0170,train
108
+ P0172,train
109
+ P0175,train
110
+ P0176,train
111
+ P0177,train
112
+ P0179,train
113
+ P0180,train
114
+ P0182,train
115
+ P0184,train
116
+ P0186,train
117
+ P0187,train
118
+ P0188,train
119
+ P0193,train
120
+ P0194,train
121
+ P0197,train
122
+ P0199,train
123
+ P0202,train
124
+ P0210,train
125
+ P0211,train
126
+ P0212,train
127
+ P0213,train
128
+ P0215,train
129
+ P0216,train
130
+ P0217,train
131
+ P0218,train
132
+ P0219,train
133
+ P0223,train
134
+ P0224,train
135
+ P0226,train
136
+ P0227,train
137
+ P0228,train
138
+ P0229,train
139
+ P0230,train
140
+ P0231,train
141
+ P0232,train
142
+ P0236,train
143
+ P0238,train
144
+ P0239,train
145
+ P0240,train
146
+ P0241,train
147
+ P0242,train
148
+ P0243,train
149
+ P0245,train
150
+ P0247,train
151
+ P0248,train
152
+ P0249,train
153
+ P0252,train
154
+ P0254,train
155
+ P0255,train
156
+ P0256,train
157
+ P0258,train
158
+ P0262,train
159
+ P0263,train
160
+ P0264,train
161
+ P0267,train
162
+ P0268,train
163
+ P0271,train
164
+ P0272,train
165
+ P0273,train
166
+ P0274,train
167
+ P0275,train
168
+ P0284,train
169
+ P0285,train
170
+ P0286,train
171
+ P0287,train
172
+ P0288,train
173
+ P0289,train
174
+ P0290,train
175
+ P0291,train
176
+ P0292,train
177
+ P0293,train
178
+ P0294,train
179
+ P0295,train
180
+ P0296,train
181
+ P0298,train
182
+ P0299,train
183
+ P0300,train
184
+ P0301,train
185
+ P0302,train
186
+ P0303,train
187
+ P0304,train
188
+ P0306,train
189
+ P0307,train
190
+ P0309,train
191
+ P0313,train
192
+ P0314,train
193
+ P0317,train
194
+ P0318,train
195
+ P0319,train
196
+ P0321,train
197
+ P0325,train
198
+ P0326,train
199
+ P0327,train
200
+ P0328,train
201
+ P0331,train
202
+ P0332,train
203
+ P0333,train
204
+ P0336,train
205
+ P0338,train
206
+ P0340,train
207
+ P0341,train
208
+ P0342,train
209
+ P0344,train
210
+ P0345,train
211
+ P0346,train
212
+ P0347,train
213
+ P0348,train
214
+ P0350,train
215
+ P0351,train
216
+ P0352,train
217
+ P0353,train
218
+ P0355,train
219
+ P0356,train
220
+ P0357,train
221
+ P0358,train
222
+ P0359,train
223
+ P0360,train
224
+ P0362,train
225
+ P0363,train
226
+ P0365,train
227
+ P0366,train
228
+ P0367,train
229
+ P0370,train
230
+ P0371,train
231
+ P0373,train
232
+ P0374,train
233
+ P0375,train
234
+ P0376,train
235
+ P0378,train
236
+ P0381,train
237
+ P0382,train
238
+ P0383,train
239
+ P0384,train
240
+ P0385,train
241
+ P0386,train
242
+ P0388,train
243
+ P0390,train
244
+ P0391,train
245
+ P0392,train
246
+ P0393,train
247
+ P0394,train
248
+ P0396,train
249
+ P0397,train
250
+ P0398,train
251
+ P0400,train
252
+ P0402,train
253
+ P0403,train
254
+ P0404,train
255
+ P0405,train
256
+ P0406,train
257
+ P0407,train
258
+ P0408,train
259
+ P0410,train
260
+ P0411,train
261
+ P0412,train
262
+ P0414,train
263
+ P0416,train
264
+ P0418,train
265
+ P0419,train
266
+ P0420,train
267
+ P0421,train
268
+ P0422,train
269
+ P0423,train
270
+ P0426,train
271
+ P0427,train
272
+ P0428,train
273
+ P0429,train
274
+ P0430,train
275
+ P0435,train
276
+ P0437,train
277
+ P0439,train
278
+ P0441,train
279
+ P0445,train
280
+ P0446,train
281
+ P0449,train
282
+ P0451,train
283
+ P0452,train
284
+ P0454,train
285
+ P0455,train
286
+ P0456,train
287
+ P0458,train
288
+ P0461,train
289
+ P0462,train
290
+ P0463,train
291
+ P0466,train
292
+ P0467,train
293
+ P0468,train
294
+ P0469,train
295
+ P0472,train
296
+ P0473,train
297
+ P0475,train
298
+ P0476,train
299
+ P0478,train
300
+ P0479,train
301
+ P0482,train
302
+ P0485,train
303
+ P0489,train
304
+ P0490,train
305
+ P0491,train
306
+ P0492,train
307
+ P0495,train
308
+ P0496,train
309
+ P0497,train
310
+ P0499,train
311
+ P0500,train
312
+ P0501,train
313
+ P0502,train
314
+ P0505,train
315
+ P0506,train
316
+ P0508,train
317
+ P0511,train
318
+ P0512,train
319
+ P0513,train
320
+ P0514,train
321
+ P0515,train
322
+ P0516,train
323
+ P0519,train
324
+ P0521,train
325
+ P0523,train
326
+ P0525,train
327
+ P0526,train
328
+ P0531,train
329
+ P0533,train
330
+ P0534,train
331
+ P0536,train
332
+ P0538,train
333
+ P0541,train
334
+ P0543,train
335
+ P0544,train
336
+ P0545,train
337
+ P0546,train
338
+ P0547,train
339
+ P0548,train
340
+ P0549,train
341
+ P0550,train
342
+ P0553,train
343
+ P0554,train
344
+ P0555,train
345
+ P0557,train
346
+ P0558,train
347
+ P0559,train
348
+ P0561,train
349
+ P0562,train
350
+ P0563,train
351
+ P0566,train
352
+ P0571,train
353
+ P0572,train
354
+ P0574,train
355
+ P0576,train
356
+ P0578,train
357
+ P0579,train
358
+ P0580,train
359
+ P0581,train
360
+ P0582,train
361
+ P0583,train
362
+ P0584,train
363
+ P0586,train
364
+ P0591,train
365
+ P0592,train
366
+ P0593,train
367
+ P0594,train
368
+ P0595,train
369
+ P0597,train
370
+ P0599,train
371
+ P0600,train
372
+ P0602,train
373
+ P0605,train
374
+ P0606,train
375
+ P0607,train
376
+ P0608,train
377
+ P0609,train
378
+ P0614,train
379
+ P0615,train
380
+ P0616,train
381
+ P0617,train
382
+ P0620,train
383
+ P0623,train
384
+ P0625,train
385
+ P0627,train
386
+ P0628,train
387
+ P0629,train
388
+ P0630,train
389
+ P0632,train
390
+ P0635,train
391
+ P0639,train
392
+ P0640,train
393
+ P0645,train
394
+ P0646,train
395
+ P0647,train
396
+ P0650,train
397
+ P0651,train
398
+ P0652,train
399
+ P0654,train
400
+ P0655,train
401
+ P0656,train
402
+ P0660,train
403
+ P0661,train
404
+ P0663,train
405
+ P0664,train
406
+ P0665,train
407
+ P0667,train
408
+ P0668,train
409
+ P0670,train
410
+ P0671,train
411
+ P0672,train
412
+ P0675,train
413
+ P0676,train
414
+ P0678,train
415
+ P0679,train
416
+ P0681,train
417
+ P0682,train
418
+ P0684,train
419
+ P0686,train
420
+ P0689,train
421
+ P0690,train
422
+ P0691,train
423
+ P0692,train
424
+ P0693,train
425
+ P0695,train
426
+ P0696,train
427
+ P0697,train
428
+ P0701,train
429
+ P0702,train
430
+ P0705,train
431
+ P0706,train
432
+ P0707,train
433
+ P0708,train
434
+ P0709,train
435
+ P0710,train
436
+ P0712,train
437
+ P0713,train
438
+ P0714,train
439
+ P0717,train
440
+ P0719,train
441
+ P0720,train
442
+ P0722,train
443
+ P0723,train
444
+ P0724,train
445
+ P0726,train
446
+ P0728,train
447
+ P0729,train
448
+ P0730,train
449
+ P0732,train
450
+ P0735,train
451
+ P0737,train
452
+ P0739,train
453
+ P0740,train
454
+ P0741,train
455
+ P0742,train
456
+ P0745,train
457
+ P0746,train
458
+ P0749,train
459
+ P0752,train
460
+ P0753,train
461
+ P0754,train
462
+ P0756,train
463
+ P0758,train
464
+ P0759,train
465
+ P0760,train
466
+ P0761,train
467
+ P0763,train
468
+ P0764,train
469
+ P0765,train
470
+ P0766,train
471
+ P0768,train
472
+ P0769,train
473
+ P0772,train
474
+ P0773,train
475
+ P0774,train
476
+ P0775,train
477
+ P0776,train
478
+ P0777,train
479
+ P0778,train
480
+ P0779,train
481
+ P0780,train
482
+ P0781,train
483
+ P0783,train
484
+ P0784,train
485
+ P0787,train
486
+ P0788,train
487
+ P0789,train
488
+ P0792,train
489
+ P0794,train
490
+ P0795,train
491
+ P0796,train
492
+ P0800,train
493
+ P0802,train
494
+ P0803,train
495
+ P0807,train
496
+ P0808,train
497
+ P0811,train
498
+ P0812,train
499
+ P0817,train
500
+ P0818,train
501
+ P0819,train
502
+ P0823,train
503
+ P0825,train
504
+ P0826,train
505
+ P0827,train
506
+ P0828,train
507
+ P0831,train
508
+ P0832,train
509
+ P0833,train
510
+ P0834,train
511
+ P0836,train
512
+ P0837,train
513
+ P0838,train
514
+ P0839,train
515
+ P0841,train
516
+ P0842,train
517
+ P0844,train
518
+ P0845,train
519
+ P0846,train
520
+ P0847,train
521
+ P0849,train
522
+ P0850,train
523
+ P0851,train
524
+ P0853,train
525
+ P0855,train
526
+ P0859,train
527
+ P0860,train
528
+ P0864,train
529
+ P0866,train
530
+ P0867,train
531
+ P0869,train
532
+ P0871,train
533
+ P0873,train
534
+ P0876,train
535
+ P0877,train
536
+ P0878,train
537
+ P0879,train
538
+ P0880,train
539
+ P0881,train
540
+ P0883,train
541
+ P0886,train
542
+ P0888,train
543
+ P0890,train
544
+ P0891,train
545
+ P0893,train
546
+ P0894,train
547
+ P0896,train
548
+ P0897,train
549
+ P0898,train
550
+ P0899,train
551
+ P0901,train
552
+ P0906,train
553
+ P0908,train
554
+ P0909,train
555
+ P0910,train
556
+ P0911,train
557
+ P0914,train
558
+ P0917,train
559
+ P0919,train
560
+ P0921,train
561
+ P0923,train
562
+ P0924,train
563
+ P0926,train
564
+ P0927,train
565
+ P0929,train
566
+ P0930,train
567
+ P0931,train
568
+ P0932,train
569
+ P0933,train
570
+ P0934,train
571
+ P0936,train
572
+ P0939,train
573
+ P0940,train
574
+ P0942,train
575
+ P0943,train
576
+ P0947,train
577
+ P0948,train
578
+ P0949,train
579
+ P0950,train
580
+ P0952,train
581
+ P0953,train
582
+ P0955,train
583
+ P0956,train
584
+ P0958,train
585
+ P0961,train
586
+ P0962,train
587
+ P0964,train
588
+ P0968,train
589
+ P0970,train
590
+ P0971,train
591
+ P0972,train
592
+ P0978,train
593
+ P0979,train
594
+ P0981,train
595
+ P0982,train
596
+ P0983,train
597
+ P0986,train
598
+ P0988,train
599
+ P0989,train
600
+ P0991,train
601
+ P0992,train
602
+ P0993,train
603
+ P0995,train
604
+ P0997,train
605
+ P1000,train
606
+ P1001,train
607
+ P1002,train
608
+ P1004,train
609
+ P1005,train
610
+ P1006,train
611
+ P1007,train
612
+ P1008,train
613
+ P1011,train
614
+ P1012,train
615
+ P1014,train
616
+ P1017,train
617
+ P1018,train
618
+ P1019,train
619
+ P1020,train
620
+ P1021,train
621
+ P1022,train
622
+ P1023,train
623
+ P1024,train
624
+ P1025,train
625
+ P1026,train
626
+ P1027,train
627
+ P1028,train
628
+ P1030,train
629
+ P1033,train
630
+ P1034,train
631
+ P1039,train
632
+ P1041,train
633
+ P1042,train
634
+ P1043,train
635
+ P1044,train
636
+ P1045,train
637
+ P1046,train
638
+ P1047,train
639
+ P1055,train
640
+ P1057,train
641
+ P1059,train
642
+ P1064,train
643
+ P1065,train
644
+ P1067,train
645
+ P1068,train
646
+ P1072,train
647
+ P1074,train
648
+ P1075,train
649
+ P1076,train
650
+ P1079,train
651
+ P1083,train
652
+ P1085,train
653
+ P1086,train
654
+ P1088,train
655
+ P1091,train
656
+ P1092,train
657
+ P1093,train
658
+ P1094,train
659
+ P1095,train
660
+ P1096,train
661
+ P1097,train
662
+ P1098,train
663
+ P1100,train
664
+ P1101,train
665
+ P1103,train
666
+ P1106,train
667
+ P1107,train
668
+ P1108,train
669
+ P1110,train
670
+ P1111,train
671
+ P1112,train
672
+ P1113,train
673
+ P1115,train
674
+ P1116,train
675
+ P1118,train
676
+ P1123,train
677
+ P1125,train
678
+ P1126,train
679
+ P1129,train
680
+ P1130,train
681
+ P1131,train
682
+ P1133,train
683
+ P1134,train
684
+ P1136,train
685
+ P1139,train
686
+ P1140,train
687
+ P1141,train
688
+ P1142,train
689
+ P1143,train
690
+ P1144,train
691
+ P1145,train
692
+ P1147,train
693
+ P1148,train
694
+ P1150,train
695
+ P1151,train
696
+ P1153,train
697
+ P1154,train
698
+ P1155,train
699
+ P1156,train
700
+ P1157,train
701
+ P1158,train
702
+ P1159,train
703
+ P1160,train
704
+ P1161,train
705
+ P1162,train
706
+ P1163,train
707
+ P1164,train
708
+ P1165,train
709
+ P1167,train
710
+ P1168,train
711
+ P1170,train
712
+ P1171,train
713
+ P1173,train
714
+ P1174,train
715
+ P1175,train
716
+ P1176,train
717
+ P1177,train
718
+ P1179,train
719
+ P1181,train
720
+ P1183,train
721
+ P1186,train
722
+ P1192,train
723
+ P1194,train
724
+ P1198,train
725
+ P1200,train
726
+ P1202,train
727
+ P1205,train
728
+ P1206,train
729
+ P1207,train
730
+ P1208,train
731
+ P1210,train
732
+ P1212,train
733
+ P1214,train
734
+ P1217,train
735
+ P1218,train
736
+ P1219,train
737
+ P1220,train
738
+ P1221,train
739
+ P1223,train
740
+ P1228,train
741
+ P1230,train
742
+ P1232,train
743
+ P1233,train
744
+ P1236,train
745
+ P1238,train
746
+ P1239,train
747
+ P1240,train
748
+ P1241,train
749
+ P1242,train
750
+ P1244,train
751
+ P1245,train
752
+ P1248,train
753
+ P1249,train
754
+ P1250,train
755
+ P1251,train
756
+ P1252,train
757
+ P1253,train
758
+ P1256,train
759
+ P1258,train
760
+ P1259,train
761
+ P1261,train
762
+ P1263,train
763
+ P1264,train
764
+ P1265,train
765
+ P1267,train
766
+ P1268,train
767
+ P1272,train
768
+ P1273,train
769
+ P1274,train
770
+ P1275,train
771
+ P1279,train
772
+ P1280,train
773
+ P1281,train
774
+ P1283,train
775
+ P1285,train
776
+ P1286,train
777
+ P1287,train
778
+ P1288,train
779
+ P1294,train
780
+ P1295,train
781
+ P1296,train
782
+ P1297,train
783
+ P1298,train
784
+ P1300,train
785
+ P1302,train
786
+ P1304,train
787
+ P1305,train
788
+ P1306,train
789
+ P1307,train
790
+ P1309,train
791
+ P1313,train
792
+ P1315,train
793
+ P1317,train
794
+ P1318,train
795
+ P1320,train
796
+ P1321,train
797
+ P1322,train
798
+ P1323,train
799
+ P1325,train
800
+ P1326,train
801
+ P1331,train
802
+ P1333,train
803
+ P1334,train
804
+ P1335,train
805
+ P1336,train
806
+ P1337,train
807
+ P1338,train
808
+ P1339,train
809
+ P1340,train
810
+ P1344,train
811
+ P1345,train
812
+ P1347,train
813
+ P1349,train
814
+ P1351,train
815
+ P1353,train
816
+ P1354,train
817
+ P1355,train
818
+ P1356,train
819
+ P1359,train
820
+ P1362,train
821
+ P1363,train
822
+ P1366,train
823
+ P1369,train
824
+ P1372,train
825
+ P1373,train
826
+ P1376,train
827
+ P1377,train
828
+ P1378,train
829
+ P1379,train
830
+ P1380,train
831
+ P1381,train
832
+ P1382,train
833
+ P1384,train
834
+ P1387,train
835
+ P1389,train
836
+ P1391,train
837
+ P1396,train
838
+ P1398,train
839
+ P1399,train
840
+ P1400,train
841
+ P1401,train
842
+ P1403,train
843
+ P1407,train
844
+ P1408,train
845
+ P1409,train
846
+ P1412,train
847
+ P1413,train
848
+ P1414,train
849
+ P1415,train
850
+ P1416,train
851
+ P1417,train
852
+ P1418,train
853
+ P1420,train
854
+ P1421,train
855
+ P1424,train
856
+ P1425,train
857
+ P1426,train
858
+ P1428,train
859
+ P1429,train
860
+ P1433,train
861
+ P1434,train
862
+ P1436,train
863
+ P1437,train
864
+ P1440,train
865
+ P1441,train
866
+ P1442,train
867
+ P1443,train
868
+ P1444,train
869
+ P1446,train
870
+ P1448,train
871
+ P1449,train
872
+ P1450,train
873
+ P1453,train
874
+ P1454,train
875
+ P1455,train
876
+ P1456,train
877
+ P1457,train
878
+ P1458,train
879
+ P1459,train
880
+ P1460,train
881
+ P1462,train
882
+ P1466,train
883
+ P1467,train
884
+ P1469,train
885
+ P1470,train
886
+ P1472,train
887
+ P1476,train
888
+ P1478,train
889
+ P1480,train
890
+ P1482,train
891
+ P1483,train
892
+ P1485,train
893
+ P1489,train
894
+ P1492,train
895
+ P1493,train
896
+ P1495,train
897
+ P1496,train
898
+ P1498,train
899
+ P1500,train
900
+ P1503,train
901
+ P1506,train
902
+ P1507,train
903
+ P1508,train
904
+ P1510,train
905
+ P1513,train
906
+ P1518,train
907
+ P1520,train
908
+ P1521,train
909
+ P1522,train
910
+ P1523,train
911
+ P1524,train
912
+ P1525,train
913
+ P1526,train
914
+ P1527,train
915
+ P1531,train
916
+ P1533,train
917
+ P1535,train
918
+ P1536,train
919
+ P1537,train
920
+ P1540,train
921
+ P1543,train
922
+ P1544,train
923
+ P1546,train
924
+ P1547,train
925
+ P1549,train
926
+ P1551,train
927
+ P1552,train
928
+ P1554,train
929
+ P1556,train
930
+ P1557,train
931
+ P1558,train
932
+ P1559,train
933
+ P1560,train
934
+ P1564,train
935
+ P1565,train
936
+ P1568,train
937
+ P1570,train
938
+ P1571,train
939
+ P1573,train
940
+ P1574,train
941
+ P1575,train
942
+ P1576,train
943
+ P1577,train
944
+ P1578,train
945
+ P1579,train
946
+ P1582,train
947
+ P1583,train
948
+ P1588,train
949
+ P1590,train
950
+ P1591,train
951
+ P1593,train
952
+ P1594,train
953
+ P1596,train
954
+ P1597,train
955
+ P1598,train
956
+ P1601,train
957
+ P1602,train
958
+ P1604,train
959
+ P1605,train
960
+ P1606,train
961
+ P1607,train
962
+ P1609,train
963
+ P1610,train
964
+ P1612,train
965
+ P1613,train
966
+ P1615,train
967
+ P1616,train
968
+ P1617,train
969
+ P1618,train
970
+ P1620,train
971
+ P1621,train
972
+ P1622,train
973
+ P1623,train
974
+ P1624,train
975
+ P1625,train
976
+ P1626,train
977
+ P1628,train
978
+ P1629,train
979
+ P1630,train
980
+ P1631,train
981
+ P1633,train
982
+ P1636,train
983
+ P1638,train
984
+ P1641,train
985
+ P1642,train
986
+ P1643,train
987
+ P1644,train
988
+ P1645,train
989
+ P1647,train
990
+ P1648,train
991
+ P1649,train
992
+ P1651,train
993
+ P1652,train
994
+ P1654,train
995
+ P1656,train
996
+ P1658,train
997
+ P1659,train
998
+ P1661,train
999
+ P1663,train
1000
+ P1664,train
1001
+ P1665,train
1002
+ P1667,train
1003
+ P1669,train
1004
+ P1672,train
1005
+ P1673,train
1006
+ P1674,train
1007
+ P1675,train
1008
+ P1677,train
1009
+ P1679,train
1010
+ P1681,train
1011
+ P1683,train
1012
+ P1685,train
1013
+ P1687,train
1014
+ P1688,train
1015
+ P1690,train
1016
+ P1691,train
1017
+ P1692,train
1018
+ P1694,train
1019
+ P1695,train
1020
+ P1697,train
1021
+ P1698,train
1022
+ P1702,train
1023
+ P1703,train
1024
+ P1708,train
1025
+ P1709,train
1026
+ P1710,train
1027
+ P1711,train
1028
+ P1714,train
1029
+ P1715,train
1030
+ P1720,train
1031
+ P1721,train
1032
+ P1723,train
1033
+ P1727,train
1034
+ P1729,train
1035
+ P1730,train
1036
+ P1731,train
1037
+ P1732,train
1038
+ P1736,train
1039
+ P1737,train
1040
+ P1738,train
1041
+ P1741,train
1042
+ P1742,train
1043
+ P1743,train
1044
+ P1744,train
1045
+ P1745,train
1046
+ P1747,train
1047
+ P1748,train
1048
+ P1749,train
1049
+ P1750,train
1050
+ P1752,train
1051
+ P1753,train
1052
+ P1754,train
1053
+ P1755,train
1054
+ P1756,train
1055
+ P1757,train
1056
+ P1758,train
1057
+ P1759,train
1058
+ P1761,train
1059
+ P1764,train
1060
+ P1765,train
1061
+ P1767,train
1062
+ P1768,train
1063
+ P1769,train
1064
+ P1771,train
1065
+ P1772,train
1066
+ P1774,train
1067
+ P1775,train
1068
+ P1778,train
1069
+ P1779,train
1070
+ P1780,train
1071
+ P1781,train
1072
+ P1782,train
1073
+ P1785,train
1074
+ P1786,train
1075
+ P1788,train
1076
+ P1790,train
1077
+ P1794,train
1078
+ P1795,train
1079
+ P1798,train
1080
+ P1799,train
1081
+ P1800,train
1082
+ P1801,train
1083
+ P1802,train
1084
+ P1803,train
1085
+ P1804,train
1086
+ P1805,train
1087
+ P1806,train
1088
+ P1809,train
1089
+ P1810,train
1090
+ P1818,train
1091
+ P1821,train
1092
+ P1822,train
1093
+ P1824,train
1094
+ P1825,train
1095
+ P1827,train
1096
+ P1828,train
1097
+ P1829,train
1098
+ P1830,train
1099
+ P1831,train
1100
+ P1832,train
1101
+ P1834,train
1102
+ P1836,train
1103
+ P1839,train
1104
+ P1840,train
1105
+ P1842,train
1106
+ P1844,train
1107
+ P1845,train
1108
+ P1847,train
1109
+ P1848,train
1110
+ P1849,train
1111
+ P1850,train
1112
+ P1851,train
1113
+ P1852,train
1114
+ P1853,train
1115
+ P1857,train
1116
+ P1858,train
1117
+ P1860,train
1118
+ P1861,train
1119
+ P1865,train
1120
+ P1867,train
1121
+ P1869,train
1122
+ P1875,train
1123
+ P1876,train
1124
+ P1877,train
1125
+ P1879,train
1126
+ P1881,train
1127
+ P1885,train
1128
+ P1886,train
1129
+ P1887,train
1130
+ P1888,train
1131
+ P1889,train
1132
+ P1890,train
1133
+ P1891,train
1134
+ P1892,train
1135
+ P1893,train
1136
+ P1894,train
1137
+ P1897,train
1138
+ P1899,train
1139
+ P1901,train
1140
+ P1902,train
1141
+ P1903,train
1142
+ P1906,train
1143
+ P1907,train
1144
+ P1909,train
1145
+ P1910,train
1146
+ P1911,train
1147
+ P1912,train
1148
+ P1913,train
1149
+ P1914,train
1150
+ P1916,train
1151
+ P1918,train
1152
+ P1920,train
1153
+ P1921,train
1154
+ P1922,train
1155
+ P1923,train
1156
+ P1924,train
1157
+ P1926,train
1158
+ P1929,train
1159
+ P1930,train
1160
+ P1931,train
1161
+ P1932,train
1162
+ P1933,train
1163
+ P1934,train
1164
+ P1935,train
1165
+ P1938,train
1166
+ P1939,train
1167
+ P1943,train
1168
+ P1944,train
1169
+ P1945,train
1170
+ P1947,train
1171
+ P1948,train
1172
+ P1949,train
1173
+ P1952,train
1174
+ P1953,train
1175
+ P1957,train
1176
+ P1958,train
1177
+ P1959,train
1178
+ P1960,train
1179
+ P1961,train
1180
+ P1967,train
1181
+ P1968,train
1182
+ P1970,train
1183
+ P1973,train
1184
+ P1976,train
1185
+ P1977,train
1186
+ P1979,train
1187
+ P1984,train
1188
+ P1985,train
1189
+ P1986,train
1190
+ P1987,train
1191
+ P1989,train
1192
+ P1991,train
1193
+ P1992,train
1194
+ P1993,train
1195
+ P1995,train
1196
+ P1997,train
1197
+ P2000,train
1198
+ P2002,train
1199
+ P2005,train
1200
+ P2007,train
1201
+ P2009,train
1202
+ P2011,train
1203
+ P2012,train
1204
+ P2013,train
1205
+ P2015,train
1206
+ P2019,train
1207
+ P2021,train
1208
+ P2022,train
1209
+ P2023,train
1210
+ P2025,train
1211
+ P2026,train
1212
+ P2029,train
1213
+ P2034,train
1214
+ P2035,train
1215
+ P2037,train
1216
+ P2038,train
1217
+ P2039,train
1218
+ P2041,train
1219
+ P2042,train
1220
+ P2043,train
1221
+ P2044,train
1222
+ P2046,train
1223
+ P2049,train
1224
+ P2050,train
1225
+ P2051,train
1226
+ P2052,train
1227
+ P2054,train
1228
+ P2056,train
1229
+ P2057,train
1230
+ P2058,train
1231
+ P2061,train
1232
+ P2063,train
1233
+ P2064,train
1234
+ P2065,train
1235
+ P2066,train
1236
+ P2067,train
1237
+ P2068,train
1238
+ P2071,train
1239
+ P2072,train
1240
+ P2073,train
1241
+ P2074,train
1242
+ P2078,train
1243
+ P2080,train
1244
+ P2081,train
1245
+ P2082,train
1246
+ P2083,train
1247
+ P2084,train
1248
+ P2085,train
1249
+ P2087,train
1250
+ P2088,train
1251
+ P2091,train
1252
+ P2093,train
1253
+ P2095,train
1254
+ P2096,train
1255
+ P2098,train
1256
+ P2099,train
1257
+ P2100,train
1258
+ P2101,train
1259
+ P2102,train
1260
+ P2103,train
1261
+ P2104,train
1262
+ P2105,train
1263
+ P2107,train
1264
+ P2109,train
1265
+ P2111,train
1266
+ P2112,train
1267
+ P2114,train
1268
+ P2115,train
1269
+ P2116,train
1270
+ P2118,train
1271
+ P2119,train
1272
+ P2120,train
1273
+ P2122,train
1274
+ P2123,train
1275
+ P2124,train
1276
+ P2125,train
1277
+ P2129,train
1278
+ P2130,train
1279
+ P2131,train
1280
+ P2132,train
1281
+ P2134,train
1282
+ P2136,train
1283
+ P2137,train
1284
+ P2138,train
1285
+ P2139,train
1286
+ P2140,train
1287
+ P2141,train
1288
+ P2144,train
1289
+ P2146,train
1290
+ P2147,train
1291
+ P2148,train
1292
+ P2149,train
1293
+ P2150,train
1294
+ P2151,train
1295
+ P2152,train
1296
+ P2153,train
1297
+ P2156,train
1298
+ P2160,train
1299
+ P2161,train
1300
+ P2163,train
1301
+ P2164,train
1302
+ P2165,train
1303
+ P2168,train
1304
+ P2169,train
1305
+ P2170,train
1306
+ P2171,train
1307
+ P2172,train
1308
+ P2173,train
1309
+ P2175,train
1310
+ P2177,train
1311
+ P2178,train
1312
+ P2180,train
1313
+ P2184,train
1314
+ P2189,train
1315
+ P2190,train
1316
+ P2192,train
1317
+ P2195,train
1318
+ P2196,train
1319
+ P2197,train
1320
+ P2199,train
1321
+ P2201,train
1322
+ P2202,train
1323
+ P2204,train
1324
+ P2205,train
1325
+ P2206,train
1326
+ P2208,train
1327
+ P2209,train
1328
+ P2212,train
1329
+ P2219,train
1330
+ P2220,train
1331
+ P2223,train
1332
+ P2225,train
1333
+ P2229,train
1334
+ P2235,train
1335
+ P2236,train
1336
+ P2243,train
1337
+ P2245,train
1338
+ P2246,train
1339
+ P2247,train
1340
+ P2249,train
1341
+ P2251,train
1342
+ P2252,train
1343
+ P2254,train
1344
+ P2255,train
1345
+ P2256,train
1346
+ P2258,train
1347
+ P2259,train
1348
+ P2260,train
1349
+ P2262,train
1350
+ P2263,train
1351
+ P2265,train
1352
+ P2267,train
1353
+ P2268,train
1354
+ P2271,train
1355
+ P2272,train
1356
+ P2273,train
1357
+ P2276,train
1358
+ P2277,train
1359
+ P2280,train
1360
+ P2281,train
1361
+ P2282,train
1362
+ P2283,train
1363
+ P2284,train
1364
+ P2285,train
1365
+ P2286,train
1366
+ P2287,train
1367
+ P2290,train
1368
+ P2293,train
1369
+ P2295,train
1370
+ P2296,train
1371
+ P2297,train
1372
+ P2300,train
1373
+ P2301,train
1374
+ P2302,train
1375
+ P2303,train
1376
+ P2308,train
1377
+ P2315,train
1378
+ P2316,train
1379
+ P2317,train
1380
+ P2318,train
1381
+ P2320,train
1382
+ P2323,train
1383
+ P2324,train
1384
+ P2325,train
1385
+ P2326,train
1386
+ P2328,train
1387
+ P2329,train
1388
+ P2330,train
1389
+ P2331,train
1390
+ P2333,train
1391
+ P2334,train
1392
+ P2335,train
1393
+ P2336,train
1394
+ P2337,train
1395
+ P2339,train
1396
+ P2340,train
1397
+ P2343,train
1398
+ P2344,train
1399
+ P2346,train
1400
+ P2347,train
1401
+ P2348,train
1402
+ P2349,train
1403
+ P2352,train
1404
+ P2353,train
1405
+ P2354,train
1406
+ P2355,train
1407
+ P2356,train
1408
+ P2368,train
1409
+ P2370,train
1410
+ P2372,train
1411
+ P2374,train
1412
+ P2375,train
1413
+ P2377,train
1414
+ P2378,train
1415
+ P2380,train
1416
+ P2382,train
1417
+ P2383,train
1418
+ P2386,train
1419
+ P2387,train
1420
+ P2389,train
1421
+ P2390,train
1422
+ P2392,train
1423
+ P2394,train
1424
+ P2395,train
1425
+ P2397,train
1426
+ P2398,train
1427
+ P2399,train
1428
+ P2401,train
1429
+ P2403,train
1430
+ P2404,train
1431
+ P2405,train
1432
+ P2406,train
1433
+ P2407,train
1434
+ P2410,train
1435
+ P2411,train
1436
+ P2413,train
1437
+ P2415,train
1438
+ P2416,train
1439
+ P2417,train
1440
+ P2419,train
1441
+ P2420,train
1442
+ P2422,train
1443
+ P2424,train
1444
+ P2425,train
1445
+ P2428,train
1446
+ P2432,train
1447
+ P2433,train
1448
+ P2435,train
1449
+ P2436,train
1450
+ P2437,train
1451
+ P2441,train
1452
+ P2442,train
1453
+ P2443,train
1454
+ P2445,train
1455
+ P2446,train
1456
+ P2448,train
1457
+ P2449,train
1458
+ P2450,train
1459
+ P2451,train
1460
+ P2452,train
1461
+ P2453,train
1462
+ P2454,train
1463
+ P2456,train
1464
+ P2457,train
1465
+ P2459,train
1466
+ P2463,train
1467
+ P2464,train
1468
+ P2465,train
1469
+ P2467,train
1470
+ P2468,train
1471
+ P2469,train
1472
+ P2471,train
1473
+ P2473,train
1474
+ P2474,train
1475
+ P2477,train
1476
+ P2478,train
1477
+ P2479,train
1478
+ P2480,train
1479
+ P2482,train
1480
+ P2483,train
1481
+ P2487,train
1482
+ P2488,train
1483
+ P2491,train
1484
+ P2492,train
1485
+ P2493,train
1486
+ P2494,train
1487
+ P2495,train
1488
+ P2496,train
1489
+ P2497,train
1490
+ P2501,train
1491
+ P2504,train
1492
+ P2506,train
1493
+ P2507,train
1494
+ P2508,train
1495
+ P2509,train
1496
+ P2511,train
1497
+ P2512,train
1498
+ P2515,train
1499
+ P2516,train
1500
+ P2518,train
1501
+ P2522,train
1502
+ P2524,train
1503
+ P2525,train
1504
+ P2527,train
1505
+ P2528,train
1506
+ P2529,train
1507
+ P2530,train
1508
+ P2531,train
1509
+ P2532,train
1510
+ P2533,train
1511
+ P2535,train
1512
+ P2536,train
1513
+ P2537,train
1514
+ P2538,train
1515
+ P2540,train
1516
+ P2541,train
1517
+ P2542,train
1518
+ P2543,train
1519
+ P2544,train
1520
+ P2545,train
1521
+ P2546,train
1522
+ P2547,train
1523
+ P2549,train
1524
+ P2550,train
1525
+ P2551,train
1526
+ P2552,train
1527
+ P2553,train
1528
+ P2554,train
1529
+ P2555,train
1530
+ P2557,train
1531
+ P2558,train
1532
+ P2559,train
1533
+ P2560,train
1534
+ P2561,train
1535
+ P2562,train
1536
+ P2563,train
1537
+ P2564,train
1538
+ P2566,train
1539
+ P2567,train
1540
+ P2569,train
1541
+ P2572,train
1542
+ P2573,train
1543
+ P2576,train
1544
+ P2578,train
1545
+ P2582,train
1546
+ P2583,train
1547
+ P2584,train
1548
+ P2585,train
1549
+ P2586,train
1550
+ P2587,train
1551
+ P2588,train
1552
+ P2589,train
1553
+ P2590,train
1554
+ P2592,train
1555
+ P2594,train
1556
+ P2597,train
1557
+ P2598,train
1558
+ P2603,train
1559
+ P2605,train
1560
+ P2606,train
1561
+ P2608,train
1562
+ P2609,train
1563
+ P2611,train
1564
+ P2612,train
1565
+ P2613,train
1566
+ P2614,train
1567
+ P2617,train
1568
+ P2618,train
1569
+ P2622,train
1570
+ P2623,train
1571
+ P2624,train
1572
+ P2625,train
1573
+ P2627,train
1574
+ P2628,train
1575
+ P2629,train
1576
+ P2631,train
1577
+ P2635,train
1578
+ P2636,train
1579
+ P2637,train
1580
+ P2638,train
1581
+ P2639,train
1582
+ P2640,train
1583
+ P2641,train
1584
+ P2644,train
1585
+ P2645,train
1586
+ P2650,train
1587
+ P2651,train
1588
+ P2655,train
1589
+ P2657,train
1590
+ P2658,train
1591
+ P2661,train
1592
+ P2662,train
1593
+ P2663,train
1594
+ P2664,train
1595
+ P2665,train
1596
+ P2666,train
1597
+ P2668,train
1598
+ P2669,train
1599
+ P2670,train
1600
+ P2671,train
1601
+ P2675,train
1602
+ P2676,train
1603
+ P2677,train
1604
+ P2678,train
1605
+ P2679,train
1606
+ P2680,train
1607
+ P2681,train
1608
+ P2683,train
1609
+ P2685,train
1610
+ P2686,train
1611
+ P2688,train
1612
+ P2689,train
1613
+ P2690,train
1614
+ P2697,train
1615
+ P2700,train
1616
+ P2701,train
1617
+ P2702,train
1618
+ P2706,train
1619
+ P2707,train
1620
+ P2708,train
1621
+ P2710,train
1622
+ P2711,train
1623
+ P2713,train
1624
+ P2714,train
1625
+ P2716,train
1626
+ P2717,train
1627
+ P2719,train
1628
+ P2720,train
1629
+ P2724,train
1630
+ P2727,train
1631
+ P2729,train
1632
+ P2731,train
1633
+ P2732,train
1634
+ P2734,train
1635
+ P2737,train
1636
+ P2738,train
1637
+ P2739,train
1638
+ P2740,train
1639
+ P2741,train
1640
+ P2742,train
1641
+ P2744,train
1642
+ P2745,train
1643
+ P2746,train
1644
+ P2747,train
1645
+ P2749,train
1646
+ P2750,train
1647
+ P2751,train
1648
+ P2753,train
1649
+ P2754,train
1650
+ P2758,train
1651
+ P2759,train
1652
+ P2760,train
1653
+ P2761,train
1654
+ P2762,train
1655
+ P2763,train
1656
+ P2764,train
1657
+ P2765,train
1658
+ P2767,train
1659
+ P2768,train
1660
+ P2769,train
1661
+ P2772,train
1662
+ P2776,train
1663
+ P2780,train
1664
+ P2781,train
1665
+ P2782,train
1666
+ P2783,train
1667
+ P2784,train
1668
+ P2787,train
1669
+ P2788,train
1670
+ P2791,train
1671
+ P2792,train
1672
+ P2795,train
1673
+ P2797,train
1674
+ P2799,train
1675
+ P2802,train
1676
+ P2803,train
1677
+ P2804,train
1678
+ P2810,train
1679
+ P2811,train
1680
+ P2812,train
1681
+ P2813,train
1682
+ P2814,train
1683
+ P2815,train
1684
+ P2817,train
1685
+ P2818,train
1686
+ P2819,train
1687
+ P2820,train
1688
+ P2825,train
1689
+ P2827,train
1690
+ P2829,train
1691
+ P2830,train
1692
+ P2831,train
1693
+ P2832,train
1694
+ P2833,train
1695
+ P2834,train
1696
+ P2837,train
1697
+ P2839,train
1698
+ P2840,train
1699
+ P2842,train
1700
+ P2843,train
1701
+ P2845,train
1702
+ P2846,train
1703
+ P2848,train
1704
+ P2850,train
1705
+ P2852,train
1706
+ P2854,train
1707
+ P2855,train
1708
+ P2856,train
1709
+ P2858,train
1710
+ P2859,train
1711
+ P2860,train
1712
+ P2861,train
1713
+ P2862,train
1714
+ P2863,train
1715
+ P2864,train
1716
+ P2865,train
1717
+ P2867,train
1718
+ P2868,train
1719
+ P2869,train
1720
+ P2871,train
1721
+ P2872,train
1722
+ P2873,train
1723
+ P2875,train
1724
+ P2876,train
1725
+ P2877,train
1726
+ P2878,train
1727
+ P2879,train
1728
+ P2881,train
1729
+ P2883,train
1730
+ P2885,train
1731
+ P2886,train
1732
+ P2889,train
1733
+ P2891,train
1734
+ P2893,train
1735
+ P2894,train
1736
+ P2896,train
1737
+ P2897,train
1738
+ P2898,train
1739
+ P2899,train
1740
+ P2900,train
1741
+ P2901,train
1742
+ P2902,train
1743
+ P2907,train
1744
+ P2908,train
1745
+ P2911,train
1746
+ P2912,train
1747
+ P2913,train
1748
+ P2914,train
1749
+ P2916,train
1750
+ P2918,train
1751
+ P2919,train
1752
+ P2920,train
1753
+ P2921,train
1754
+ P2923,train
1755
+ P2924,train
1756
+ P2925,train
1757
+ P2926,train
1758
+ P2927,train
1759
+ P2929,train
1760
+ P2930,train
1761
+ P2931,train
1762
+ P2932,train
1763
+ P2933,train
1764
+ P2934,train
1765
+ P2938,train
1766
+ P2940,train
1767
+ P2941,train
1768
+ P2943,train
1769
+ P2945,train
1770
+ P2947,train
1771
+ P2948,train
1772
+ P2949,train
1773
+ P2951,train
1774
+ P2952,train
1775
+ P2954,train
1776
+ P2955,train
1777
+ P2956,train
1778
+ P2959,train
1779
+ P2960,train
1780
+ P2962,train
1781
+ P2966,train
1782
+ P2968,train
1783
+ P2969,train
1784
+ P2970,train
1785
+ P2971,train
1786
+ P2974,train
1787
+ P2975,train
1788
+ P2976,train
1789
+ P2977,train
1790
+ P2978,train
1791
+ P2982,train
1792
+ P2984,train
1793
+ P2985,train
1794
+ P2986,train
1795
+ P2988,train
1796
+ P2993,train
1797
+ P2994,train
1798
+ P2996,train
1799
+ P2997,train
1800
+ P2998,train
1801
+ P3000,train
1802
+ P0002,test
1803
+ P0003,test
1804
+ P0004,test
1805
+ P0005,test
1806
+ P0008,test
1807
+ P0009,test
1808
+ P0012,test
1809
+ P0014,test
1810
+ P0018,test
1811
+ P0020,test
1812
+ P0024,test
1813
+ P0025,test
1814
+ P0028,test
1815
+ P0030,test
1816
+ P0031,test
1817
+ P0033,test
1818
+ P0040,test
1819
+ P0045,test
1820
+ P0046,test
1821
+ P0054,test
1822
+ P0059,test
1823
+ P0067,test
1824
+ P0069,test
1825
+ P0075,test
1826
+ P0083,test
1827
+ P0085,test
1828
+ P0086,test
1829
+ P0087,test
1830
+ P0089,test
1831
+ P0090,test
1832
+ P0092,test
1833
+ P0097,test
1834
+ P0102,test
1835
+ P0103,test
1836
+ P0110,test
1837
+ P0114,test
1838
+ P0118,test
1839
+ P0123,test
1840
+ P0124,test
1841
+ P0127,test
1842
+ P0130,test
1843
+ P0133,test
1844
+ P0138,test
1845
+ P0142,test
1846
+ P0147,test
1847
+ P0148,test
1848
+ P0149,test
1849
+ P0151,test
1850
+ P0154,test
1851
+ P0161,test
1852
+ P0162,test
1853
+ P0165,test
1854
+ P0166,test
1855
+ P0171,test
1856
+ P0173,test
1857
+ P0174,test
1858
+ P0178,test
1859
+ P0181,test
1860
+ P0189,test
1861
+ P0190,test
1862
+ P0191,test
1863
+ P0195,test
1864
+ P0200,test
1865
+ P0201,test
1866
+ P0203,test
1867
+ P0204,test
1868
+ P0205,test
1869
+ P0206,test
1870
+ P0207,test
1871
+ P0208,test
1872
+ P0214,test
1873
+ P0220,test
1874
+ P0222,test
1875
+ P0225,test
1876
+ P0233,test
1877
+ P0234,test
1878
+ P0237,test
1879
+ P0246,test
1880
+ P0250,test
1881
+ P0259,test
1882
+ P0260,test
1883
+ P0261,test
1884
+ P0265,test
1885
+ P0266,test
1886
+ P0276,test
1887
+ P0277,test
1888
+ P0278,test
1889
+ P0281,test
1890
+ P0282,test
1891
+ P0283,test
1892
+ P0305,test
1893
+ P0310,test
1894
+ P0311,test
1895
+ P0315,test
1896
+ P0316,test
1897
+ P0322,test
1898
+ P0323,test
1899
+ P0324,test
1900
+ P0329,test
1901
+ P0330,test
1902
+ P0334,test
1903
+ P0335,test
1904
+ P0343,test
1905
+ P0349,test
1906
+ P0354,test
1907
+ P0361,test
1908
+ P0364,test
1909
+ P0368,test
1910
+ P0369,test
1911
+ P0372,test
1912
+ P0377,test
1913
+ P0379,test
1914
+ P0380,test
1915
+ P0387,test
1916
+ P0395,test
1917
+ P0401,test
1918
+ P0409,test
1919
+ P0413,test
1920
+ P0415,test
1921
+ P0417,test
1922
+ P0424,test
1923
+ P0425,test
1924
+ P0431,test
1925
+ P0432,test
1926
+ P0434,test
1927
+ P0436,test
1928
+ P0438,test
1929
+ P0440,test
1930
+ P0442,test
1931
+ P0444,test
1932
+ P0447,test
1933
+ P0448,test
1934
+ P0450,test
1935
+ P0453,test
1936
+ P0459,test
1937
+ P0460,test
1938
+ P0465,test
1939
+ P0470,test
1940
+ P0474,test
1941
+ P0477,test
1942
+ P0480,test
1943
+ P0483,test
1944
+ P0484,test
1945
+ P0486,test
1946
+ P0487,test
1947
+ P0488,test
1948
+ P0493,test
1949
+ P0504,test
1950
+ P0507,test
1951
+ P0509,test
1952
+ P0510,test
1953
+ P0517,test
1954
+ P0518,test
1955
+ P0520,test
1956
+ P0524,test
1957
+ P0527,test
1958
+ P0530,test
1959
+ P0532,test
1960
+ P0535,test
1961
+ P0537,test
1962
+ P0539,test
1963
+ P0542,test
1964
+ P0551,test
1965
+ P0552,test
1966
+ P0556,test
1967
+ P0565,test
1968
+ P0567,test
1969
+ P0568,test
1970
+ P0569,test
1971
+ P0570,test
1972
+ P0573,test
1973
+ P0577,test
1974
+ P0585,test
1975
+ P0587,test
1976
+ P0596,test
1977
+ P0598,test
1978
+ P0603,test
1979
+ P0604,test
1980
+ P0610,test
1981
+ P0612,test
1982
+ P0613,test
1983
+ P0618,test
1984
+ P0621,test
1985
+ P0622,test
1986
+ P0624,test
1987
+ P0626,test
1988
+ P0634,test
1989
+ P0636,test
1990
+ P0637,test
1991
+ P0641,test
1992
+ P0643,test
1993
+ P0644,test
1994
+ P0649,test
1995
+ P0653,test
1996
+ P0657,test
1997
+ P0659,test
1998
+ P0662,test
1999
+ P0666,test
2000
+ P0669,test
2001
+ P0673,test
2002
+ P0674,test
2003
+ P0677,test
2004
+ P0685,test
2005
+ P0687,test
2006
+ P0688,test
2007
+ P0694,test
2008
+ P0698,test
2009
+ P0699,test
2010
+ P0703,test
2011
+ P0704,test
2012
+ P0711,test
2013
+ P0715,test
2014
+ P0716,test
2015
+ P0718,test
2016
+ P0721,test
2017
+ P0725,test
2018
+ P0727,test
2019
+ P0734,test
2020
+ P0736,test
2021
+ P0743,test
2022
+ P0747,test
2023
+ P0750,test
2024
+ P0751,test
2025
+ P0757,test
2026
+ P0762,test
2027
+ P0770,test
2028
+ P0771,test
2029
+ P0782,test
2030
+ P0785,test
2031
+ P0786,test
2032
+ P0791,test
2033
+ P0793,test
2034
+ P0797,test
2035
+ P0798,test
2036
+ P0799,test
2037
+ P0801,test
2038
+ P0804,test
2039
+ P0806,test
2040
+ P0809,test
2041
+ P0810,test
2042
+ P0813,test
2043
+ P0814,test
2044
+ P0815,test
2045
+ P0820,test
2046
+ P0821,test
2047
+ P0822,test
2048
+ P0824,test
2049
+ P0829,test
2050
+ P0830,test
2051
+ P0840,test
2052
+ P0843,test
2053
+ P0854,test
2054
+ P0857,test
2055
+ P0861,test
2056
+ P0862,test
2057
+ P0865,test
2058
+ P0868,test
2059
+ P0870,test
2060
+ P0872,test
2061
+ P0874,test
2062
+ P0875,test
2063
+ P0882,test
2064
+ P0884,test
2065
+ P0892,test
2066
+ P0895,test
2067
+ P0900,test
2068
+ P0902,test
2069
+ P0903,test
2070
+ P0904,test
2071
+ P0905,test
2072
+ P0907,test
2073
+ P0912,test
2074
+ P0915,test
2075
+ P0920,test
2076
+ P0922,test
2077
+ P0925,test
2078
+ P0928,test
2079
+ P0935,test
2080
+ P0941,test
2081
+ P0945,test
2082
+ P0951,test
2083
+ P0954,test
2084
+ P0957,test
2085
+ P0959,test
2086
+ P0960,test
2087
+ P0963,test
2088
+ P0965,test
2089
+ P0966,test
2090
+ P0969,test
2091
+ P0973,test
2092
+ P0974,test
2093
+ P0976,test
2094
+ P0977,test
2095
+ P0985,test
2096
+ P0987,test
2097
+ P0990,test
2098
+ P0994,test
2099
+ P0996,test
2100
+ P0998,test
2101
+ P0999,test
2102
+ P1010,test
2103
+ P1015,test
2104
+ P1016,test
2105
+ P1029,test
2106
+ P1031,test
2107
+ P1032,test
2108
+ P1035,test
2109
+ P1036,test
2110
+ P1037,test
2111
+ P1038,test
2112
+ P1040,test
2113
+ P1049,test
2114
+ P1050,test
2115
+ P1051,test
2116
+ P1052,test
2117
+ P1053,test
2118
+ P1056,test
2119
+ P1058,test
2120
+ P1060,test
2121
+ P1061,test
2122
+ P1066,test
2123
+ P1069,test
2124
+ P1071,test
2125
+ P1073,test
2126
+ P1077,test
2127
+ P1078,test
2128
+ P1080,test
2129
+ P1081,test
2130
+ P1084,test
2131
+ P1089,test
2132
+ P1090,test
2133
+ P1099,test
2134
+ P1102,test
2135
+ P1104,test
2136
+ P1105,test
2137
+ P1114,test
2138
+ P1117,test
2139
+ P1119,test
2140
+ P1120,test
2141
+ P1121,test
2142
+ P1122,test
2143
+ P1127,test
2144
+ P1128,test
2145
+ P1132,test
2146
+ P1137,test
2147
+ P1146,test
2148
+ P1149,test
2149
+ P1172,test
2150
+ P1178,test
2151
+ P1180,test
2152
+ P1182,test
2153
+ P1187,test
2154
+ P1188,test
2155
+ P1189,test
2156
+ P1191,test
2157
+ P1195,test
2158
+ P1196,test
2159
+ P1197,test
2160
+ P1201,test
2161
+ P1204,test
2162
+ P1209,test
2163
+ P1215,test
2164
+ P1224,test
2165
+ P1227,test
2166
+ P1229,test
2167
+ P1231,test
2168
+ P1234,test
2169
+ P1235,test
2170
+ P1237,test
2171
+ P1243,test
2172
+ P1247,test
2173
+ P1254,test
2174
+ P1255,test
2175
+ P1257,test
2176
+ P1260,test
2177
+ P1262,test
2178
+ P1266,test
2179
+ P1269,test
2180
+ P1270,test
2181
+ P1271,test
2182
+ P1278,test
2183
+ P1282,test
2184
+ P1290,test
2185
+ P1291,test
2186
+ P1292,test
2187
+ P1299,test
2188
+ P1301,test
2189
+ P1303,test
2190
+ P1308,test
2191
+ P1310,test
2192
+ P1311,test
2193
+ P1312,test
2194
+ P1314,test
2195
+ P1319,test
2196
+ P1327,test
2197
+ P1328,test
2198
+ P1330,test
2199
+ P1341,test
2200
+ P1343,test
2201
+ P1350,test
2202
+ P1357,test
2203
+ P1358,test
2204
+ P1360,test
2205
+ P1364,test
2206
+ P1367,test
2207
+ P1368,test
2208
+ P1370,test
2209
+ P1371,test
2210
+ P1374,test
2211
+ P1375,test
2212
+ P1383,test
2213
+ P1385,test
2214
+ P1386,test
2215
+ P1388,test
2216
+ P1390,test
2217
+ P1392,test
2218
+ P1393,test
2219
+ P1397,test
2220
+ P1402,test
2221
+ P1405,test
2222
+ P1411,test
2223
+ P1419,test
2224
+ P1423,test
2225
+ P1430,test
2226
+ P1431,test
2227
+ P1432,test
2228
+ P1435,test
2229
+ P1438,test
2230
+ P1439,test
2231
+ P1447,test
2232
+ P1451,test
2233
+ P1463,test
2234
+ P1464,test
2235
+ P1465,test
2236
+ P1468,test
2237
+ P1471,test
2238
+ P1473,test
2239
+ P1474,test
2240
+ P1475,test
2241
+ P1477,test
2242
+ P1479,test
2243
+ P1481,test
2244
+ P1484,test
2245
+ P1486,test
2246
+ P1487,test
2247
+ P1488,test
2248
+ P1490,test
2249
+ P1497,test
2250
+ P1502,test
2251
+ P1505,test
2252
+ P1509,test
2253
+ P1514,test
2254
+ P1515,test
2255
+ P1516,test
2256
+ P1528,test
2257
+ P1529,test
2258
+ P1530,test
2259
+ P1532,test
2260
+ P1538,test
2261
+ P1539,test
2262
+ P1541,test
2263
+ P1545,test
2264
+ P1548,test
2265
+ P1550,test
2266
+ P1553,test
2267
+ P1555,test
2268
+ P1561,test
2269
+ P1562,test
2270
+ P1563,test
2271
+ P1566,test
2272
+ P1567,test
2273
+ P1569,test
2274
+ P1572,test
2275
+ P1580,test
2276
+ P1584,test
2277
+ P1585,test
2278
+ P1586,test
2279
+ P1589,test
2280
+ P1592,test
2281
+ P1599,test
2282
+ P1600,test
2283
+ P1603,test
2284
+ P1608,test
2285
+ P1611,test
2286
+ P1614,test
2287
+ P1619,test
2288
+ P1627,test
2289
+ P1634,test
2290
+ P1635,test
2291
+ P1640,test
2292
+ P1650,test
2293
+ P1653,test
2294
+ P1660,test
2295
+ P1662,test
2296
+ P1666,test
2297
+ P1668,test
2298
+ P1670,test
2299
+ P1671,test
2300
+ P1676,test
2301
+ P1678,test
2302
+ P1682,test
2303
+ P1684,test
2304
+ P1693,test
2305
+ P1696,test
2306
+ P1699,test
2307
+ P1700,test
2308
+ P1701,test
2309
+ P1704,test
2310
+ P1706,test
2311
+ P1707,test
2312
+ P1713,test
2313
+ P1716,test
2314
+ P1717,test
2315
+ P1718,test
2316
+ P1722,test
2317
+ P1725,test
2318
+ P1728,test
2319
+ P1733,test
2320
+ P1734,test
2321
+ P1735,test
2322
+ P1739,test
2323
+ P1740,test
2324
+ P1751,test
2325
+ P1760,test
2326
+ P1762,test
2327
+ P1763,test
2328
+ P1766,test
2329
+ P1773,test
2330
+ P1777,test
2331
+ P1783,test
2332
+ P1784,test
2333
+ P1787,test
2334
+ P1789,test
2335
+ P1791,test
2336
+ P1792,test
2337
+ P1793,test
2338
+ P1796,test
2339
+ P1797,test
2340
+ P1807,test
2341
+ P1811,test
2342
+ P1812,test
2343
+ P1813,test
2344
+ P1815,test
2345
+ P1816,test
2346
+ P1817,test
2347
+ P1820,test
2348
+ P1823,test
2349
+ P1826,test
2350
+ P1833,test
2351
+ P1835,test
2352
+ P1837,test
2353
+ P1838,test
2354
+ P1841,test
2355
+ P1843,test
2356
+ P1846,test
2357
+ P1854,test
2358
+ P1855,test
2359
+ P1863,test
2360
+ P1864,test
2361
+ P1866,test
2362
+ P1868,test
2363
+ P1872,test
2364
+ P1873,test
2365
+ P1880,test
2366
+ P1882,test
2367
+ P1883,test
2368
+ P1884,test
2369
+ P1895,test
2370
+ P1896,test
2371
+ P1898,test
2372
+ P1904,test
2373
+ P1908,test
2374
+ P1915,test
2375
+ P1917,test
2376
+ P1919,test
2377
+ P1925,test
2378
+ P1927,test
2379
+ P1928,test
2380
+ P1937,test
2381
+ P1940,test
2382
+ P1942,test
2383
+ P1946,test
2384
+ P1950,test
2385
+ P1951,test
2386
+ P1954,test
2387
+ P1955,test
2388
+ P1956,test
2389
+ P1962,test
2390
+ P1963,test
2391
+ P1965,test
2392
+ P1966,test
2393
+ P1969,test
2394
+ P1971,test
2395
+ P1972,test
2396
+ P1974,test
2397
+ P1975,test
2398
+ P1978,test
2399
+ P1980,test
2400
+ P1982,test
2401
+ P1983,test
2402
+ P1988,test
2403
+ P1990,test
2404
+ P1994,test
2405
+ P1996,test
2406
+ P1998,test
2407
+ P1999,test
2408
+ P2001,test
2409
+ P2003,test
2410
+ P2004,test
2411
+ P2006,test
2412
+ P2010,test
2413
+ P2014,test
2414
+ P2016,test
2415
+ P2017,test
2416
+ P2020,test
2417
+ P2027,test
2418
+ P2028,test
2419
+ P2031,test
2420
+ P2032,test
2421
+ P2033,test
2422
+ P2040,test
2423
+ P2045,test
2424
+ P2047,test
2425
+ P2048,test
2426
+ P2053,test
2427
+ P2055,test
2428
+ P2060,test
2429
+ P2062,test
2430
+ P2069,test
2431
+ P2070,test
2432
+ P2076,test
2433
+ P2077,test
2434
+ P2086,test
2435
+ P2089,test
2436
+ P2090,test
2437
+ P2094,test
2438
+ P2097,test
2439
+ P2106,test
2440
+ P2110,test
2441
+ P2113,test
2442
+ P2121,test
2443
+ P2126,test
2444
+ P2127,test
2445
+ P2128,test
2446
+ P2133,test
2447
+ P2135,test
2448
+ P2142,test
2449
+ P2145,test
2450
+ P2155,test
2451
+ P2157,test
2452
+ P2158,test
2453
+ P2159,test
2454
+ P2162,test
2455
+ P2166,test
2456
+ P2167,test
2457
+ P2174,test
2458
+ P2176,test
2459
+ P2179,test
2460
+ P2181,test
2461
+ P2182,test
2462
+ P2183,test
2463
+ P2185,test
2464
+ P2186,test
2465
+ P2187,test
2466
+ P2188,test
2467
+ P2191,test
2468
+ P2198,test
2469
+ P2200,test
2470
+ P2203,test
2471
+ P2210,test
2472
+ P2213,test
2473
+ P2214,test
2474
+ P2217,test
2475
+ P2218,test
2476
+ P2221,test
2477
+ P2222,test
2478
+ P2224,test
2479
+ P2226,test
2480
+ P2227,test
2481
+ P2228,test
2482
+ P2230,test
2483
+ P2231,test
2484
+ P2233,test
2485
+ P2234,test
2486
+ P2237,test
2487
+ P2238,test
2488
+ P2239,test
2489
+ P2240,test
2490
+ P2241,test
2491
+ P2242,test
2492
+ P2244,test
2493
+ P2253,test
2494
+ P2261,test
2495
+ P2264,test
2496
+ P2269,test
2497
+ P2270,test
2498
+ P2274,test
2499
+ P2275,test
2500
+ P2278,test
2501
+ P2279,test
2502
+ P2289,test
2503
+ P2291,test
2504
+ P2292,test
2505
+ P2294,test
2506
+ P2305,test
2507
+ P2307,test
2508
+ P2310,test
2509
+ P2312,test
2510
+ P2313,test
2511
+ P2319,test
2512
+ P2321,test
2513
+ P2322,test
2514
+ P2332,test
2515
+ P2338,test
2516
+ P2341,test
2517
+ P2345,test
2518
+ P2351,test
2519
+ P2357,test
2520
+ P2359,test
2521
+ P2360,test
2522
+ P2361,test
2523
+ P2362,test
2524
+ P2364,test
2525
+ P2365,test
2526
+ P2366,test
2527
+ P2369,test
2528
+ P2379,test
2529
+ P2381,test
2530
+ P2384,test
2531
+ P2388,test
2532
+ P2396,test
2533
+ P2400,test
2534
+ P2402,test
2535
+ P2409,test
2536
+ P2414,test
2537
+ P2418,test
2538
+ P2421,test
2539
+ P2423,test
2540
+ P2426,test
2541
+ P2427,test
2542
+ P2430,test
2543
+ P2431,test
2544
+ P2444,test
2545
+ P2447,test
2546
+ P2455,test
2547
+ P2458,test
2548
+ P2460,test
2549
+ P2461,test
2550
+ P2462,test
2551
+ P2470,test
2552
+ P2475,test
2553
+ P2476,test
2554
+ P2481,test
2555
+ P2484,test
2556
+ P2485,test
2557
+ P2486,test
2558
+ P2489,test
2559
+ P2490,test
2560
+ P2498,test
2561
+ P2499,test
2562
+ P2513,test
2563
+ P2517,test
2564
+ P2519,test
2565
+ P2520,test
2566
+ P2521,test
2567
+ P2523,test
2568
+ P2539,test
2569
+ P2548,test
2570
+ P2556,test
2571
+ P2568,test
2572
+ P2574,test
2573
+ P2575,test
2574
+ P2577,test
2575
+ P2580,test
2576
+ P2581,test
2577
+ P2591,test
2578
+ P2593,test
2579
+ P2595,test
2580
+ P2599,test
2581
+ P2601,test
2582
+ P2602,test
2583
+ P2604,test
2584
+ P2619,test
2585
+ P2621,test
2586
+ P2626,test
2587
+ P2630,test
2588
+ P2632,test
2589
+ P2633,test
2590
+ P2634,test
2591
+ P2642,test
2592
+ P2643,test
2593
+ P2646,test
2594
+ P2647,test
2595
+ P2648,test
2596
+ P2649,test
2597
+ P2652,test
2598
+ P2653,test
2599
+ P2659,test
2600
+ P2660,test
2601
+ P2667,test
2602
+ P2672,test
2603
+ P2673,test
2604
+ P2682,test
2605
+ P2684,test
2606
+ P2687,test
2607
+ P2691,test
2608
+ P2692,test
2609
+ P2693,test
2610
+ P2694,test
2611
+ P2696,test
2612
+ P2698,test
2613
+ P2699,test
2614
+ P2703,test
2615
+ P2705,test
2616
+ P2712,test
2617
+ P2715,test
2618
+ P2718,test
2619
+ P2723,test
2620
+ P2725,test
2621
+ P2728,test
2622
+ P2733,test
2623
+ P2735,test
2624
+ P2736,test
2625
+ P2743,test
2626
+ P2752,test
2627
+ P2755,test
2628
+ P2756,test
2629
+ P2766,test
2630
+ P2770,test
2631
+ P2771,test
2632
+ P2774,test
2633
+ P2775,test
2634
+ P2778,test
2635
+ P2779,test
2636
+ P2785,test
2637
+ P2786,test
2638
+ P2789,test
2639
+ P2790,test
2640
+ P2793,test
2641
+ P2794,test
2642
+ P2798,test
2643
+ P2801,test
2644
+ P2805,test
2645
+ P2806,test
2646
+ P2807,test
2647
+ P2808,test
2648
+ P2809,test
2649
+ P2816,test
2650
+ P2821,test
2651
+ P2822,test
2652
+ P2823,test
2653
+ P2824,test
2654
+ P2826,test
2655
+ P2828,test
2656
+ P2835,test
2657
+ P2838,test
2658
+ P2844,test
2659
+ P2847,test
2660
+ P2851,test
2661
+ P2853,test
2662
+ P2857,test
2663
+ P2866,test
2664
+ P2874,test
2665
+ P2880,test
2666
+ P2882,test
2667
+ P2887,test
2668
+ P2888,test
2669
+ P2890,test
2670
+ P2892,test
2671
+ P2904,test
2672
+ P2906,test
2673
+ P2909,test
2674
+ P2910,test
2675
+ P2915,test
2676
+ P2917,test
2677
+ P2928,test
2678
+ P2935,test
2679
+ P2936,test
2680
+ P2937,test
2681
+ P2939,test
2682
+ P2942,test
2683
+ P2944,test
2684
+ P2946,test
2685
+ P2953,test
2686
+ P2957,test
2687
+ P2961,test
2688
+ P2963,test
2689
+ P2964,test
2690
+ P2965,test
2691
+ P2972,test
2692
+ P2973,test
2693
+ P2979,test
2694
+ P2980,test
2695
+ P2981,test
2696
+ P2983,test
2697
+ P2987,test
2698
+ P2989,test
2699
+ P2992,test
2700
+ P2995,test
2701
+ P2999,test
2702
+ P0013,validation
2703
+ P0019,validation
2704
+ P0029,validation
2705
+ P0041,validation
2706
+ P0051,validation
2707
+ P0079,validation
2708
+ P0098,validation
2709
+ P0108,validation
2710
+ P0134,validation
2711
+ P0143,validation
2712
+ P0153,validation
2713
+ P0183,validation
2714
+ P0185,validation
2715
+ P0192,validation
2716
+ P0196,validation
2717
+ P0198,validation
2718
+ P0209,validation
2719
+ P0221,validation
2720
+ P0235,validation
2721
+ P0244,validation
2722
+ P0251,validation
2723
+ P0253,validation
2724
+ P0257,validation
2725
+ P0269,validation
2726
+ P0270,validation
2727
+ P0279,validation
2728
+ P0280,validation
2729
+ P0297,validation
2730
+ P0308,validation
2731
+ P0312,validation
2732
+ P0320,validation
2733
+ P0337,validation
2734
+ P0339,validation
2735
+ P0389,validation
2736
+ P0399,validation
2737
+ P0433,validation
2738
+ P0443,validation
2739
+ P0457,validation
2740
+ P0464,validation
2741
+ P0471,validation
2742
+ P0481,validation
2743
+ P0494,validation
2744
+ P0498,validation
2745
+ P0503,validation
2746
+ P0522,validation
2747
+ P0528,validation
2748
+ P0529,validation
2749
+ P0540,validation
2750
+ P0560,validation
2751
+ P0564,validation
2752
+ P0575,validation
2753
+ P0588,validation
2754
+ P0589,validation
2755
+ P0590,validation
2756
+ P0601,validation
2757
+ P0611,validation
2758
+ P0619,validation
2759
+ P0631,validation
2760
+ P0633,validation
2761
+ P0638,validation
2762
+ P0642,validation
2763
+ P0648,validation
2764
+ P0658,validation
2765
+ P0680,validation
2766
+ P0683,validation
2767
+ P0700,validation
2768
+ P0731,validation
2769
+ P0733,validation
2770
+ P0738,validation
2771
+ P0744,validation
2772
+ P0748,validation
2773
+ P0755,validation
2774
+ P0767,validation
2775
+ P0790,validation
2776
+ P0805,validation
2777
+ P0816,validation
2778
+ P0835,validation
2779
+ P0848,validation
2780
+ P0852,validation
2781
+ P0856,validation
2782
+ P0858,validation
2783
+ P0863,validation
2784
+ P0885,validation
2785
+ P0887,validation
2786
+ P0889,validation
2787
+ P0913,validation
2788
+ P0916,validation
2789
+ P0918,validation
2790
+ P0937,validation
2791
+ P0938,validation
2792
+ P0944,validation
2793
+ P0946,validation
2794
+ P0967,validation
2795
+ P0975,validation
2796
+ P0980,validation
2797
+ P0984,validation
2798
+ P1003,validation
2799
+ P1009,validation
2800
+ P1013,validation
2801
+ P1048,validation
2802
+ P1054,validation
2803
+ P1062,validation
2804
+ P1063,validation
2805
+ P1070,validation
2806
+ P1082,validation
2807
+ P1087,validation
2808
+ P1109,validation
2809
+ P1124,validation
2810
+ P1135,validation
2811
+ P1138,validation
2812
+ P1152,validation
2813
+ P1166,validation
2814
+ P1169,validation
2815
+ P1184,validation
2816
+ P1185,validation
2817
+ P1190,validation
2818
+ P1193,validation
2819
+ P1199,validation
2820
+ P1203,validation
2821
+ P1211,validation
2822
+ P1213,validation
2823
+ P1216,validation
2824
+ P1222,validation
2825
+ P1225,validation
2826
+ P1226,validation
2827
+ P1246,validation
2828
+ P1276,validation
2829
+ P1277,validation
2830
+ P1284,validation
2831
+ P1289,validation
2832
+ P1293,validation
2833
+ P1316,validation
2834
+ P1324,validation
2835
+ P1329,validation
2836
+ P1332,validation
2837
+ P1342,validation
2838
+ P1346,validation
2839
+ P1348,validation
2840
+ P1352,validation
2841
+ P1361,validation
2842
+ P1365,validation
2843
+ P1394,validation
2844
+ P1395,validation
2845
+ P1404,validation
2846
+ P1406,validation
2847
+ P1410,validation
2848
+ P1422,validation
2849
+ P1427,validation
2850
+ P1445,validation
2851
+ P1452,validation
2852
+ P1461,validation
2853
+ P1491,validation
2854
+ P1494,validation
2855
+ P1499,validation
2856
+ P1501,validation
2857
+ P1504,validation
2858
+ P1511,validation
2859
+ P1512,validation
2860
+ P1517,validation
2861
+ P1519,validation
2862
+ P1534,validation
2863
+ P1542,validation
2864
+ P1581,validation
2865
+ P1587,validation
2866
+ P1595,validation
2867
+ P1632,validation
2868
+ P1637,validation
2869
+ P1639,validation
2870
+ P1646,validation
2871
+ P1655,validation
2872
+ P1657,validation
2873
+ P1680,validation
2874
+ P1686,validation
2875
+ P1689,validation
2876
+ P1705,validation
2877
+ P1712,validation
2878
+ P1719,validation
2879
+ P1724,validation
2880
+ P1726,validation
2881
+ P1746,validation
2882
+ P1770,validation
2883
+ P1776,validation
2884
+ P1808,validation
2885
+ P1814,validation
2886
+ P1819,validation
2887
+ P1856,validation
2888
+ P1859,validation
2889
+ P1862,validation
2890
+ P1870,validation
2891
+ P1871,validation
2892
+ P1874,validation
2893
+ P1878,validation
2894
+ P1900,validation
2895
+ P1905,validation
2896
+ P1936,validation
2897
+ P1941,validation
2898
+ P1964,validation
2899
+ P1981,validation
2900
+ P2008,validation
2901
+ P2018,validation
2902
+ P2024,validation
2903
+ P2030,validation
2904
+ P2036,validation
2905
+ P2059,validation
2906
+ P2075,validation
2907
+ P2079,validation
2908
+ P2092,validation
2909
+ P2108,validation
2910
+ P2117,validation
2911
+ P2143,validation
2912
+ P2154,validation
2913
+ P2193,validation
2914
+ P2194,validation
2915
+ P2207,validation
2916
+ P2211,validation
2917
+ P2215,validation
2918
+ P2216,validation
2919
+ P2232,validation
2920
+ P2248,validation
2921
+ P2250,validation
2922
+ P2257,validation
2923
+ P2266,validation
2924
+ P2288,validation
2925
+ P2298,validation
2926
+ P2299,validation
2927
+ P2304,validation
2928
+ P2306,validation
2929
+ P2309,validation
2930
+ P2311,validation
2931
+ P2314,validation
2932
+ P2327,validation
2933
+ P2342,validation
2934
+ P2350,validation
2935
+ P2358,validation
2936
+ P2363,validation
2937
+ P2367,validation
2938
+ P2371,validation
2939
+ P2373,validation
2940
+ P2376,validation
2941
+ P2385,validation
2942
+ P2391,validation
2943
+ P2393,validation
2944
+ P2408,validation
2945
+ P2412,validation
2946
+ P2429,validation
2947
+ P2434,validation
2948
+ P2438,validation
2949
+ P2439,validation
2950
+ P2440,validation
2951
+ P2466,validation
2952
+ P2472,validation
2953
+ P2500,validation
2954
+ P2502,validation
2955
+ P2503,validation
2956
+ P2505,validation
2957
+ P2510,validation
2958
+ P2514,validation
2959
+ P2526,validation
2960
+ P2534,validation
2961
+ P2565,validation
2962
+ P2570,validation
2963
+ P2571,validation
2964
+ P2579,validation
2965
+ P2596,validation
2966
+ P2600,validation
2967
+ P2607,validation
2968
+ P2610,validation
2969
+ P2615,validation
2970
+ P2616,validation
2971
+ P2620,validation
2972
+ P2654,validation
2973
+ P2656,validation
2974
+ P2674,validation
2975
+ P2695,validation
2976
+ P2704,validation
2977
+ P2709,validation
2978
+ P2721,validation
2979
+ P2722,validation
2980
+ P2726,validation
2981
+ P2730,validation
2982
+ P2748,validation
2983
+ P2757,validation
2984
+ P2773,validation
2985
+ P2777,validation
2986
+ P2796,validation
2987
+ P2800,validation
2988
+ P2836,validation
2989
+ P2841,validation
2990
+ P2849,validation
2991
+ P2870,validation
2992
+ P2884,validation
2993
+ P2895,validation
2994
+ P2903,validation
2995
+ P2905,validation
2996
+ P2922,validation
2997
+ P2950,validation
2998
+ P2958,validation
2999
+ P2967,validation
3000
+ P2990,validation
3001
+ P2991,validation
data/splits/probes/synthetic/exp3_2_probe_split_ids_wide.csv ADDED
@@ -0,0 +1,1801 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ Train_ID,Test_ID,Validation_ID
2
+ P0001,P0002,P0013
3
+ P0006,P0003,P0019
4
+ P0007,P0004,P0029
5
+ P0010,P0005,P0041
6
+ P0011,P0008,P0051
7
+ P0015,P0009,P0079
8
+ P0016,P0012,P0098
9
+ P0017,P0014,P0108
10
+ P0021,P0018,P0134
11
+ P0022,P0020,P0143
12
+ P0023,P0024,P0153
13
+ P0026,P0025,P0183
14
+ P0027,P0028,P0185
15
+ P0032,P0030,P0192
16
+ P0034,P0031,P0196
17
+ P0035,P0033,P0198
18
+ P0036,P0040,P0209
19
+ P0037,P0045,P0221
20
+ P0038,P0046,P0235
21
+ P0039,P0054,P0244
22
+ P0042,P0059,P0251
23
+ P0043,P0067,P0253
24
+ P0044,P0069,P0257
25
+ P0047,P0075,P0269
26
+ P0048,P0083,P0270
27
+ P0049,P0085,P0279
28
+ P0050,P0086,P0280
29
+ P0052,P0087,P0297
30
+ P0053,P0089,P0308
31
+ P0055,P0090,P0312
32
+ P0056,P0092,P0320
33
+ P0057,P0097,P0337
34
+ P0058,P0102,P0339
35
+ P0060,P0103,P0389
36
+ P0061,P0110,P0399
37
+ P0062,P0114,P0433
38
+ P0063,P0118,P0443
39
+ P0064,P0123,P0457
40
+ P0065,P0124,P0464
41
+ P0066,P0127,P0471
42
+ P0068,P0130,P0481
43
+ P0070,P0133,P0494
44
+ P0071,P0138,P0498
45
+ P0072,P0142,P0503
46
+ P0073,P0147,P0522
47
+ P0074,P0148,P0528
48
+ P0076,P0149,P0529
49
+ P0077,P0151,P0540
50
+ P0078,P0154,P0560
51
+ P0080,P0161,P0564
52
+ P0081,P0162,P0575
53
+ P0082,P0165,P0588
54
+ P0084,P0166,P0589
55
+ P0088,P0171,P0590
56
+ P0091,P0173,P0601
57
+ P0093,P0174,P0611
58
+ P0094,P0178,P0619
59
+ P0095,P0181,P0631
60
+ P0096,P0189,P0633
61
+ P0099,P0190,P0638
62
+ P0100,P0191,P0642
63
+ P0101,P0195,P0648
64
+ P0104,P0200,P0658
65
+ P0105,P0201,P0680
66
+ P0106,P0203,P0683
67
+ P0107,P0204,P0700
68
+ P0109,P0205,P0731
69
+ P0111,P0206,P0733
70
+ P0112,P0207,P0738
71
+ P0113,P0208,P0744
72
+ P0115,P0214,P0748
73
+ P0116,P0220,P0755
74
+ P0117,P0222,P0767
75
+ P0119,P0225,P0790
76
+ P0120,P0233,P0805
77
+ P0121,P0234,P0816
78
+ P0122,P0237,P0835
79
+ P0125,P0246,P0848
80
+ P0126,P0250,P0852
81
+ P0128,P0259,P0856
82
+ P0129,P0260,P0858
83
+ P0131,P0261,P0863
84
+ P0132,P0265,P0885
85
+ P0135,P0266,P0887
86
+ P0136,P0276,P0889
87
+ P0137,P0277,P0913
88
+ P0139,P0278,P0916
89
+ P0140,P0281,P0918
90
+ P0141,P0282,P0937
91
+ P0144,P0283,P0938
92
+ P0145,P0305,P0944
93
+ P0146,P0310,P0946
94
+ P0150,P0311,P0967
95
+ P0152,P0315,P0975
96
+ P0155,P0316,P0980
97
+ P0156,P0322,P0984
98
+ P0157,P0323,P1003
99
+ P0158,P0324,P1009
100
+ P0159,P0329,P1013
101
+ P0160,P0330,P1048
102
+ P0163,P0334,P1054
103
+ P0164,P0335,P1062
104
+ P0167,P0343,P1063
105
+ P0168,P0349,P1070
106
+ P0169,P0354,P1082
107
+ P0170,P0361,P1087
108
+ P0172,P0364,P1109
109
+ P0175,P0368,P1124
110
+ P0176,P0369,P1135
111
+ P0177,P0372,P1138
112
+ P0179,P0377,P1152
113
+ P0180,P0379,P1166
114
+ P0182,P0380,P1169
115
+ P0184,P0387,P1184
116
+ P0186,P0395,P1185
117
+ P0187,P0401,P1190
118
+ P0188,P0409,P1193
119
+ P0193,P0413,P1199
120
+ P0194,P0415,P1203
121
+ P0197,P0417,P1211
122
+ P0199,P0424,P1213
123
+ P0202,P0425,P1216
124
+ P0210,P0431,P1222
125
+ P0211,P0432,P1225
126
+ P0212,P0434,P1226
127
+ P0213,P0436,P1246
128
+ P0215,P0438,P1276
129
+ P0216,P0440,P1277
130
+ P0217,P0442,P1284
131
+ P0218,P0444,P1289
132
+ P0219,P0447,P1293
133
+ P0223,P0448,P1316
134
+ P0224,P0450,P1324
135
+ P0226,P0453,P1329
136
+ P0227,P0459,P1332
137
+ P0228,P0460,P1342
138
+ P0229,P0465,P1346
139
+ P0230,P0470,P1348
140
+ P0231,P0474,P1352
141
+ P0232,P0477,P1361
142
+ P0236,P0480,P1365
143
+ P0238,P0483,P1394
144
+ P0239,P0484,P1395
145
+ P0240,P0486,P1404
146
+ P0241,P0487,P1406
147
+ P0242,P0488,P1410
148
+ P0243,P0493,P1422
149
+ P0245,P0504,P1427
150
+ P0247,P0507,P1445
151
+ P0248,P0509,P1452
152
+ P0249,P0510,P1461
153
+ P0252,P0517,P1491
154
+ P0254,P0518,P1494
155
+ P0255,P0520,P1499
156
+ P0256,P0524,P1501
157
+ P0258,P0527,P1504
158
+ P0262,P0530,P1511
159
+ P0263,P0532,P1512
160
+ P0264,P0535,P1517
161
+ P0267,P0537,P1519
162
+ P0268,P0539,P1534
163
+ P0271,P0542,P1542
164
+ P0272,P0551,P1581
165
+ P0273,P0552,P1587
166
+ P0274,P0556,P1595
167
+ P0275,P0565,P1632
168
+ P0284,P0567,P1637
169
+ P0285,P0568,P1639
170
+ P0286,P0569,P1646
171
+ P0287,P0570,P1655
172
+ P0288,P0573,P1657
173
+ P0289,P0577,P1680
174
+ P0290,P0585,P1686
175
+ P0291,P0587,P1689
176
+ P0292,P0596,P1705
177
+ P0293,P0598,P1712
178
+ P0294,P0603,P1719
179
+ P0295,P0604,P1724
180
+ P0296,P0610,P1726
181
+ P0298,P0612,P1746
182
+ P0299,P0613,P1770
183
+ P0300,P0618,P1776
184
+ P0301,P0621,P1808
185
+ P0302,P0622,P1814
186
+ P0303,P0624,P1819
187
+ P0304,P0626,P1856
188
+ P0306,P0634,P1859
189
+ P0307,P0636,P1862
190
+ P0309,P0637,P1870
191
+ P0313,P0641,P1871
192
+ P0314,P0643,P1874
193
+ P0317,P0644,P1878
194
+ P0318,P0649,P1900
195
+ P0319,P0653,P1905
196
+ P0321,P0657,P1936
197
+ P0325,P0659,P1941
198
+ P0326,P0662,P1964
199
+ P0327,P0666,P1981
200
+ P0328,P0669,P2008
201
+ P0331,P0673,P2018
202
+ P0332,P0674,P2024
203
+ P0333,P0677,P2030
204
+ P0336,P0685,P2036
205
+ P0338,P0687,P2059
206
+ P0340,P0688,P2075
207
+ P0341,P0694,P2079
208
+ P0342,P0698,P2092
209
+ P0344,P0699,P2108
210
+ P0345,P0703,P2117
211
+ P0346,P0704,P2143
212
+ P0347,P0711,P2154
213
+ P0348,P0715,P2193
214
+ P0350,P0716,P2194
215
+ P0351,P0718,P2207
216
+ P0352,P0721,P2211
217
+ P0353,P0725,P2215
218
+ P0355,P0727,P2216
219
+ P0356,P0734,P2232
220
+ P0357,P0736,P2248
221
+ P0358,P0743,P2250
222
+ P0359,P0747,P2257
223
+ P0360,P0750,P2266
224
+ P0362,P0751,P2288
225
+ P0363,P0757,P2298
226
+ P0365,P0762,P2299
227
+ P0366,P0770,P2304
228
+ P0367,P0771,P2306
229
+ P0370,P0782,P2309
230
+ P0371,P0785,P2311
231
+ P0373,P0786,P2314
232
+ P0374,P0791,P2327
233
+ P0375,P0793,P2342
234
+ P0376,P0797,P2350
235
+ P0378,P0798,P2358
236
+ P0381,P0799,P2363
237
+ P0382,P0801,P2367
238
+ P0383,P0804,P2371
239
+ P0384,P0806,P2373
240
+ P0385,P0809,P2376
241
+ P0386,P0810,P2385
242
+ P0388,P0813,P2391
243
+ P0390,P0814,P2393
244
+ P0391,P0815,P2408
245
+ P0392,P0820,P2412
246
+ P0393,P0821,P2429
247
+ P0394,P0822,P2434
248
+ P0396,P0824,P2438
249
+ P0397,P0829,P2439
250
+ P0398,P0830,P2440
251
+ P0400,P0840,P2466
252
+ P0402,P0843,P2472
253
+ P0403,P0854,P2500
254
+ P0404,P0857,P2502
255
+ P0405,P0861,P2503
256
+ P0406,P0862,P2505
257
+ P0407,P0865,P2510
258
+ P0408,P0868,P2514
259
+ P0410,P0870,P2526
260
+ P0411,P0872,P2534
261
+ P0412,P0874,P2565
262
+ P0414,P0875,P2570
263
+ P0416,P0882,P2571
264
+ P0418,P0884,P2579
265
+ P0419,P0892,P2596
266
+ P0420,P0895,P2600
267
+ P0421,P0900,P2607
268
+ P0422,P0902,P2610
269
+ P0423,P0903,P2615
270
+ P0426,P0904,P2616
271
+ P0427,P0905,P2620
272
+ P0428,P0907,P2654
273
+ P0429,P0912,P2656
274
+ P0430,P0915,P2674
275
+ P0435,P0920,P2695
276
+ P0437,P0922,P2704
277
+ P0439,P0925,P2709
278
+ P0441,P0928,P2721
279
+ P0445,P0935,P2722
280
+ P0446,P0941,P2726
281
+ P0449,P0945,P2730
282
+ P0451,P0951,P2748
283
+ P0452,P0954,P2757
284
+ P0454,P0957,P2773
285
+ P0455,P0959,P2777
286
+ P0456,P0960,P2796
287
+ P0458,P0963,P2800
288
+ P0461,P0965,P2836
289
+ P0462,P0966,P2841
290
+ P0463,P0969,P2849
291
+ P0466,P0973,P2870
292
+ P0467,P0974,P2884
293
+ P0468,P0976,P2895
294
+ P0469,P0977,P2903
295
+ P0472,P0985,P2905
296
+ P0473,P0987,P2922
297
+ P0475,P0990,P2950
298
+ P0476,P0994,P2958
299
+ P0478,P0996,P2967
300
+ P0479,P0998,P2990
301
+ P0482,P0999,P2991
302
+ P0485,P1010,
303
+ P0489,P1015,
304
+ P0490,P1016,
305
+ P0491,P1029,
306
+ P0492,P1031,
307
+ P0495,P1032,
308
+ P0496,P1035,
309
+ P0497,P1036,
310
+ P0499,P1037,
311
+ P0500,P1038,
312
+ P0501,P1040,
313
+ P0502,P1049,
314
+ P0505,P1050,
315
+ P0506,P1051,
316
+ P0508,P1052,
317
+ P0511,P1053,
318
+ P0512,P1056,
319
+ P0513,P1058,
320
+ P0514,P1060,
321
+ P0515,P1061,
322
+ P0516,P1066,
323
+ P0519,P1069,
324
+ P0521,P1071,
325
+ P0523,P1073,
326
+ P0525,P1077,
327
+ P0526,P1078,
328
+ P0531,P1080,
329
+ P0533,P1081,
330
+ P0534,P1084,
331
+ P0536,P1089,
332
+ P0538,P1090,
333
+ P0541,P1099,
334
+ P0543,P1102,
335
+ P0544,P1104,
336
+ P0545,P1105,
337
+ P0546,P1114,
338
+ P0547,P1117,
339
+ P0548,P1119,
340
+ P0549,P1120,
341
+ P0550,P1121,
342
+ P0553,P1122,
343
+ P0554,P1127,
344
+ P0555,P1128,
345
+ P0557,P1132,
346
+ P0558,P1137,
347
+ P0559,P1146,
348
+ P0561,P1149,
349
+ P0562,P1172,
350
+ P0563,P1178,
351
+ P0566,P1180,
352
+ P0571,P1182,
353
+ P0572,P1187,
354
+ P0574,P1188,
355
+ P0576,P1189,
356
+ P0578,P1191,
357
+ P0579,P1195,
358
+ P0580,P1196,
359
+ P0581,P1197,
360
+ P0582,P1201,
361
+ P0583,P1204,
362
+ P0584,P1209,
363
+ P0586,P1215,
364
+ P0591,P1224,
365
+ P0592,P1227,
366
+ P0593,P1229,
367
+ P0594,P1231,
368
+ P0595,P1234,
369
+ P0597,P1235,
370
+ P0599,P1237,
371
+ P0600,P1243,
372
+ P0602,P1247,
373
+ P0605,P1254,
374
+ P0606,P1255,
375
+ P0607,P1257,
376
+ P0608,P1260,
377
+ P0609,P1262,
378
+ P0614,P1266,
379
+ P0615,P1269,
380
+ P0616,P1270,
381
+ P0617,P1271,
382
+ P0620,P1278,
383
+ P0623,P1282,
384
+ P0625,P1290,
385
+ P0627,P1291,
386
+ P0628,P1292,
387
+ P0629,P1299,
388
+ P0630,P1301,
389
+ P0632,P1303,
390
+ P0635,P1308,
391
+ P0639,P1310,
392
+ P0640,P1311,
393
+ P0645,P1312,
394
+ P0646,P1314,
395
+ P0647,P1319,
396
+ P0650,P1327,
397
+ P0651,P1328,
398
+ P0652,P1330,
399
+ P0654,P1341,
400
+ P0655,P1343,
401
+ P0656,P1350,
402
+ P0660,P1357,
403
+ P0661,P1358,
404
+ P0663,P1360,
405
+ P0664,P1364,
406
+ P0665,P1367,
407
+ P0667,P1368,
408
+ P0668,P1370,
409
+ P0670,P1371,
410
+ P0671,P1374,
411
+ P0672,P1375,
412
+ P0675,P1383,
413
+ P0676,P1385,
414
+ P0678,P1386,
415
+ P0679,P1388,
416
+ P0681,P1390,
417
+ P0682,P1392,
418
+ P0684,P1393,
419
+ P0686,P1397,
420
+ P0689,P1402,
421
+ P0690,P1405,
422
+ P0691,P1411,
423
+ P0692,P1419,
424
+ P0693,P1423,
425
+ P0695,P1430,
426
+ P0696,P1431,
427
+ P0697,P1432,
428
+ P0701,P1435,
429
+ P0702,P1438,
430
+ P0705,P1439,
431
+ P0706,P1447,
432
+ P0707,P1451,
433
+ P0708,P1463,
434
+ P0709,P1464,
435
+ P0710,P1465,
436
+ P0712,P1468,
437
+ P0713,P1471,
438
+ P0714,P1473,
439
+ P0717,P1474,
440
+ P0719,P1475,
441
+ P0720,P1477,
442
+ P0722,P1479,
443
+ P0723,P1481,
444
+ P0724,P1484,
445
+ P0726,P1486,
446
+ P0728,P1487,
447
+ P0729,P1488,
448
+ P0730,P1490,
449
+ P0732,P1497,
450
+ P0735,P1502,
451
+ P0737,P1505,
452
+ P0739,P1509,
453
+ P0740,P1514,
454
+ P0741,P1515,
455
+ P0742,P1516,
456
+ P0745,P1528,
457
+ P0746,P1529,
458
+ P0749,P1530,
459
+ P0752,P1532,
460
+ P0753,P1538,
461
+ P0754,P1539,
462
+ P0756,P1541,
463
+ P0758,P1545,
464
+ P0759,P1548,
465
+ P0760,P1550,
466
+ P0761,P1553,
467
+ P0763,P1555,
468
+ P0764,P1561,
469
+ P0765,P1562,
470
+ P0766,P1563,
471
+ P0768,P1566,
472
+ P0769,P1567,
473
+ P0772,P1569,
474
+ P0773,P1572,
475
+ P0774,P1580,
476
+ P0775,P1584,
477
+ P0776,P1585,
478
+ P0777,P1586,
479
+ P0778,P1589,
480
+ P0779,P1592,
481
+ P0780,P1599,
482
+ P0781,P1600,
483
+ P0783,P1603,
484
+ P0784,P1608,
485
+ P0787,P1611,
486
+ P0788,P1614,
487
+ P0789,P1619,
488
+ P0792,P1627,
489
+ P0794,P1634,
490
+ P0795,P1635,
491
+ P0796,P1640,
492
+ P0800,P1650,
493
+ P0802,P1653,
494
+ P0803,P1660,
495
+ P0807,P1662,
496
+ P0808,P1666,
497
+ P0811,P1668,
498
+ P0812,P1670,
499
+ P0817,P1671,
500
+ P0818,P1676,
501
+ P0819,P1678,
502
+ P0823,P1682,
503
+ P0825,P1684,
504
+ P0826,P1693,
505
+ P0827,P1696,
506
+ P0828,P1699,
507
+ P0831,P1700,
508
+ P0832,P1701,
509
+ P0833,P1704,
510
+ P0834,P1706,
511
+ P0836,P1707,
512
+ P0837,P1713,
513
+ P0838,P1716,
514
+ P0839,P1717,
515
+ P0841,P1718,
516
+ P0842,P1722,
517
+ P0844,P1725,
518
+ P0845,P1728,
519
+ P0846,P1733,
520
+ P0847,P1734,
521
+ P0849,P1735,
522
+ P0850,P1739,
523
+ P0851,P1740,
524
+ P0853,P1751,
525
+ P0855,P1760,
526
+ P0859,P1762,
527
+ P0860,P1763,
528
+ P0864,P1766,
529
+ P0866,P1773,
530
+ P0867,P1777,
531
+ P0869,P1783,
532
+ P0871,P1784,
533
+ P0873,P1787,
534
+ P0876,P1789,
535
+ P0877,P1791,
536
+ P0878,P1792,
537
+ P0879,P1793,
538
+ P0880,P1796,
539
+ P0881,P1797,
540
+ P0883,P1807,
541
+ P0886,P1811,
542
+ P0888,P1812,
543
+ P0890,P1813,
544
+ P0891,P1815,
545
+ P0893,P1816,
546
+ P0894,P1817,
547
+ P0896,P1820,
548
+ P0897,P1823,
549
+ P0898,P1826,
550
+ P0899,P1833,
551
+ P0901,P1835,
552
+ P0906,P1837,
553
+ P0908,P1838,
554
+ P0909,P1841,
555
+ P0910,P1843,
556
+ P0911,P1846,
557
+ P0914,P1854,
558
+ P0917,P1855,
559
+ P0919,P1863,
560
+ P0921,P1864,
561
+ P0923,P1866,
562
+ P0924,P1868,
563
+ P0926,P1872,
564
+ P0927,P1873,
565
+ P0929,P1880,
566
+ P0930,P1882,
567
+ P0931,P1883,
568
+ P0932,P1884,
569
+ P0933,P1895,
570
+ P0934,P1896,
571
+ P0936,P1898,
572
+ P0939,P1904,
573
+ P0940,P1908,
574
+ P0942,P1915,
575
+ P0943,P1917,
576
+ P0947,P1919,
577
+ P0948,P1925,
578
+ P0949,P1927,
579
+ P0950,P1928,
580
+ P0952,P1937,
581
+ P0953,P1940,
582
+ P0955,P1942,
583
+ P0956,P1946,
584
+ P0958,P1950,
585
+ P0961,P1951,
586
+ P0962,P1954,
587
+ P0964,P1955,
588
+ P0968,P1956,
589
+ P0970,P1962,
590
+ P0971,P1963,
591
+ P0972,P1965,
592
+ P0978,P1966,
593
+ P0979,P1969,
594
+ P0981,P1971,
595
+ P0982,P1972,
596
+ P0983,P1974,
597
+ P0986,P1975,
598
+ P0988,P1978,
599
+ P0989,P1980,
600
+ P0991,P1982,
601
+ P0992,P1983,
602
+ P0993,P1988,
603
+ P0995,P1990,
604
+ P0997,P1994,
605
+ P1000,P1996,
606
+ P1001,P1998,
607
+ P1002,P1999,
608
+ P1004,P2001,
609
+ P1005,P2003,
610
+ P1006,P2004,
611
+ P1007,P2006,
612
+ P1008,P2010,
613
+ P1011,P2014,
614
+ P1012,P2016,
615
+ P1014,P2017,
616
+ P1017,P2020,
617
+ P1018,P2027,
618
+ P1019,P2028,
619
+ P1020,P2031,
620
+ P1021,P2032,
621
+ P1022,P2033,
622
+ P1023,P2040,
623
+ P1024,P2045,
624
+ P1025,P2047,
625
+ P1026,P2048,
626
+ P1027,P2053,
627
+ P1028,P2055,
628
+ P1030,P2060,
629
+ P1033,P2062,
630
+ P1034,P2069,
631
+ P1039,P2070,
632
+ P1041,P2076,
633
+ P1042,P2077,
634
+ P1043,P2086,
635
+ P1044,P2089,
636
+ P1045,P2090,
637
+ P1046,P2094,
638
+ P1047,P2097,
639
+ P1055,P2106,
640
+ P1057,P2110,
641
+ P1059,P2113,
642
+ P1064,P2121,
643
+ P1065,P2126,
644
+ P1067,P2127,
645
+ P1068,P2128,
646
+ P1072,P2133,
647
+ P1074,P2135,
648
+ P1075,P2142,
649
+ P1076,P2145,
650
+ P1079,P2155,
651
+ P1083,P2157,
652
+ P1085,P2158,
653
+ P1086,P2159,
654
+ P1088,P2162,
655
+ P1091,P2166,
656
+ P1092,P2167,
657
+ P1093,P2174,
658
+ P1094,P2176,
659
+ P1095,P2179,
660
+ P1096,P2181,
661
+ P1097,P2182,
662
+ P1098,P2183,
663
+ P1100,P2185,
664
+ P1101,P2186,
665
+ P1103,P2187,
666
+ P1106,P2188,
667
+ P1107,P2191,
668
+ P1108,P2198,
669
+ P1110,P2200,
670
+ P1111,P2203,
671
+ P1112,P2210,
672
+ P1113,P2213,
673
+ P1115,P2214,
674
+ P1116,P2217,
675
+ P1118,P2218,
676
+ P1123,P2221,
677
+ P1125,P2222,
678
+ P1126,P2224,
679
+ P1129,P2226,
680
+ P1130,P2227,
681
+ P1131,P2228,
682
+ P1133,P2230,
683
+ P1134,P2231,
684
+ P1136,P2233,
685
+ P1139,P2234,
686
+ P1140,P2237,
687
+ P1141,P2238,
688
+ P1142,P2239,
689
+ P1143,P2240,
690
+ P1144,P2241,
691
+ P1145,P2242,
692
+ P1147,P2244,
693
+ P1148,P2253,
694
+ P1150,P2261,
695
+ P1151,P2264,
696
+ P1153,P2269,
697
+ P1154,P2270,
698
+ P1155,P2274,
699
+ P1156,P2275,
700
+ P1157,P2278,
701
+ P1158,P2279,
702
+ P1159,P2289,
703
+ P1160,P2291,
704
+ P1161,P2292,
705
+ P1162,P2294,
706
+ P1163,P2305,
707
+ P1164,P2307,
708
+ P1165,P2310,
709
+ P1167,P2312,
710
+ P1168,P2313,
711
+ P1170,P2319,
712
+ P1171,P2321,
713
+ P1173,P2322,
714
+ P1174,P2332,
715
+ P1175,P2338,
716
+ P1176,P2341,
717
+ P1177,P2345,
718
+ P1179,P2351,
719
+ P1181,P2357,
720
+ P1183,P2359,
721
+ P1186,P2360,
722
+ P1192,P2361,
723
+ P1194,P2362,
724
+ P1198,P2364,
725
+ P1200,P2365,
726
+ P1202,P2366,
727
+ P1205,P2369,
728
+ P1206,P2379,
729
+ P1207,P2381,
730
+ P1208,P2384,
731
+ P1210,P2388,
732
+ P1212,P2396,
733
+ P1214,P2400,
734
+ P1217,P2402,
735
+ P1218,P2409,
736
+ P1219,P2414,
737
+ P1220,P2418,
738
+ P1221,P2421,
739
+ P1223,P2423,
740
+ P1228,P2426,
741
+ P1230,P2427,
742
+ P1232,P2430,
743
+ P1233,P2431,
744
+ P1236,P2444,
745
+ P1238,P2447,
746
+ P1239,P2455,
747
+ P1240,P2458,
748
+ P1241,P2460,
749
+ P1242,P2461,
750
+ P1244,P2462,
751
+ P1245,P2470,
752
+ P1248,P2475,
753
+ P1249,P2476,
754
+ P1250,P2481,
755
+ P1251,P2484,
756
+ P1252,P2485,
757
+ P1253,P2486,
758
+ P1256,P2489,
759
+ P1258,P2490,
760
+ P1259,P2498,
761
+ P1261,P2499,
762
+ P1263,P2513,
763
+ P1264,P2517,
764
+ P1265,P2519,
765
+ P1267,P2520,
766
+ P1268,P2521,
767
+ P1272,P2523,
768
+ P1273,P2539,
769
+ P1274,P2548,
770
+ P1275,P2556,
771
+ P1279,P2568,
772
+ P1280,P2574,
773
+ P1281,P2575,
774
+ P1283,P2577,
775
+ P1285,P2580,
776
+ P1286,P2581,
777
+ P1287,P2591,
778
+ P1288,P2593,
779
+ P1294,P2595,
780
+ P1295,P2599,
781
+ P1296,P2601,
782
+ P1297,P2602,
783
+ P1298,P2604,
784
+ P1300,P2619,
785
+ P1302,P2621,
786
+ P1304,P2626,
787
+ P1305,P2630,
788
+ P1306,P2632,
789
+ P1307,P2633,
790
+ P1309,P2634,
791
+ P1313,P2642,
792
+ P1315,P2643,
793
+ P1317,P2646,
794
+ P1318,P2647,
795
+ P1320,P2648,
796
+ P1321,P2649,
797
+ P1322,P2652,
798
+ P1323,P2653,
799
+ P1325,P2659,
800
+ P1326,P2660,
801
+ P1331,P2667,
802
+ P1333,P2672,
803
+ P1334,P2673,
804
+ P1335,P2682,
805
+ P1336,P2684,
806
+ P1337,P2687,
807
+ P1338,P2691,
808
+ P1339,P2692,
809
+ P1340,P2693,
810
+ P1344,P2694,
811
+ P1345,P2696,
812
+ P1347,P2698,
813
+ P1349,P2699,
814
+ P1351,P2703,
815
+ P1353,P2705,
816
+ P1354,P2712,
817
+ P1355,P2715,
818
+ P1356,P2718,
819
+ P1359,P2723,
820
+ P1362,P2725,
821
+ P1363,P2728,
822
+ P1366,P2733,
823
+ P1369,P2735,
824
+ P1372,P2736,
825
+ P1373,P2743,
826
+ P1376,P2752,
827
+ P1377,P2755,
828
+ P1378,P2756,
829
+ P1379,P2766,
830
+ P1380,P2770,
831
+ P1381,P2771,
832
+ P1382,P2774,
833
+ P1384,P2775,
834
+ P1387,P2778,
835
+ P1389,P2779,
836
+ P1391,P2785,
837
+ P1396,P2786,
838
+ P1398,P2789,
839
+ P1399,P2790,
840
+ P1400,P2793,
841
+ P1401,P2794,
842
+ P1403,P2798,
843
+ P1407,P2801,
844
+ P1408,P2805,
845
+ P1409,P2806,
846
+ P1412,P2807,
847
+ P1413,P2808,
848
+ P1414,P2809,
849
+ P1415,P2816,
850
+ P1416,P2821,
851
+ P1417,P2822,
852
+ P1418,P2823,
853
+ P1420,P2824,
854
+ P1421,P2826,
855
+ P1424,P2828,
856
+ P1425,P2835,
857
+ P1426,P2838,
858
+ P1428,P2844,
859
+ P1429,P2847,
860
+ P1433,P2851,
861
+ P1434,P2853,
862
+ P1436,P2857,
863
+ P1437,P2866,
864
+ P1440,P2874,
865
+ P1441,P2880,
866
+ P1442,P2882,
867
+ P1443,P2887,
868
+ P1444,P2888,
869
+ P1446,P2890,
870
+ P1448,P2892,
871
+ P1449,P2904,
872
+ P1450,P2906,
873
+ P1453,P2909,
874
+ P1454,P2910,
875
+ P1455,P2915,
876
+ P1456,P2917,
877
+ P1457,P2928,
878
+ P1458,P2935,
879
+ P1459,P2936,
880
+ P1460,P2937,
881
+ P1462,P2939,
882
+ P1466,P2942,
883
+ P1467,P2944,
884
+ P1469,P2946,
885
+ P1470,P2953,
886
+ P1472,P2957,
887
+ P1476,P2961,
888
+ P1478,P2963,
889
+ P1480,P2964,
890
+ P1482,P2965,
891
+ P1483,P2972,
892
+ P1485,P2973,
893
+ P1489,P2979,
894
+ P1492,P2980,
895
+ P1493,P2981,
896
+ P1495,P2983,
897
+ P1496,P2987,
898
+ P1498,P2989,
899
+ P1500,P2992,
900
+ P1503,P2995,
901
+ P1506,P2999,
902
+ P1507,,
903
+ P1508,,
904
+ P1510,,
905
+ P1513,,
906
+ P1518,,
907
+ P1520,,
908
+ P1521,,
909
+ P1522,,
910
+ P1523,,
911
+ P1524,,
912
+ P1525,,
913
+ P1526,,
914
+ P1527,,
915
+ P1531,,
916
+ P1533,,
917
+ P1535,,
918
+ P1536,,
919
+ P1537,,
920
+ P1540,,
921
+ P1543,,
922
+ P1544,,
923
+ P1546,,
924
+ P1547,,
925
+ P1549,,
926
+ P1551,,
927
+ P1552,,
928
+ P1554,,
929
+ P1556,,
930
+ P1557,,
931
+ P1558,,
932
+ P1559,,
933
+ P1560,,
934
+ P1564,,
935
+ P1565,,
936
+ P1568,,
937
+ P1570,,
938
+ P1571,,
939
+ P1573,,
940
+ P1574,,
941
+ P1575,,
942
+ P1576,,
943
+ P1577,,
944
+ P1578,,
945
+ P1579,,
946
+ P1582,,
947
+ P1583,,
948
+ P1588,,
949
+ P1590,,
950
+ P1591,,
951
+ P1593,,
952
+ P1594,,
953
+ P1596,,
954
+ P1597,,
955
+ P1598,,
956
+ P1601,,
957
+ P1602,,
958
+ P1604,,
959
+ P1605,,
960
+ P1606,,
961
+ P1607,,
962
+ P1609,,
963
+ P1610,,
964
+ P1612,,
965
+ P1613,,
966
+ P1615,,
967
+ P1616,,
968
+ P1617,,
969
+ P1618,,
970
+ P1620,,
971
+ P1621,,
972
+ P1622,,
973
+ P1623,,
974
+ P1624,,
975
+ P1625,,
976
+ P1626,,
977
+ P1628,,
978
+ P1629,,
979
+ P1630,,
980
+ P1631,,
981
+ P1633,,
982
+ P1636,,
983
+ P1638,,
984
+ P1641,,
985
+ P1642,,
986
+ P1643,,
987
+ P1644,,
988
+ P1645,,
989
+ P1647,,
990
+ P1648,,
991
+ P1649,,
992
+ P1651,,
993
+ P1652,,
994
+ P1654,,
995
+ P1656,,
996
+ P1658,,
997
+ P1659,,
998
+ P1661,,
999
+ P1663,,
1000
+ P1664,,
1001
+ P1665,,
1002
+ P1667,,
1003
+ P1669,,
1004
+ P1672,,
1005
+ P1673,,
1006
+ P1674,,
1007
+ P1675,,
1008
+ P1677,,
1009
+ P1679,,
1010
+ P1681,,
1011
+ P1683,,
1012
+ P1685,,
1013
+ P1687,,
1014
+ P1688,,
1015
+ P1690,,
1016
+ P1691,,
1017
+ P1692,,
1018
+ P1694,,
1019
+ P1695,,
1020
+ P1697,,
1021
+ P1698,,
1022
+ P1702,,
1023
+ P1703,,
1024
+ P1708,,
1025
+ P1709,,
1026
+ P1710,,
1027
+ P1711,,
1028
+ P1714,,
1029
+ P1715,,
1030
+ P1720,,
1031
+ P1721,,
1032
+ P1723,,
1033
+ P1727,,
1034
+ P1729,,
1035
+ P1730,,
1036
+ P1731,,
1037
+ P1732,,
1038
+ P1736,,
1039
+ P1737,,
1040
+ P1738,,
1041
+ P1741,,
1042
+ P1742,,
1043
+ P1743,,
1044
+ P1744,,
1045
+ P1745,,
1046
+ P1747,,
1047
+ P1748,,
1048
+ P1749,,
1049
+ P1750,,
1050
+ P1752,,
1051
+ P1753,,
1052
+ P1754,,
1053
+ P1755,,
1054
+ P1756,,
1055
+ P1757,,
1056
+ P1758,,
1057
+ P1759,,
1058
+ P1761,,
1059
+ P1764,,
1060
+ P1765,,
1061
+ P1767,,
1062
+ P1768,,
1063
+ P1769,,
1064
+ P1771,,
1065
+ P1772,,
1066
+ P1774,,
1067
+ P1775,,
1068
+ P1778,,
1069
+ P1779,,
1070
+ P1780,,
1071
+ P1781,,
1072
+ P1782,,
1073
+ P1785,,
1074
+ P1786,,
1075
+ P1788,,
1076
+ P1790,,
1077
+ P1794,,
1078
+ P1795,,
1079
+ P1798,,
1080
+ P1799,,
1081
+ P1800,,
1082
+ P1801,,
1083
+ P1802,,
1084
+ P1803,,
1085
+ P1804,,
1086
+ P1805,,
1087
+ P1806,,
1088
+ P1809,,
1089
+ P1810,,
1090
+ P1818,,
1091
+ P1821,,
1092
+ P1822,,
1093
+ P1824,,
1094
+ P1825,,
1095
+ P1827,,
1096
+ P1828,,
1097
+ P1829,,
1098
+ P1830,,
1099
+ P1831,,
1100
+ P1832,,
1101
+ P1834,,
1102
+ P1836,,
1103
+ P1839,,
1104
+ P1840,,
1105
+ P1842,,
1106
+ P1844,,
1107
+ P1845,,
1108
+ P1847,,
1109
+ P1848,,
1110
+ P1849,,
1111
+ P1850,,
1112
+ P1851,,
1113
+ P1852,,
1114
+ P1853,,
1115
+ P1857,,
1116
+ P1858,,
1117
+ P1860,,
1118
+ P1861,,
1119
+ P1865,,
1120
+ P1867,,
1121
+ P1869,,
1122
+ P1875,,
1123
+ P1876,,
1124
+ P1877,,
1125
+ P1879,,
1126
+ P1881,,
1127
+ P1885,,
1128
+ P1886,,
1129
+ P1887,,
1130
+ P1888,,
1131
+ P1889,,
1132
+ P1890,,
1133
+ P1891,,
1134
+ P1892,,
1135
+ P1893,,
1136
+ P1894,,
1137
+ P1897,,
1138
+ P1899,,
1139
+ P1901,,
1140
+ P1902,,
1141
+ P1903,,
1142
+ P1906,,
1143
+ P1907,,
1144
+ P1909,,
1145
+ P1910,,
1146
+ P1911,,
1147
+ P1912,,
1148
+ P1913,,
1149
+ P1914,,
1150
+ P1916,,
1151
+ P1918,,
1152
+ P1920,,
1153
+ P1921,,
1154
+ P1922,,
1155
+ P1923,,
1156
+ P1924,,
1157
+ P1926,,
1158
+ P1929,,
1159
+ P1930,,
1160
+ P1931,,
1161
+ P1932,,
1162
+ P1933,,
1163
+ P1934,,
1164
+ P1935,,
1165
+ P1938,,
1166
+ P1939,,
1167
+ P1943,,
1168
+ P1944,,
1169
+ P1945,,
1170
+ P1947,,
1171
+ P1948,,
1172
+ P1949,,
1173
+ P1952,,
1174
+ P1953,,
1175
+ P1957,,
1176
+ P1958,,
1177
+ P1959,,
1178
+ P1960,,
1179
+ P1961,,
1180
+ P1967,,
1181
+ P1968,,
1182
+ P1970,,
1183
+ P1973,,
1184
+ P1976,,
1185
+ P1977,,
1186
+ P1979,,
1187
+ P1984,,
1188
+ P1985,,
1189
+ P1986,,
1190
+ P1987,,
1191
+ P1989,,
1192
+ P1991,,
1193
+ P1992,,
1194
+ P1993,,
1195
+ P1995,,
1196
+ P1997,,
1197
+ P2000,,
1198
+ P2002,,
1199
+ P2005,,
1200
+ P2007,,
1201
+ P2009,,
1202
+ P2011,,
1203
+ P2012,,
1204
+ P2013,,
1205
+ P2015,,
1206
+ P2019,,
1207
+ P2021,,
1208
+ P2022,,
1209
+ P2023,,
1210
+ P2025,,
1211
+ P2026,,
1212
+ P2029,,
1213
+ P2034,,
1214
+ P2035,,
1215
+ P2037,,
1216
+ P2038,,
1217
+ P2039,,
1218
+ P2041,,
1219
+ P2042,,
1220
+ P2043,,
1221
+ P2044,,
1222
+ P2046,,
1223
+ P2049,,
1224
+ P2050,,
1225
+ P2051,,
1226
+ P2052,,
1227
+ P2054,,
1228
+ P2056,,
1229
+ P2057,,
1230
+ P2058,,
1231
+ P2061,,
1232
+ P2063,,
1233
+ P2064,,
1234
+ P2065,,
1235
+ P2066,,
1236
+ P2067,,
1237
+ P2068,,
1238
+ P2071,,
1239
+ P2072,,
1240
+ P2073,,
1241
+ P2074,,
1242
+ P2078,,
1243
+ P2080,,
1244
+ P2081,,
1245
+ P2082,,
1246
+ P2083,,
1247
+ P2084,,
1248
+ P2085,,
1249
+ P2087,,
1250
+ P2088,,
1251
+ P2091,,
1252
+ P2093,,
1253
+ P2095,,
1254
+ P2096,,
1255
+ P2098,,
1256
+ P2099,,
1257
+ P2100,,
1258
+ P2101,,
1259
+ P2102,,
1260
+ P2103,,
1261
+ P2104,,
1262
+ P2105,,
1263
+ P2107,,
1264
+ P2109,,
1265
+ P2111,,
1266
+ P2112,,
1267
+ P2114,,
1268
+ P2115,,
1269
+ P2116,,
1270
+ P2118,,
1271
+ P2119,,
1272
+ P2120,,
1273
+ P2122,,
1274
+ P2123,,
1275
+ P2124,,
1276
+ P2125,,
1277
+ P2129,,
1278
+ P2130,,
1279
+ P2131,,
1280
+ P2132,,
1281
+ P2134,,
1282
+ P2136,,
1283
+ P2137,,
1284
+ P2138,,
1285
+ P2139,,
1286
+ P2140,,
1287
+ P2141,,
1288
+ P2144,,
1289
+ P2146,,
1290
+ P2147,,
1291
+ P2148,,
1292
+ P2149,,
1293
+ P2150,,
1294
+ P2151,,
1295
+ P2152,,
1296
+ P2153,,
1297
+ P2156,,
1298
+ P2160,,
1299
+ P2161,,
1300
+ P2163,,
1301
+ P2164,,
1302
+ P2165,,
1303
+ P2168,,
1304
+ P2169,,
1305
+ P2170,,
1306
+ P2171,,
1307
+ P2172,,
1308
+ P2173,,
1309
+ P2175,,
1310
+ P2177,,
1311
+ P2178,,
1312
+ P2180,,
1313
+ P2184,,
1314
+ P2189,,
1315
+ P2190,,
1316
+ P2192,,
1317
+ P2195,,
1318
+ P2196,,
1319
+ P2197,,
1320
+ P2199,,
1321
+ P2201,,
1322
+ P2202,,
1323
+ P2204,,
1324
+ P2205,,
1325
+ P2206,,
1326
+ P2208,,
1327
+ P2209,,
1328
+ P2212,,
1329
+ P2219,,
1330
+ P2220,,
1331
+ P2223,,
1332
+ P2225,,
1333
+ P2229,,
1334
+ P2235,,
1335
+ P2236,,
1336
+ P2243,,
1337
+ P2245,,
1338
+ P2246,,
1339
+ P2247,,
1340
+ P2249,,
1341
+ P2251,,
1342
+ P2252,,
1343
+ P2254,,
1344
+ P2255,,
1345
+ P2256,,
1346
+ P2258,,
1347
+ P2259,,
1348
+ P2260,,
1349
+ P2262,,
1350
+ P2263,,
1351
+ P2265,,
1352
+ P2267,,
1353
+ P2268,,
1354
+ P2271,,
1355
+ P2272,,
1356
+ P2273,,
1357
+ P2276,,
1358
+ P2277,,
1359
+ P2280,,
1360
+ P2281,,
1361
+ P2282,,
1362
+ P2283,,
1363
+ P2284,,
1364
+ P2285,,
1365
+ P2286,,
1366
+ P2287,,
1367
+ P2290,,
1368
+ P2293,,
1369
+ P2295,,
1370
+ P2296,,
1371
+ P2297,,
1372
+ P2300,,
1373
+ P2301,,
1374
+ P2302,,
1375
+ P2303,,
1376
+ P2308,,
1377
+ P2315,,
1378
+ P2316,,
1379
+ P2317,,
1380
+ P2318,,
1381
+ P2320,,
1382
+ P2323,,
1383
+ P2324,,
1384
+ P2325,,
1385
+ P2326,,
1386
+ P2328,,
1387
+ P2329,,
1388
+ P2330,,
1389
+ P2331,,
1390
+ P2333,,
1391
+ P2334,,
1392
+ P2335,,
1393
+ P2336,,
1394
+ P2337,,
1395
+ P2339,,
1396
+ P2340,,
1397
+ P2343,,
1398
+ P2344,,
1399
+ P2346,,
1400
+ P2347,,
1401
+ P2348,,
1402
+ P2349,,
1403
+ P2352,,
1404
+ P2353,,
1405
+ P2354,,
1406
+ P2355,,
1407
+ P2356,,
1408
+ P2368,,
1409
+ P2370,,
1410
+ P2372,,
1411
+ P2374,,
1412
+ P2375,,
1413
+ P2377,,
1414
+ P2378,,
1415
+ P2380,,
1416
+ P2382,,
1417
+ P2383,,
1418
+ P2386,,
1419
+ P2387,,
1420
+ P2389,,
1421
+ P2390,,
1422
+ P2392,,
1423
+ P2394,,
1424
+ P2395,,
1425
+ P2397,,
1426
+ P2398,,
1427
+ P2399,,
1428
+ P2401,,
1429
+ P2403,,
1430
+ P2404,,
1431
+ P2405,,
1432
+ P2406,,
1433
+ P2407,,
1434
+ P2410,,
1435
+ P2411,,
1436
+ P2413,,
1437
+ P2415,,
1438
+ P2416,,
1439
+ P2417,,
1440
+ P2419,,
1441
+ P2420,,
1442
+ P2422,,
1443
+ P2424,,
1444
+ P2425,,
1445
+ P2428,,
1446
+ P2432,,
1447
+ P2433,,
1448
+ P2435,,
1449
+ P2436,,
1450
+ P2437,,
1451
+ P2441,,
1452
+ P2442,,
1453
+ P2443,,
1454
+ P2445,,
1455
+ P2446,,
1456
+ P2448,,
1457
+ P2449,,
1458
+ P2450,,
1459
+ P2451,,
1460
+ P2452,,
1461
+ P2453,,
1462
+ P2454,,
1463
+ P2456,,
1464
+ P2457,,
1465
+ P2459,,
1466
+ P2463,,
1467
+ P2464,,
1468
+ P2465,,
1469
+ P2467,,
1470
+ P2468,,
1471
+ P2469,,
1472
+ P2471,,
1473
+ P2473,,
1474
+ P2474,,
1475
+ P2477,,
1476
+ P2478,,
1477
+ P2479,,
1478
+ P2480,,
1479
+ P2482,,
1480
+ P2483,,
1481
+ P2487,,
1482
+ P2488,,
1483
+ P2491,,
1484
+ P2492,,
1485
+ P2493,,
1486
+ P2494,,
1487
+ P2495,,
1488
+ P2496,,
1489
+ P2497,,
1490
+ P2501,,
1491
+ P2504,,
1492
+ P2506,,
1493
+ P2507,,
1494
+ P2508,,
1495
+ P2509,,
1496
+ P2511,,
1497
+ P2512,,
1498
+ P2515,,
1499
+ P2516,,
1500
+ P2518,,
1501
+ P2522,,
1502
+ P2524,,
1503
+ P2525,,
1504
+ P2527,,
1505
+ P2528,,
1506
+ P2529,,
1507
+ P2530,,
1508
+ P2531,,
1509
+ P2532,,
1510
+ P2533,,
1511
+ P2535,,
1512
+ P2536,,
1513
+ P2537,,
1514
+ P2538,,
1515
+ P2540,,
1516
+ P2541,,
1517
+ P2542,,
1518
+ P2543,,
1519
+ P2544,,
1520
+ P2545,,
1521
+ P2546,,
1522
+ P2547,,
1523
+ P2549,,
1524
+ P2550,,
1525
+ P2551,,
1526
+ P2552,,
1527
+ P2553,,
1528
+ P2554,,
1529
+ P2555,,
1530
+ P2557,,
1531
+ P2558,,
1532
+ P2559,,
1533
+ P2560,,
1534
+ P2561,,
1535
+ P2562,,
1536
+ P2563,,
1537
+ P2564,,
1538
+ P2566,,
1539
+ P2567,,
1540
+ P2569,,
1541
+ P2572,,
1542
+ P2573,,
1543
+ P2576,,
1544
+ P2578,,
1545
+ P2582,,
1546
+ P2583,,
1547
+ P2584,,
1548
+ P2585,,
1549
+ P2586,,
1550
+ P2587,,
1551
+ P2588,,
1552
+ P2589,,
1553
+ P2590,,
1554
+ P2592,,
1555
+ P2594,,
1556
+ P2597,,
1557
+ P2598,,
1558
+ P2603,,
1559
+ P2605,,
1560
+ P2606,,
1561
+ P2608,,
1562
+ P2609,,
1563
+ P2611,,
1564
+ P2612,,
1565
+ P2613,,
1566
+ P2614,,
1567
+ P2617,,
1568
+ P2618,,
1569
+ P2622,,
1570
+ P2623,,
1571
+ P2624,,
1572
+ P2625,,
1573
+ P2627,,
1574
+ P2628,,
1575
+ P2629,,
1576
+ P2631,,
1577
+ P2635,,
1578
+ P2636,,
1579
+ P2637,,
1580
+ P2638,,
1581
+ P2639,,
1582
+ P2640,,
1583
+ P2641,,
1584
+ P2644,,
1585
+ P2645,,
1586
+ P2650,,
1587
+ P2651,,
1588
+ P2655,,
1589
+ P2657,,
1590
+ P2658,,
1591
+ P2661,,
1592
+ P2662,,
1593
+ P2663,,
1594
+ P2664,,
1595
+ P2665,,
1596
+ P2666,,
1597
+ P2668,,
1598
+ P2669,,
1599
+ P2670,,
1600
+ P2671,,
1601
+ P2675,,
1602
+ P2676,,
1603
+ P2677,,
1604
+ P2678,,
1605
+ P2679,,
1606
+ P2680,,
1607
+ P2681,,
1608
+ P2683,,
1609
+ P2685,,
1610
+ P2686,,
1611
+ P2688,,
1612
+ P2689,,
1613
+ P2690,,
1614
+ P2697,,
1615
+ P2700,,
1616
+ P2701,,
1617
+ P2702,,
1618
+ P2706,,
1619
+ P2707,,
1620
+ P2708,,
1621
+ P2710,,
1622
+ P2711,,
1623
+ P2713,,
1624
+ P2714,,
1625
+ P2716,,
1626
+ P2717,,
1627
+ P2719,,
1628
+ P2720,,
1629
+ P2724,,
1630
+ P2727,,
1631
+ P2729,,
1632
+ P2731,,
1633
+ P2732,,
1634
+ P2734,,
1635
+ P2737,,
1636
+ P2738,,
1637
+ P2739,,
1638
+ P2740,,
1639
+ P2741,,
1640
+ P2742,,
1641
+ P2744,,
1642
+ P2745,,
1643
+ P2746,,
1644
+ P2747,,
1645
+ P2749,,
1646
+ P2750,,
1647
+ P2751,,
1648
+ P2753,,
1649
+ P2754,,
1650
+ P2758,,
1651
+ P2759,,
1652
+ P2760,,
1653
+ P2761,,
1654
+ P2762,,
1655
+ P2763,,
1656
+ P2764,,
1657
+ P2765,,
1658
+ P2767,,
1659
+ P2768,,
1660
+ P2769,,
1661
+ P2772,,
1662
+ P2776,,
1663
+ P2780,,
1664
+ P2781,,
1665
+ P2782,,
1666
+ P2783,,
1667
+ P2784,,
1668
+ P2787,,
1669
+ P2788,,
1670
+ P2791,,
1671
+ P2792,,
1672
+ P2795,,
1673
+ P2797,,
1674
+ P2799,,
1675
+ P2802,,
1676
+ P2803,,
1677
+ P2804,,
1678
+ P2810,,
1679
+ P2811,,
1680
+ P2812,,
1681
+ P2813,,
1682
+ P2814,,
1683
+ P2815,,
1684
+ P2817,,
1685
+ P2818,,
1686
+ P2819,,
1687
+ P2820,,
1688
+ P2825,,
1689
+ P2827,,
1690
+ P2829,,
1691
+ P2830,,
1692
+ P2831,,
1693
+ P2832,,
1694
+ P2833,,
1695
+ P2834,,
1696
+ P2837,,
1697
+ P2839,,
1698
+ P2840,,
1699
+ P2842,,
1700
+ P2843,,
1701
+ P2845,,
1702
+ P2846,,
1703
+ P2848,,
1704
+ P2850,,
1705
+ P2852,,
1706
+ P2854,,
1707
+ P2855,,
1708
+ P2856,,
1709
+ P2858,,
1710
+ P2859,,
1711
+ P2860,,
1712
+ P2861,,
1713
+ P2862,,
1714
+ P2863,,
1715
+ P2864,,
1716
+ P2865,,
1717
+ P2867,,
1718
+ P2868,,
1719
+ P2869,,
1720
+ P2871,,
1721
+ P2872,,
1722
+ P2873,,
1723
+ P2875,,
1724
+ P2876,,
1725
+ P2877,,
1726
+ P2878,,
1727
+ P2879,,
1728
+ P2881,,
1729
+ P2883,,
1730
+ P2885,,
1731
+ P2886,,
1732
+ P2889,,
1733
+ P2891,,
1734
+ P2893,,
1735
+ P2894,,
1736
+ P2896,,
1737
+ P2897,,
1738
+ P2898,,
1739
+ P2899,,
1740
+ P2900,,
1741
+ P2901,,
1742
+ P2902,,
1743
+ P2907,,
1744
+ P2908,,
1745
+ P2911,,
1746
+ P2912,,
1747
+ P2913,,
1748
+ P2914,,
1749
+ P2916,,
1750
+ P2918,,
1751
+ P2919,,
1752
+ P2920,,
1753
+ P2921,,
1754
+ P2923,,
1755
+ P2924,,
1756
+ P2925,,
1757
+ P2926,,
1758
+ P2927,,
1759
+ P2929,,
1760
+ P2930,,
1761
+ P2931,,
1762
+ P2932,,
1763
+ P2933,,
1764
+ P2934,,
1765
+ P2938,,
1766
+ P2940,,
1767
+ P2941,,
1768
+ P2943,,
1769
+ P2945,,
1770
+ P2947,,
1771
+ P2948,,
1772
+ P2949,,
1773
+ P2951,,
1774
+ P2952,,
1775
+ P2954,,
1776
+ P2955,,
1777
+ P2956,,
1778
+ P2959,,
1779
+ P2960,,
1780
+ P2962,,
1781
+ P2966,,
1782
+ P2968,,
1783
+ P2969,,
1784
+ P2970,,
1785
+ P2971,,
1786
+ P2974,,
1787
+ P2975,,
1788
+ P2976,,
1789
+ P2977,,
1790
+ P2978,,
1791
+ P2982,,
1792
+ P2984,,
1793
+ P2985,,
1794
+ P2986,,
1795
+ P2988,,
1796
+ P2993,,
1797
+ P2994,,
1798
+ P2996,,
1799
+ P2997,,
1800
+ P2998,,
1801
+ P3000,,
data/splits/probes/synthetic/exp3_2_probe_split_summary.csv ADDED
@@ -0,0 +1,4 @@
 
 
 
 
 
1
+ Split,Rows,Unique_Paragraphs,Unique_Tuples,Probe_1_Rows,Probe_2_Rows,Probe_3_Rows,Probe_4_Rows,Probe_5_Rows
2
+ train,22301,1790,4471,4460,4461,4463,4453,4464
3
+ test,11220,898,2245,2245,2245,2245,2240,2245
4
+ validation,3747,300,750,750,750,750,748,749
data/splits/probes/synthetic/exp3_2_probe_test.csv ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:dcf200d81df4f78f8ccfc35533c3f45625fb4bef826038c26141d93bf80314ef
3
+ size 12444562
data/splits/probes/synthetic/exp3_2_probe_train.csv ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:2cebc26be63a858c559601f2fac42bf363eed0bdf0726fee7c77317ef39ad99a
3
+ size 24711508
data/splits/probes/synthetic/exp3_2_probe_validation.csv ADDED
The diff for this file is too large to render. See raw diff
 
data_dictionary.md ADDED
@@ -0,0 +1,27 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ # Data dictionary
2
+
3
+ Canonical probe tables use these fields:
4
+
5
+ | Field | Meaning |
6
+ |---|---|
7
+ | `Domain` | Synthetic, PubMed, or Reddit |
8
+ | `Paragraph_ID` | Stable paragraph identifier |
9
+ | `Source_Document_ID` | Grouping identifier used to keep source material together |
10
+ | `Tuple_ID` | Base conditional-tuple/family identifier |
11
+ | `ProbeID` | Unique individual probe identifier |
12
+ | `Probe_Number` | Integer P1–P5 |
13
+ | `Probe_Type` | Named transformation used to form the probe |
14
+ | `Paragraph` | Evidence text |
15
+ | `Probe_Question` | Handcrafted probe claim/question |
16
+ | `Gold_Label` | Supported, Not Supported, or Not Enough Evidence |
17
+
18
+ Prediction files add `predicted_label` and omit raw generations. The run manifest
19
+ maps every result row to its prediction file and records model, train domain, test
20
+ domain, training fraction, and prompt template.
21
+
22
+ For PubMed, `Source_Document_ID` is derived from the benchmark paragraph prefix
23
+ (for example `P12PR3` groups under `P12`). It is a stable internal grouping key, not
24
+ a claimed PMID. Synthetic and Reddit canonical files use the paragraph identifier
25
+ as a conservative grouping key; the domain split CSVs preserve any more specific
26
+ source identifiers recorded during split construction.
27
+
probe_construction.md ADDED
@@ -0,0 +1,24 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ # P1–P5 probe construction
2
+
3
+ Probes were handcrafted from each base conditional relation tuple. They were not
4
+ generated by a model, so there is no probe-generation prompt or generator to run.
5
+ Each tuple family has five intended claims:
6
+
7
+ | Probe | Transformation | Gold label |
8
+ |---|---|---|
9
+ | P1 | Contradict the relation | Not Supported |
10
+ | P2 | Replace the condition | Not Enough Evidence |
11
+ | P3 | Remove the condition | Not Enough Evidence |
12
+ | P4 | Preserve the original condition-scoped relation | Supported |
13
+ | P5 | Contradict the condition | Not Supported |
14
+
15
+ Boundary rule: the label concerns whether the complete claim is licensed in the
16
+ given paragraph. General plausibility outside the supplied text is irrelevant.
17
+ `Tuple_ID` is the family key and `ProbeID` identifies the individual claim. The
18
+ canonical files in `data/probes/` contain the released claim text and label.
19
+
20
+ There was no distinct machine-readable “manual filtering and audit decisions” file.
21
+ The deposited canonical rows reflect the completed manual construction. The review
22
+ spreadsheets retained in `provenance/manual_review_sources/` are contextual source
23
+ materials and should not be described as an exhaustive decision ledger.
24
+
split_protocol.md ADDED
@@ -0,0 +1,26 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ # Split protocol
2
+
3
+ Train, validation, and test partitions use 60%, 10%, and 30% of unique paragraph
4
+ groups, respectively. The deposited assignment CSVs are the authoritative allocation
5
+ and remove any dependence on library-specific random shuffling.
6
+
7
+ All rows sharing a `Paragraph_ID` stay together. Since every `Tuple_ID` belongs to a
8
+ single paragraph, this also keeps every P1–P5 tuple family together and prevents
9
+ tuple-family leakage. Reddit extraction additionally groups by `Document_ID` where
10
+ that identifier is available. `src/validation/validate_splits.py` checks these
11
+ invariants across all released partitions.
12
+
13
+ `src/preprocessing/materialize_probe_splits.py` rebuilds probe partitions directly
14
+ from a canonical probe table and the deposited assignments. Example:
15
+
16
+ ```bash
17
+ python src/preprocessing/materialize_probe_splits.py \
18
+ --probes data/probes/pubmed_probes.csv \
19
+ --assignments data/splits/probes/pubmed/split_assignments.csv \
20
+ --output-dir /tmp/pubmed_splits
21
+ ```
22
+
23
+ Synthetic assignments are in
24
+ `data/splits/probes/synthetic/exp3_2_probe_split_assignments.csv`; PubMed and Reddit
25
+ use `split_assignments.csv` in their domain directories.
26
+